DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11q14.1	11	78008566	intergenic	INTS4 - KCTD14	ENSG00000149262	ENSG00000151364		13895	7149	rs10899426-?	rs10899426	0	10899426	intergenic_variant	1	NR	2E-7	6.698970004336019		2.74		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13492506	PTH	PTH			ENSG00000152266			rs6256-?	rs6256	0	6256	stop_gained	0	NR	1E-6	6.0		1.93		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13553087	intergenic	PTH - HMGN2P36	ENSG00000152266	ENSG00000228901		56906	57276	rs10832063-?	rs10832063	0	10832063	intergenic_variant	1	NR	5E-6	5.301029995663981		1.8		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13401400	BTBD10	BTBD10			ENSG00000148925			rs10500780-?	rs10500780	0	10500780	intron_variant	0	NR	5E-6	5.301029995663981		1.79		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	10p12.1	10	26722183	PDSS1	PDSS1			ENSG00000148459			rs1564271-?	rs1564271	0	1564271	intron_variant	0	NR	9E-6	5.045757490560675		1.62		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	11q14.1	11	78008566	intergenic	INTS4 - KCTD14	ENSG00000149262	ENSG00000151364		13895	7149	rs10899426-?	rs10899426	0	10899426	intergenic_variant	1	NR	9E-6	5.045757490560675		2.29		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	6p25.3	6	1492427	intergenic	FOXF2 - RN7SL352P	ENSG00000137273	ENSG00000243439		96824	14895	rs4618572-?	rs4618572	0	4618572	intergenic_variant	1	NR	9E-6	5.045757490560675		1.86		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	3q23	3	141643383	intergenic	RASA2 - LINC02618	ENSG00000155903	ENSG00000242104		28039	17153	rs295315-?	rs295315	0	295315	intergenic_variant	1	NR	8E-7	6.096910013008056		1.82		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	10q23.1	10	80608465	SH2D4B	SH2D4B			ENSG00000178217			rs17693104-?	rs17693104	0	17693104	intron_variant	0	NR	8E-7	6.096910013008056		1.65		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	3q23	3	141658488	LOC646730	RASA2 - LINC02618	ENSG00000155903	ENSG00000242104		43144	2048	rs868767-?	rs868767	0	868767	upstream_gene_variant	1	NR	2E-6	5.698970004336019		2.12		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	20p11.21	20	24451198	intergenic	GAPDHP53 - SYNDIG1	ENSG00000234069	ENSG00000101463		4884	18431	rs2050203-?	rs2050203	0	2050203	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.78		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	14q32.31	14	101629499	intergenic	DIO3 - LINC02320	ENSG00000197406	ENSG00000258404		66047	4955	rs11621975-?	rs11621975	0	11621975	intron_variant	1	NR	5E-6	5.301029995663981		2.31		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	12q23.2	12	102981636	intergenic	ASCL1 - NA	ENSG00000139352			21123		rs17548007-?	rs17548007	0	17548007	intergenic_variant	1	NR	5E-6	5.301029995663981		1.86		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	8q21.13	8	81290982	intergenic	FABP5 - NA	ENSG00000164687			6205		rs202280-?	rs202280	0	202280	intergenic_variant	1	NR	6E-6	5.221848749616356		2.0		Illumina [636555]	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29492	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	5E-7	6.301029995663981		1.4226197	[1.23974783491848-1.63246639995579]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	4q32.3	4	164987569	NR	TRIM61 - TRIM60	ENSG00000183439	ENSG00000176979		9901	28889	rs4691139-G	rs4691139	0	4691139	non_coding_transcript_exon_variant	1	0.467	4E-7	6.3979400086720375		1.1581223	[1.09413051760919-1.22585676557555]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	9p22.2	9	16915876	NR	BNC2 - NA	ENSG00000173068			45033		rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	1E-14	14.0		1.3346913	[1.24035297950519-1.43620468676761]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	7E-6	5.154901959985743		1.1804551	[1.0983093028467-1.26874471717965]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	4E-14	13.397940008672037		1.1120843	[1.08193543636327-1.14307327686388]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	4E-14	13.397940008672037		1.1121821	[1.0819829343715-1.14322428681774]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29492	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	5E-38	37.30102999566398		1.4494933	[1.3698151996842-1.53380589540381]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	4q26	4	119028805	NR	SYNPO2			ENSG00000172403			rs17329882-C	rs17329882	0	17329882	intron_variant	0	0.241	3E-6	5.522878745280337		1.07509	[1.0431816063-1.1079744406]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	3E-8	7.522878745280337		1.0865872	[1.05501477967445-1.11910451351639]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	7E-10	9.154901959985743		1.0913801	[1.06151189081851-1.12208885346329]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	2E-8	7.698970004336019		1.1555611	[1.09892839652449-1.21511227508431]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	7E-16	15.154901959985743		1.1769707	[1.13116083835271-1.22463593511406]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - NA	ENSG00000173068			45033		rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	9E-36	35.045757490560675		1.2424945	[1.20065901834152-1.28578755258347]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	8E-10	9.096910013008056		1.1083262	[1.07253217567565-1.14531490798434]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911	intron_variant	0	0.309302	8E-10	9.096910013008056		1.0908245	[1.06101278339562-1.12147377629663]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	15q26.1	15	90963407	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282	2633	rs8037137-C	rs8037137	0	8037137	intergenic_variant	1	0.134	5E-7	6.301029995663981		1.098901	[1.06-1.15]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	17q11.2	17	30854203	NR	ATAD5			ENSG00000176208			rs143663961-A	rs143663961	0	143663961	intron_variant	0	0.72942	1E-7	7.0		1.0819896	[1.05072828447598-1.11418107368593]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	2E-13	12.698970004336019		1.1339011	[1.09660984313914-1.1724605092959]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	8E-13	12.096910013008056		1.1105318	[1.07914609971847-1.14283031731538]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	2E-17	16.69897000433602		1.1302502	[1.09887004937136-1.1625264094177]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.898635	3E-7	6.522878745280337		1.1211612	[1.07314763387262-1.17132308995474]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	8E-7	6.096910013008056		1.0780069	[1.04637703624974-1.11059270801828]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	6E-6	5.221848749616356		1.0621586	[1.0348111352015-1.09022867520121]	Illumina [11595112] (imputed)	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1q23.3	1	161352208	SDHC	SDHC			ENSG00000143252			rs12140361-?	rs12140361	0	12140361	intron_variant	0	NR	3E-6	5.522878745280337	(adjusted for dose, GFR & AST)	7.098	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1q22	1	156193927	SLC25A44	SEMA4A - SLC25A44	ENSG00000196189	ENSG00000160785		16175	5	rs2241111-?	rs2241111	0	2241111	TF_binding_site_variant	1	NR	6E-6	5.221848749616356		4.844	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	15q25.2	15	81554938	TMC3, MEX3B	TMC3-AS1 - NA	ENSG00000259343			36738		rs969348-?	rs969348	0	969348	intron_variant	1	NR	6E-6	5.221848749616356		5.866	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	2q14.3	2	122620366	TSN, CNTNAP5							rs7566539-?	rs7566539	0	7566539	intron_variant	1	NR	3E-6	5.522878745280337	(adjusted for dose, GFR & AST)	7.171	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	16q23.2	16	79311795	WWOX, MAF	RNA5SP431 - NA	ENSG00000222244			47222		rs9934640-?	rs9934640	0	9934640	regulatory_region_variant	1	NR	5E-6	5.301029995663981	(adjusted for dose, GFR & AST)	8.074	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	3q26.1	3	166315136	ZBBX, BCHE							rs9283636-?	rs9283636	0	9283636	intergenic_variant	1	NR	5E-7	6.301029995663981	(adjusted for dose, GFR & AST)	3.049	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	2q35	2	217010416	DIRC3, TNP1							rs12165173-?	rs12165173	0	12165173	TF_binding_site_variant	1	NR	5E-6	5.301029995663981	(adjusted for dose, GFR & AST)	1.06	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10q22.1	10	69910197	COL13A1	COL13A1			ENSG00000197467			rs12412836-?	rs12412836	0	12412836	intron_variant	0	NR	4E-6	5.3979400086720375	(adjusted for dose, GFR & AST)	0.75	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10q23.1	10	85041429	FAM190B, LOC100507470							rs12571637-?	rs12571637	0	12571637	intergenic_variant	1	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	1.59	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	14q32.2	14	96778118	PAPOLA, VRK1	LINC02299			ENSG00000258979			rs17280534-?	rs17280534	0	17280534	intron_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	7q36.1	7	151487834	RHEB	RHEB			ENSG00000106615			rs17635967-?	rs17635967	0	17635967	intron_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	6q21	6	105789630	PREP, PRDM1							rs2202766-?	rs2202766	0	2202766	intron_variant	1	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	1.47	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	15q14	15	38490292	RASGRP1	RASGRP1			ENSG00000172575			rs4313770-?	rs4313770	0	4313770	3_prime_UTR_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	4p15.2	4	27184810	STIM2, MIR4275	NA - LINC02261		ENSG00000249699			32669	rs4692174-?	rs4692174	0	4692174	intergenic_variant	1	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	0.88	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	20q11.23	20	38323940	BPI	BPI			ENSG00000101425			rs5741804-?	rs5741804	0	5741804	missense_variant	0	NR	9E-6	5.045757490560675	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	11q12.2	11	61792563	C11orf10	TMEM258			ENSG00000134825			rs7102974-?	rs7102974	0	7102974	5_prime_UTR_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	18q11.2	18	27347470	RP11-739N10	NA - UBA52P9		ENSG00000244329			7936	rs7230264-?	rs7230264	0	7230264	intron_variant	1	NR	9E-7	6.045757490560675	(adjusted for dose, GFR & AST)	0.65	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10p12.1	10	25602315	GPR158	GPR158 - GPN3P1	ENSG00000151025	ENSG00000227465		86	45255	rs7909167-?	rs7909167	0	7909167	intergenic_variant	1	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10q24.2	10	99850776	ABCC2	ABCC2			ENSG00000023839			rs8187707-?	rs8187707	0	8187707	synonymous_variant	0	NR	5E-6	5.301029995663981	(adjusted for dose, GFR & AST)	1.21	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	21q21.3	21	25631797	MRPL39, JAM2	MRPL39 - JAM2	ENSG00000154719	ENSG00000154721		24280	7461	rs9982086-?	rs9982086	0	9982086	intergenic_variant	1	NR	9E-6	5.045757490560675	(adjusted for dose, GFR & AST)	1.06	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	13q33.3	13	107290084	FAM155A	FAM155A						rs9558996-?	rs9558996	0	9558996	intron_variant	0	NR	5E-6	5.301029995663981		1.285	unit increase (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	3p14.3	3	55376983	CACNA2D3, WNT5A	LINC02030 - WNT5A	ENSG00000240708	ENSG00000114251		76245	88732	rs11130471-?	rs11130471	0	11130471	intergenic_variant	1	NR	9E-6	5.045757490560675		1.641	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	4q31.21	4	145811502	ZNF827	ZNF827			ENSG00000151612			rs17806780-?	rs17806780	0	17806780	intron_variant	0	NR	9E-6	5.045757490560675		1.484	unit increase (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	5q31.2	5	138109311	WNT8A, NME5	WNT8A - NME5	ENSG00000061492	ENSG00000112981		16946	5864	rs12516561-?	rs12516561	0	12516561	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.671	unit increase (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	17q24.3	17	69228706	ABCA10	ABCA10			ENSG00000154263			rs9302891-?	rs9302891	0	9302891	5_prime_UTR_variant	0	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	6.616	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	10q25.3	10	114642349	ABLIM1	ABLIM1			ENSG00000099204			rs2483519-?	rs2483519	0	2483519	intron_variant	0	NR	2E-6	5.698970004336019	(adjusted for dose, GFR & AST)	2.729	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	13q33.3	13	107030239	ARGLU1, FAM155A	LINC00393 - NA	ENSG00000224853			33368348		rs16969611-?	rs16969611	0	16969611	intergenic_variant	1	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	3.629	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	3q26.1	3	166329716	BCHE, ZBBX							rs1574560-?	rs1574560	0	1574560	intergenic_variant	1	NR	6E-7	6.221848749616356	(adjusted for dose, GFR & AST)	3.049	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	14q24.3	14	76937083	C14orf166B, IRF2BPL	RN7SKP17 - LINC01629	ENSG00000223174	ENSG00000258602		46470	22555	rs2056859-?	rs2056859	0	2056859	regulatory_region_variant	1	NR	2E-6	5.698970004336019		11.03	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	10q22.2	10	73894042	CAMK2G, C10orf55	CAMK2G - PLAU	ENSG00000148660	ENSG00000122861		19451	15135	rs17741873-?	rs17741873	0	17741873	intergenic_variant	1	NR	8E-6	5.096910013008056	(adjusted for dose, GFR & AST)	2.888	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	2p16.1	2	57804114	CCDC85A, VRK2	ACTG1P22 - NA	ENSG00000271615			38062		rs1851138-?	rs1851138	0	1851138	intergenic_variant	1	NR	6E-6	5.221848749616356		6.833	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1p36.12	1	20620263	CDA, PINK1	CDA - PINK1	ENSG00000158825	ENSG00000158828		1360	13195	rs1614627-?	rs1614627	0	1614627	intergenic_variant	1	NR	6E-7	6.221848749616356		7.424	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	10p14	10	8603200	GATA3	KRT8P37 - CHCHD3P1	ENSG00000213771	ENSG00000236420		88094	16733	rs9787692-?	rs9787692	0	9787692	intergenic_variant	1	NR	7E-7	6.154901959985743	(adjusted for dose, GFR & AST)	3.672	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	4q34.1	4	174644094	GLRA3	GLRA3			ENSG00000145451			rs4235212-?	rs4235212	0	4235212	intron_variant	0	NR	6E-6	5.221848749616356		2.503	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	3p26.1	3	7956266	GRM7, LOC100288428	LMCD1-AS1			ENSG00000227110			rs10510382-?	rs10510382	0	10510382	intron_variant	0	NR	6E-6	5.221848749616356		3.033	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	16p12.1	16	25955783	HS3ST4	HS3ST4			ENSG00000182601			rs9938946-?	rs9938946	0	9938946	intron_variant	0	NR	3E-6	5.522878745280337		3.774	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	18q11.2	18	26521596	KCTD1	KCTD1			ENSG00000134504			rs8083427-?	rs8083427	0	8083427	intron_variant	0	NR	3E-6	5.522878745280337		5.467	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	10p11.23	10	30080931	KIAA1462, MTPAP	JCAD			ENSG00000165757			rs2505127-?	rs2505127	0	2505127	intron_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	5.005	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1p22.3	1	87773925	LOC100505768, PKN2	PKN2-AS1			ENSG00000237505			rs17130142-?	rs17130142	0	17130142	intron_variant	0	NR	2E-7	6.698970004336019		8.641	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1p31.1	1	81208812	LPHN2	NA - RN7SKP247		ENSG00000223026			42977	rs17131753-?	rs17131753	0	17131753	non_coding_transcript_exon_variant	1	NR	7E-6	5.154901959985743		7.784	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	18q23	18	77003313	MBP	MBP			ENSG00000197971			rs470903-?	rs470903	0	470903	non_coding_transcript_exon_variant	0	NR	3E-6	5.522878745280337	(adjusted for dose, GFR & AST)	5.453	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	13q34	13	109657033	MYO16, IRS2	NA - LINC00676		ENSG00000234854			71249	rs11840576-?	rs11840576	0	11840576	intron_variant	1	NR	2E-6	5.698970004336019		8.684	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	12p13.33	12	674318	NINJ2, WNK1	NINJ2-AS1 - LINC02455	ENSG00000177406	ENSG00000256672		10122	483	rs12425791-?	rs12425791	0	12425791	intergenic_variant	1	NR	4E-6	5.3979400086720375		2.026	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	14q31.1	14	79888998	NRXN3, DIO2	NRXN3 - NA	ENSG00000021645			20707		rs2205226-?	rs2205226	0	2205226	intergenic_variant	1	NR	5E-6	5.301029995663981		4.956	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	8q23.1	8	106314611	OXR1	OXR1			ENSG00000164830			rs7013285-?	rs7013285	0	7013285	intron_variant	0	NR	3E-6	5.522878745280337	(adjusted for dose, GFR & AST)	3.067	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1q22	1	156219495	PMF1, PMF1-BGLAP	PMF1, PMF1-BGLAP			ENSG00000160783, ENSG00000260238			rs2758596-?	rs2758596	0	2758596	intron_variant	0	NR	6E-6	5.221848749616356		4.844	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	7q33	7	137259485	PTN	PTN			ENSG00000105894			rs17169015-?	rs17169015	0	17169015	intron_variant	0	NR	5E-6	5.301029995663981		18.28	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	1p35.3	1	29429306	PTPRU, MATN1	LINC01756 - NA	ENSG00000230523			79192		rs16838233-?	rs16838233	0	16838233	intergenic_variant	1	NR	4E-6	5.3979400086720375		5.346	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases	NA	14q11.2	14	20698124	RNASE4	RNASE4, EGILA, ANG			ENSG00000258818, ENSG00000258451, ENSG00000214274			rs17211649-?	rs17211649	0	17211649	intron_variant	0	NR	2E-6	5.698970004336019		14.22	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	1p36.13	1	16013277	HSPB7	SRARP - HSPB7	ENSG00000183888	ENSG00000173641		4470	751	rs1763604-C	rs1763604	0	1763604	downstream_gene_variant	1	0.42085	7E-9	8.154901959985743		0.0372	[0.025-0.05] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	1q21.3	1	155016057	ZBTB7B	ZBTB7B			ENSG00000160685			rs77548871-C	rs77548871	0	77548871	intron_variant	0	0.0472	5E-9	8.301029995663981		0.0991	[0.066-0.132] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	2p11.2	2	85573959	NR	VAMP8			ENSG00000118640			rs13007211-A	rs13007211	0	13007211	intron_variant	0	0.6935	1E-9	9.0		0.0432	[0.029-0.057] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	2q13	2	111138666	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs17041869-A	rs17041869	0	17041869	intron_variant	0	0.8804	2E-9	8.698970004336019		0.0571	[0.038-0.076] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	4q24	4	105137029	TET2	NA - TET2		ENSG00000168769			8846	rs57251748-CT	rs57251748	0	57251748	regulatory_region_variant	1	0.15	9E-12	11.045757490560675		0.0598	[0.043-0.077] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	7p15.1	7	27950149	JAZF1	JAZF1			ENSG00000153814			rs739704-A	rs739704	0	739704	intron_variant	0	0.2515	3E-14	13.522878745280337		0.0542	[0.04-0.068] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	7q35	7	144377836	ARHGEF5	ARHGEF5, ARHGEF5			ENSG00000050327, ENSG00000284933			rs720475-A	rs720475	0	720475	intron_variant	0	0.25455	7E-12	11.154901959985743		0.0495	[0.035-0.064] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	8q24.21	8	126990792	PCAT1/PCAT2	PCAT1			ENSG00000253438			rs17762342-A	rs17762342	0	17762342	intron_variant	0	0.7935	2E-15	14.698970004336019		0.061	[0.046-0.076] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	8q24.21	8	128187668	MIR1208/PVT1	PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		567	32836	rs3802173-T	rs3802173	0	3802173	intergenic_variant	1	0.2261	3E-11	10.522878745280337		0.0521	[0.037-0.068] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	9p21.3	9	21956231	CDKN2A/CDKN2B	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		18580	10698	rs9657608-T	rs9657608	0	9657608	intron_variant	1	0.0923	1E-10	10.0		0.0685	[0.048-0.089] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	10p12.31	10	22010574	DNAJC1	DNAJC1 - NA	ENSG00000136770			6805		rs7898685-A	rs7898685	0	7898685	regulatory_region_variant	1	0.2913	3E-10	9.522878745280337		0.0428	[0.029-0.056] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	10q25.3	10	113390512	HABP2	RNU7-165P - PPIAP39	ENSG00000238380	ENSG00000230018		37028	92104	rs568110-T	rs568110	0	568110	regulatory_region_variant	1	0.2057	5E-12	11.301029995663981		0.0523	[0.037-0.067] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	11q12.3	11	62126500	INCENP	INCENP			ENSG00000149503			rs7937840-T	rs7937840	0	7937840	intron_variant	0	0.26465	2E-9	8.698970004336019		0.0446	[0.03-0.059] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	11q13.2	11	66324772	NR	CD248 - RIN1	ENSG00000174807	ENSG00000174791		7728	5469	rs118151305-A	rs118151305	0	118151305	intergenic_variant	1	0.12004999999999999	6E-9	8.221848749616356		0.0672	[0.045-0.09] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	11q13.3	11	69138652	TPCN2	TPCN2 - SMIM38	ENSG00000162341	ENSG00000284713		2336	16826	rs72932523-A	rs72932523	0	72932523	intron_variant	1	0.10565	1E-9	9.0		0.0601	[0.041-0.08] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	14q32.11	14	91283251	CCDC88C	CCDC88C			ENSG00000015133			rs2277509-A	rs2277509	0	2277509	intron_variant	0	0.69865	9E-12	11.045757490560675		0.0466	[0.033-0.06] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	17q22	17	55135212	STXBP4	STXBP4			ENSG00000166263			rs2628317-A	rs2628317	0	2628317	intron_variant	0	0.72985	4E-16	15.397940008672037		0.0582	[0.044-0.072] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls	NA	19p13.11	19	19417997	GATAD2A	GATAD2A			ENSG00000167491			rs1469713-A	rs1469713	0	1469713	intron_variant	0	0.64405	1E-10	10.0		0.043	[0.03-0.056] unit decrease	Illumina [NR]	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Luteinizing hormone levels in polycystic ovary syndrome	645 European ancestry cases	607 European ancestry cases	1q31.3	1	197372771	intergenic	CRB1			ENSG00000134376			rs76169311-A	rs76169311	0	76169311	intron_variant	0	0.1	3E-7	6.522878745280337		3.75	[2.28-5.22] mIU/mL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Luteinizing hormone levels in polycystic ovary syndrome	645 European ancestry cases	607 European ancestry cases	9q22.2	9	90167763	IL6RL1, OR7E31P	IL6RP1 - OR7E31P	ENSG00000234910	ENSG00000185074		85194	48276	rs56949836-T	rs56949836	0	56949836	intergenic_variant	1	0.06	4E-7	6.3979400086720375		4.66	[2.84-6.48] mIU/mL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Luteinizing hormone levels in polycystic ovary syndrome	645 European ancestry cases	607 European ancestry cases	11p14.1	11	30204981	KCNA4, FSHB	ARL14EP-DT			ENSG00000254532			rs11031006-A	rs11031006	0	11031006	intron_variant	0	0.2	3E-16	15.522878745280337		3.19	[2.15-4.23] mIU/mL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Follicle stimulating hormone levels in polycystic ovary syndrome	647 European ancestry cases	606 European ancestry cases	2q23.3	2	152959707	intergenic	UBQLN4P2 - NA	ENSG00000226213			81940		rs77667361-T	rs77667361	0	77667361	intergenic_variant	1	0.04	5E-6	5.301029995663981		0.1	[-0.15600-0.23600] log10(mIU/mL) decrease	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Follicle stimulating hormone levels in polycystic ovary syndrome	647 European ancestry cases	606 European ancestry cases	6q13	6	69410439	intergenic	ADGRB3 - NA	ENSG00000135298			19868		rs140485756-C	rs140485756	0	140485756	intergenic_variant	1	0.03	2E-7	6.698970004336019		0.14	[0.081-0.199] log10(mIU/mL) increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Follicle stimulating hormone levels in polycystic ovary syndrome	647 European ancestry cases	606 European ancestry cases				intergenic							chr10:119956844-TCA	chr10:119956844	0			1	0.02	7E-7	6.154901959985743		0.27	[0.17-0.37] log10(mIU/mL) increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Follicle stimulating hormone levels in polycystic ovary syndrome	647 European ancestry cases	606 European ancestry cases	12p12.1	12	23857104	intergenic	SOX5			ENSG00000134532			rs112137861-A	rs112137861	0	112137861	intron_variant	0	0.05	3E-7	6.522878745280337		0.08	[0.041-0.119] log10(mIU/mL) increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Sex hormone-binding globulin levels in polycystic ovary syndrome	903 European ancestry cases	1,156 European ancestry cases				intergenic							chr10:65193342-T	chr10:65193342	0			1	0.43	2E-7	6.698970004336019		0.07	[0.050-0.090] log10 (nmol/L) decrease	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Testosterone levels in polycystic ovary syndrome	957 European ancestry cases	1,516 European ancestry cases	10p11.23	10	31088634	intergenic	ZNF438 - LINC02664	ENSG00000183621	ENSG00000272381		56697	99081	rs181791462-C	rs181791462	0	181791462	intron_variant	1	0.02	5E-6	5.301029995663981		33.08	[20.59-45.57] ng/dL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Testosterone levels in polycystic ovary syndrome	957 European ancestry cases	1,516 European ancestry cases	2p12	2	81214976	intergenic	ANKRD11P1 - NA	ENSG00000234429			13792		rs74585555-A	rs74585555	0	74585555	intergenic_variant	1	0.07	5E-7	6.301029995663981		15.56	[9.82-21.30] ng/dL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Testosterone levels in polycystic ovary syndrome	957 European ancestry cases	1,516 European ancestry cases	7q33	7	137590308	DGKI	DGKI			ENSG00000157680			rs706560-G	rs706560	0	706560	intron_variant	0	0.02	6E-6	5.221848749616356		33.29	[21.82-44.76] ng/dL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Testosterone levels in polycystic ovary syndrome	957 European ancestry cases	1,516 European ancestry cases	16p12.1	16	25557251	intergenic							rs146813585-G	rs146813585	0	146813585	intergenic_variant	1	0.04	3E-6	5.522878745280337		22.27	[14.04-30.50] ng/dL increase	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	9q33.3	9	123787676	DENND1A	DENND1A			ENSG00000119522			rs10986105-T	rs10986105	0	10986105	intron_variant	0	0.05	2E-6	5.698970004336019		1.69	[1.3-2.2]	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	2q14.3	2	123613428	LOC728241, LOC100131284	NA - ELOAP1		ENSG00000235640			81874	rs7574059-C	rs7574059	0	7574059	intergenic_variant	1	0.58	2E-7	6.698970004336019		1.19	[1.06-1.34]	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	8p23.1	8	11766380	NEIL2, GATA4, C8orf49, FDFT1	GATA4 - NEIL2	ENSG00000285109	ENSG00000154328		6378	3259	rs804279-A	rs804279	0	804279	regulatory_region_variant	1	0.26	8E-10	9.096910013008056		1.35	[1.18-1.54]	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	9q22.32	9	94917489	C9orf3, FANCC	AOPEP			ENSG00000148120			rs10993397-C	rs10993397	0	10993397	intron_variant	0	0.56	5E-13	12.301029995663981		1.37	[1.22-1.54]	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	11p14.1	11	30204981	KCNA4, FSHB, ARL14EP	ARL14EP-DT			ENSG00000254532			rs11031006-A	rs11031006	0	11031006	intron_variant	0	0.15	2E-8	7.698970004336019		1.41	[1.21-1.65]	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	11q23.2	11	114078510	ZBTB16	ZBTB16			ENSG00000109906			rs1784692-T	rs1784692	0	1784692	intron_variant	0	0.82	1E-6	6.0		1.39	[1.19-1.61]	Illumina [at least 624044] (imputed)	N
2018-02-06	26284813	Hayes MG	2015-08-18	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26284813	Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.	Polycystic ovary syndrome	984 European ancestry cases, 2,964 European ancestry controls	2,021 European ancestry cases, 2,566 European ancestry controls	12p11.22	12	28568792	LOC100130792, FAR2	CCDC91			ENSG00000123106			rs1355471-A	rs1355471	0	1355471	intron_variant	0	0.49	8E-8	7.096910013008056		1.15	[1.02-1.29]	Illumina [at least 624044] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	2p21	2	43411699	NR	THADA			ENSG00000115970			rs13429458-A	rs13429458	0	13429458	intron_variant	0	NR	4E-13	12.397940008672037		1.49	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	9q33.3	9	123762933	NR	DENND1A			ENSG00000119522			rs2479106-G	rs2479106	0	2479106	intron_variant	0	NR	5E-10	9.301029995663981		1.35	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	2p16.3	2	48751020	LHCGR	LHCGR, STON1-GTF2A1L			ENSG00000138039, ENSG00000068781			rs13405728-A	rs13405728	0	13405728	intron_variant	0	NR	4E-9	8.397940008672037		1.35	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	2p16.3	2	48974473	FSHR	FSHR			ENSG00000170820			rs2268361-C	rs2268361	0	2268361	intron_variant	0	0.504	1E-12	12.0		1.15	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	9q22.32	9	94979054	C9orf3	AOPEP			ENSG00000148120			rs3802457-G	rs3802457	0	3802457	intron_variant	0	0.904	5E-14	13.301029995663981		1.3	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	11q22.1	11	102199908	YAP1	YAP1			ENSG00000137693			rs1894116-G	rs1894116	0	1894116	intron_variant	0	0.194	1E-22	22.0		1.27	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	12q13.2	12	55996852	RAB5B, SUOX	RAB5B - SUOX	ENSG00000111540	ENSG00000139531		169	328	rs705702-G	rs705702	0	705702	upstream_gene_variant	1	0.245	9E-26	25.045757490560675		1.27	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	12q14.3	12	65830681	HMGA2	HMGA2			ENSG00000149948			rs2272046-A	rs2272046	0	2272046	intron_variant	0	0.907	2E-21	20.69897000433602		1.43	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	16q12.1	16	52313907	TOX3	CASC22 - TOX3	ENSG00000260887	ENSG00000103460		33269	122510	rs4784165-G	rs4784165	0	4784165	intergenic_variant	1	0.325	4E-11	10.397940008672037		1.15	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	19p13.2	19	7166098	INSR	INSR			ENSG00000171105			rs2059807-G	rs2059807	0	2059807	intron_variant	0	0.301	1E-8	8.0		1.14	[NR]	Affymetrix [NR] (imputed)	N
2012-10-09	22885925	Shi Y	2012-08-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22885925	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Polycystic ovary syndrome	2,254 Han Chinese ancestry cases, 3,001 Han Chinese ancestry controls	8,226 Han Chinese ancestry cases, 7,578 Han Chinese ancestry controls	20q13.2	20	53830764	SUMO1P1	NA - SUMO1P1		ENSG00000241721			44488	rs6022786-A	rs6022786	0	6022786	TF_binding_site_variant	1	0.339	2E-9	8.698970004336019		1.13	[NR]	Affymetrix [NR] (imputed)	N
2014-02-10	21964575	Rafnar T	2011-10-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21964575	Mutations in BRIP1 confer high risk of ovarian cancer.	Ovarian cancer	640 European ancestry cases, 41,607 European ancestry controls	NA	17q23.2	17	61803285	BRIP1	BRIP1			ENSG00000136492			rs34289250-C	rs34289250	0	34289250	intron_variant	0	0.0089	6E-13	12.221848749616356		7.95	[NR]	Illumina [15957390] (imputed)	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	10p11.21	10	36880367	NAMPTL, ANKRD30A	NA - MKNK2P1		ENSG00000233533			63744	rs1192691-C	rs1192691	0	1192691	intergenic_variant	1	0.54	3E-8	7.522878745280337		1.23	[1.05-1.43]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	12q14.2	12	63871057	SRGAP1	SRGAP1			ENSG00000196935			rs11175194-G	rs11175194	0	11175194	intron_variant	0	0.59	1E-7	7.0		1.19	[1.02-1.39]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	9q34.2	9	133279871	SURF6, ABO	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3847	22599	rs633862-A	rs633862	0	633862	upstream_gene_variant	1	0.54	9E-7	6.045757490560675		1.19	[1.02-1.39]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	9q22.33	9	98998959	TGFBR1, COL15A1	COL15A1			ENSG00000204291			rs1413299-C	rs1413299	0	1413299	intron_variant	0	0.38	2E-8	7.698970004336019		1.2	[1.03-1.41]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	1q44	1	244077146	ZNF238, ADSS	ZBTB18 - RN7SL148P	ENSG00000179456	ENSG00000244066		19670	26786	rs2500488-C	rs2500488	0	2500488	intron_variant	1	0.33	4E-6	5.3979400086720375		1.472	[1.246-1.739]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	7q21.11	7	83667946	SEMA3E, ABCB4	RAD23BP2 - NA	ENSG00000230244			3321		rs6976769-C	rs6976769	0	6976769	intergenic_variant	1	.05	4E-6	5.3979400086720375		1.458	[1.056-2.012]	Illumina [710714]	N
2017-03-27	27506219	Wang W	2016-08-09	Reprod Sci	www.ncbi.nlm.nih.gov/pubmed/27506219	Pooling-Based Genome-Wide Association Study Identifies Risk Loci in the Pathogenesis of Ovarian Endometrioma in Chinese Han Women.	Endometriosis	50 Chinese Han ancestry cases, 50 Chinese Han ancestry uterine myoma or hydrosalpinx controls	1,466 Chinese Han ancestry cases, 1,410 Chinese Han ancestry uterine myoma or hydrosalpinx controls	2p14	2	66496567	MEIS1	MEIS1			ENSG00000143995			rs11692361-?	rs11692361	0	11692361	intron_variant	0	NR	4E-7	6.3979400086720375		1.4388489	[1.25-1.65]	Affymetrix [906600]	N
2017-03-27	27506219	Wang W	2016-08-09	Reprod Sci	www.ncbi.nlm.nih.gov/pubmed/27506219	Pooling-Based Genome-Wide Association Study Identifies Risk Loci in the Pathogenesis of Ovarian Endometrioma in Chinese Han Women.	Endometriosis	50 Chinese Han ancestry cases, 50 Chinese Han ancestry uterine myoma or hydrosalpinx controls	1,466 Chinese Han ancestry cases, 1,410 Chinese Han ancestry uterine myoma or hydrosalpinx controls	7p22.3	7	999367	C7orf50	C7orf50			ENSG00000146540			rs10256972-?	rs10256972	0	10256972	intron_variant	0	NR	3E-6	5.522878745280337		1.29	[1.162-1.433]	Affymetrix [906600]	N
2017-03-27	27506219	Wang W	2016-08-09	Reprod Sci	www.ncbi.nlm.nih.gov/pubmed/27506219	Pooling-Based Genome-Wide Association Study Identifies Risk Loci in the Pathogenesis of Ovarian Endometrioma in Chinese Han Women.	Endometriosis	50 Chinese Han ancestry cases, 50 Chinese Han ancestry uterine myoma or hydrosalpinx controls	1,466 Chinese Han ancestry cases, 1,410 Chinese Han ancestry uterine myoma or hydrosalpinx controls	15q26.3	15	98903403	IGF1R	IGF1R			ENSG00000140443			rs4966038-?	rs4966038	0	4966038	intron_variant	0	NR	2E-9	8.698970004336019		1.378	[1.242-1.529]	Affymetrix [906600]	N
2017-03-27	27506219	Wang W	2016-08-09	Reprod Sci	www.ncbi.nlm.nih.gov/pubmed/27506219	Pooling-Based Genome-Wide Association Study Identifies Risk Loci in the Pathogenesis of Ovarian Endometrioma in Chinese Han Women.	Endometriosis	50 Chinese Han ancestry cases, 50 Chinese Han ancestry uterine myoma or hydrosalpinx controls	1,466 Chinese Han ancestry cases, 1,410 Chinese Han ancestry uterine myoma or hydrosalpinx controls	18q12.2	18	35977503	C18orf21	C18orf21			ENSG00000141428			rs2276314-?	rs2276314	0	2276314	missense_variant	0	NR	7E-6	5.154901959985743		1.3140606	[1.17-1.48]	Affymetrix [906600]	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls	NA	3p26.1	3	7963141	LOC101927394	LMCD1-AS1			ENSG00000227110			rs7643459-T	rs7643459	0	7643459	intron_variant	0	0.362	8E-7	6.096910013008056		1.4	[1.22-1.60]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls	NA	4q13.3	4	69576447	UGT2A2	UGT2B4 - UGT2A1	ENSG00000156096	ENSG00000173610		50433	11970	rs4286604-G	rs4286604	0	4286604	intron_variant	1	0.732	9E-7	6.045757490560675		1.4492754	[1.25-1.69]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls	NA	5q34	5	168286995	WWC1	CTB-178M22.2 - WWC1	ENSG00000253978	ENSG00000113645		17580	4650	rs142091544-T	rs142091544	0	142091544	regulatory_region_variant	1	0.034	9E-7	6.045757490560675		3.22	[2.02-5.13]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls	NA	10p15.1	10	5049762	AKR1C3	AKR1C3			ENSG00000196139			rs4525119-C	rs4525119	0	4525119	intron_variant	0	0.669	5E-7	6.301029995663981		1.4285715	[1.23-1.64]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls	NA	5q11.2	5	53348817	FST							rs37792-A	rs37792	0	37792	intergenic_variant	1	0.658	6E-8	7.221848749616356		1.5384616	[1.32-1.82]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls	NA	Xq27.2	X	141990766	MAGEC1	MAGEC1 - NA	ENSG00000155495			81392		rs57403204-G	rs57403204	0	57403204	intron_variant	1	0.064	2E-7	6.698970004336019		2.62	[1.83-3.76]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls	NA	10p15.2	10	3641956	LOC105376360							rs79079890-G	rs79079890	0	79079890	intergenic_variant	1	0.032	3E-7	6.522878745280337		3.2	[2.05-4.99]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls	NA	17q25.1	17	76359184	PRPSAP1	PRPSAP1			ENSG00000161542			rs66459581-A	rs66459581	0	66459581	intron_variant	0	0.234	5E-7	6.301029995663981		1.63	[1.35-1.97]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls	NA	15q12	15	26986803	GABRG3	GABRG3			ENSG00000182256			rs116046250-G	rs116046250	0	116046250	intron_variant	0	0.046	9E-7	6.045757490560675		2.95	[1.92-4.54]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls	NA	4q21.21	4	79376097	LOC105377300, GK2	NAA11 - GK2	ENSG00000156269	ENSG00000196475		50036	30264	rs192876988-C	rs192876988	0	192876988	intergenic_variant	1	0.046	9E-7	6.045757490560675		3.01	[1.94-4.68]	Illumina [11083029] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	ENSG00000107404	ENSG00000162576		2257	1014	rs186507655-A	rs186507655	0	186507655	regulatory_region_variant	1	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212373	MTX1	MTX1			ENSG00000173171			rs2075570-T	rs2075570	0	2075570	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3p24.1	3	27285723	NEK10	NEK10			ENSG00000163491			rs481519-T	rs481519	0	481519	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	4q24	4	105140377	Intergenic	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606	5498	rs7679673-A	rs7679673	0	7679673	intron_variant	1	NR	1E-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5p15.33	5	1282299	TERT	TERT			ENSG00000164362			rs7725218-A	rs7725218	0	7725218	intron_variant	0	NR	2E-10	9.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5q11.2	5	56737113	Intergenic	NA - MAP3K1		ENSG00000095015			78436	rs1862626-T	rs1862626	0	1862626	intergenic_variant	1	NR	4E-12	11.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	29785031	Intergenic	IFITM4P - HLA-V	ENSG00000233023	ENSG00000223606		33883	5923	rs147680653-G	rs147680653	1	9258375	intergenic_variant	1	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	5E-7	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		45362	6868	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	3E-7	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	6E-8	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	10q26.13	10	121575416	FGFR2	FGFR2			ENSG00000066468			rs11200014-A	rs11200014	0	11200014	intron_variant	0	NR	8E-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q13.3	11	69227030	Intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67278	67121	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	4E-14	13.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103813371	Intergenic	NA - MIR4693		ENSG00000264200			36535	rs148883465-G	rs148883465	0	148883465	intron_variant	1	NR	3E-8	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.12	12	49251457	TUBA1C	TUBA1C			ENSG00000167553			rs11168936-C	rs11168936	0	11168936	intron_variant	0	NR	9E-7	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.13	12	52918828	KRT8	KRT8			ENSG00000170421			rs73110464-T	rs73110464	0	73110464	intron_variant	0	NR	2E-15	14.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	ATXN2, SH2B3			ENSG00000204842, ENSG00000111252			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32394673	BRCA2	BRCA2			ENSG00000139618			rs11571818-C	rs11571818	0	11571818	intron_variant	0	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	14q24.1	14	68559662	RAD51B	RAD51B			ENSG00000182185			rs11844632-A	rs11844632	0	11844632	intron_variant	0	NR	3E-10	9.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	7E-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-T	rs11907546	0	11907546	intergenic_variant	1	NR	3E-6	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103745837	Intergenic							rs141752671-G	rs141752671	0	141752671	intron_variant	1	NR	1E-7	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111621753	Intergenic	ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-C	rs2300206	0	2300206	intron_variant	0	NR	6E-6	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32295727	FRY	FRY			ENSG00000073910			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155216951	GBAP1	GBAP1			ENSG00000160766			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212052	MTX1	MTX1			ENSG00000173171			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q32.2	1	210816167	KCNH1	KCNH1			ENSG00000143473			rs11119608-T	rs11119608	0	11119608	intron_variant	0	NR	1E-7	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3q26.2	3	169043635	Intergenic	LINC01997 - MECOM	ENSG00000241383	ENSG00000085276		5219	39864	rs75316749-G	rs75316749	0	75316749	intergenic_variant	1	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		45362	6868	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	9E-6	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	5E-7	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6q14.1	6	80398959	Intergenic	RPL17P25 - RPSAP72	ENSG00000219547	ENSG00000219361		24390	71112	rs4604234-C	rs4604234	0	4604234	intergenic_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	21951903	Intergenic	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		14252	15026	rs12349081-A	rs12349081	0	12349081	intron_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	ATXN2, SH2B3			ENSG00000204842, ENSG00000111252			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32398489	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	NR	8E-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	1E-9	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	4E-7	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-C	rs11907546	0	11907546	intergenic_variant	1	NR	3E-9	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32265853	FRY	FRY			ENSG00000073910			rs56404467-A	rs56404467	0	56404467	intron_variant	0	NR	1E-7	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-G	rs2300206	0	2300206	intron_variant	0	NR	2E-8	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	18q21.1	18	48561565	CTIF	CTIF, CTIF			ENSG00000282825, ENSG00000134030			rs8091660-?	rs8091660	0	8091660	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4q21.21	4	78088155	FRAS1	FRAS1			ENSG00000138759			rs150303591-?	rs150303591	0	150303591	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	1q44	1	247193430	ZNF731P	ZNF731P			ENSG00000227671			rs12025262-?	rs12025262	0	12025262	intron_variant	0	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	13q21.2	13	61317943	PCDH20	NA - PCDH20		ENSG00000280165			91742	rs10674174-?	rs10674174	0	10674174	intergenic_variant	1	NR	8E-7	6.096910013008056				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	2p23.2	2	28097166	BRE	BABAM2			ENSG00000158019			rs7572644-?	rs7572644	0	7572644	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	6q12	6	65027022	EYS	EYS			ENSG00000188107			rs201083182-?	rs201083182	0	201083182	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	5q23.2	5	122442912	MGC32805, SNCAIP	SNCAIP, MGC32805			ENSG00000064692, ENSG00000250328			rs3842595-?	rs3842595	0	3842595	intron_variant	0	NR	3E-7	6.522878745280337				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4p15.33	4	13607505	BOD1L1	BOD1L1			ENSG00000038219			rs185229225-?	rs185229225	0	185229225	intron_variant	0	NR	2E-7	6.698970004336019				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	3q24	3	143384827	SLC9A9	SLC9A9			ENSG00000181804			rs201023017-?	rs201023017	0	201023017	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	10q26.11	10	119607441	TIAL1	TIAL1 - RAD1P1	ENSG00000151923	ENSG00000234569		10412	13627	rs66696671-?	rs66696671	0	66696671	intergenic_variant	1	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	2p21	2	43334641	THADA	THADA			ENSG00000115970			rs7563201-G	rs7563201	0	7563201	intron_variant	0	0.54	3E-10	9.522878745280337		1.13	[1.091.17]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	2q34	2	212529988	ERBB4	ERBB4			ENSG00000178568			rs1351592-G	rs1351592	0	1351592	intron_variant	0	0.17	1E-12	12.0		1.18	[1.131.23]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	11q22.1	11	102172509	YAP1	YAP1			ENSG00000137693			rs11225154-A	rs11225154	0	11225154	intron_variant	0	0.09	8E-11	10.096910013008056		1.22	[1.151.29]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	11p14.1	11	30204981	FSHB	ARL14EP-DT			ENSG00000254532			rs11031006-A	rs11031006	0	11031006	intron_variant	0	0.14	1E-9	9.0		1.16	[1.111.22]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	5q31.1	5	132477512	RAD50	IRF1, IRF1-AS1			ENSG00000125347, ENSG00000197536			rs13164856-T	rs13164856	0	13164856	intron_variant	0	0.73	4E-9	8.397940008672037		1.13	[1.091.18]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	12q21.2	12	75541377	KRR1	KRR1 - NA	ENSG00000111615			29741		rs1275468-C	rs1275468	0	1275468	intergenic_variant	1	0.75	2E-8	7.698970004336019		1.13	[1.081.18]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	12q13.2	12	56073803	ERBB3	RPS26 - ERBB3	ENSG00000197728	ENSG00000065361		29106	2996	rs7312770-C	rs7312770	0	7312770	upstream_gene_variant	1	0.47	2E-7	6.698970004336019		1.1	[1.061.15]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	17q12	17	39569151	ERBB2	CDK12 - NEUROD2	ENSG00000167258	ENSG00000171532		4244	34385	rs7218361-A	rs7218361	0	7218361	regulatory_region_variant	1	0.04	1E-6	6.0		1.25	[1.141.37]	Illumina [~ 9000000] (imputed)	N
2016-09-07	26416764	Day FR	2015-09-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26416764	Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.	Polycystic ovary syndrome	5,184 European ancestry cases, 82,759 European ancestry controls	374 European ancestry cases, 92,681 European ancestry controls, 1,671 cases, 6,205 controls	9q33.3	9	124101917	DENND1A	LHX2 - NA	ENSG00000106689			68616		rs10760321-A	rs10760321	0	10760321	TF_binding_site_variant	1	0.71	1E-6	6.0		1.11	[1.071.16]	Illumina [~ 9000000] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q14.1	2	113215368	PAX8	PAX8-AS1			ENSG00000189223			rs752590-?	rs752590	0	752590	intron_variant	0	0.21	3E-8	7.522878745280337		1.34	[1.21-1.49]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q31.1	2	176172583	HOXD3	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-?	rs711830	0	711830	3_prime_UTR_variant	0	0.32	8E-12	11.096910013008056		1.3	[1.20-1.40]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	19q13.2	19	39242112	IFNL3, IFNL4	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819	1441	rs688187-?	rs688187	0	688187	intergenic_variant	1	0.68	7E-13	12.154901959985743		1.4925373	[1.33-1.67]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q14.1	2	113258824	PAX8	PAX8, PAX8-AS1			ENSG00000125618, ENSG00000189223			rs72831838-?	rs72831838	0	72831838	non_coding_transcript_exon_variant	0	0.14	8E-7	6.096910013008056	(Invasive Only)	1.39	[1.22-1.58]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q31.1	2	176172583	HOXD3	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-?	rs711830	0	711830	3_prime_UTR_variant	0	0.32	8E-7	6.096910013008056	(Invasive Only)	1.26	[1.15-1.39]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	19q13.2	19	39242112	IFNL3, IFNL4	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819	1441	rs688187-?	rs688187	0	688187	intergenic_variant	1	0.68	1E-8	8.0	(Invasive Only)	1.4084507	[1.25-1.59]	Illumina [15504273] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Ovarian disease with few adhesions	1,686 European ancestry cases, 7,060 European ancestry controls.		6q26	6	161081992	MAP3K4	MAP3K4			ENSG00000085511			rs144240142-?	rs144240142	0	144240142	intron_variant	0	NR	6E-8	7.221848749616356		1.71	[1.23-2.37]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Ovarian disease with few adhesions	1,686 European ancestry cases, 7,060 European ancestry controls.		1q31.2	1	193234362	CDC73	CDC73			ENSG00000134371			rs200922190-?	rs200922190	0	200922190	intron_variant	0	NR	2E-7	6.698970004336019		1.2048193	[1.10-1.33]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Ovarian disease with few adhesions	1,686 European ancestry cases, 7,060 European ancestry controls.		10q26.11	10	117684248	EMX2	NA - LINC02674		ENSG00000234952			50262	rs855965-?	rs855965	0	855965	intergenic_variant	1	NR	4E-7	6.3979400086720375		1.2345679	[1.14-1.35]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Ovarian disease with few adhesions	1,686 European ancestry cases, 7,060 European ancestry controls.		3q13.11	3	104131556	ALCAM	RAP1BP2 - NA	ENSG00000214405			67974		rs113850637-?	rs113850637	0	113850637	intergenic_variant	1	NR	8E-7	6.096910013008056		1.28	[1.16-1.41]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	7p15.2	7	25862019	NFE2L3	TSEN15P3 - MIR148A	ENSG00000234922	ENSG00000199085		595729	87900	rs12700667-?	rs12700667	0	12700667	intergenic_variant	1	NR	2E-9	8.698970004336019		1.32	[1.20-1.46]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	3q26.31	3	174633096	NAALADL2	NAALADL2			ENSG00000177694			rs517875-?	rs517875	0	517875	intron_variant	0	NR	1E-7	7.0		1.23	[1.13-1.33]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	9p21.3	9	22162795	CDKN2BAS1	CDKN2B-AS1 - NA	ENSG00000240498			34692		rs7041895-?	rs7041895	0	7041895	intergenic_variant	1	NR	1E-7	7.0		1.26	[1.16-1.37]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	2q35	2	215435462	FNI	FN1			ENSG00000115414			rs1250258-?	rs1250258	0	1250258	intron_variant	0	NR	3E-8	7.522878745280337		1.2345679	[1.14-1.35]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	14q32.2	14	95977621	C14orf132	TUNAR - C14orf132	ENSG00000250366	ENSG00000227051		51958	61741	rs71415016-?	rs71415016	0	71415016	regulatory_region_variant	1	NR	3E-7	6.522878745280337		1.38	[1.20-1.59]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	7q31.1	7	114391119	FOXP2	FOXP2			ENSG00000128573			rs62469231-?	rs62469231	0	62469231	intron_variant	0	NR	5E-7	6.301029995663981		1.77	[1.37-2.27]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	1p36.12	1	22166394	WNT4	WNT4 - MIR4418	ENSG00000162552	ENSG00000266564		22425	99845	rs3920498-?	rs3920498	0	3920498	intergenic_variant	1	NR	6E-7	6.221848749616356		1.3	[1.18-1.43]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	6p22.3	6	19773699	ID4	LNC-LBCS			ENSG00000228412			rs6908034-?	rs6908034	0	6908034	intron_variant	0	NR	7E-7	6.154901959985743		1.3	[1.17-1.45]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	18q21.32	18	61173285	CDH20							rs12455952-?	rs12455952	0	12455952	intergenic_variant	1	NR	1E-6	6.0		1.27	[1.15-1.40]	Illumina [NR] (imputed)	N
2017-07-19	28333195	Uimari O	2017-04-01	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/28333195	Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.	Deep ovarian and/or rectovaginal disease with dense adhesions	1,364 European ancestry cases, 7,060 European ancestry controls.	NA	9q34.12	9	131022553	LAMC3	LAMC3			ENSG00000050555			rs138913144-?	rs138913144	1	61088633	intron_variant	0	NR	1E-6	6.0		1.4705882	[1.23-1.75]	Illumina [NR] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	6E-8	7.221848749616356		1.1783675	[1.11072142428685-1.25013339797474]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	3q28	3	190807727	NR	CCT6P4 - GMNC	ENSG00000232610	ENSG00000205835		91328	45010	rs9870207-A	rs9870207	0	9870207	regulatory_region_variant	1	0.691354	5E-8	7.301029995663981		1.1929355	[1.11921837700174-1.27150779447142]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	1E-9	9.0		1.2150546	[1.14168685260085-1.29313711208919]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	2E-20	19.69897000433602		1.3236618	[1.24799798080348-1.40391301421926]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	1E-16	16.0		1.465133	[1.33389097997879-1.60928789514469]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	10q24.33	10	103934543	NR	STN1 - SLK	ENSG00000107960	ENSG00000065613		16359	32597	rs7902587-T	rs7902587	0	7902587	intergenic_variant	1	0.0975691	4E-8	7.3979400086720375		1.2930167	[1.18179536270929-1.41470527615789]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	1E-6	6.0		1.1517414	[1.0876255656695-1.21963673962283]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	1E-7	7.0		1.1787505	[1.10925120766678-1.25260426998392]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	18q11.2	18	23825589	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244	intron_variant	0	0.275360999999999	4E-8	7.3979400086720375		1.1902364	[1.11903760649588-1.2659653630658]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	8q21.13	8	76408119	NR	LINC01111			ENSG00000254300			rs150293538-T	rs150293538	0	150293538	intron_variant	0	0.9784417	2E-9	8.698970004336019		2.1880746	[1.65336168482279-2.89571888582476]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	6E-6	5.221848749616356		1.1389422	[1.07652961941979-1.20497334696891]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	3E-6	5.522878745280337		1.1855859	[1.10400745880938-1.27319220749772]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA2 mutation carriers	954 European ancestry carrier cases, 11,458 European ancestry carrier controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29492	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.048	3E-7	6.522878745280337		1.85	[1.46354854927152-2.33435588308994]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA2 mutation carriers	954 European ancestry carrier cases, 11,458 European ancestry carrier controls	NA	9p22.2	9	16915876	NR	BNC2 - NA	ENSG00000173068			45033		rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	9E-11	10.045757490560675		1.5	[1.32777950250739-1.69772989025038]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29492	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.048	2E-57	56.69897000433602		1.57	[1.48-1.66]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319	3E-15	14.522878745280337		1.12	[1.09-1.15]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319	3E-15	14.522878745280337		1.12	[1.09-1.15]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	1p34.3	1	37630749	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170	intron_variant	0	0.221	1E-9	9.0		1.1	[1.07-1.13]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	18q11.2	18	23825589	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244	intron_variant	0	0.275	2E-7	6.698970004336019		1.11	[1.07-1.16]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.899	9E-6	5.045757490560675		1.1	[1.05-1.15]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	2E-8	7.698970004336019		1.086051	[1.05456961053472-1.11847227897416]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	8q24.21	8	127805637	NR	PVT1			ENSG00000249859			rs9886651-G	rs9886651	0	9886651	intron_variant	0	0.461222	2E-9	8.698970004336019		1.0802044	[1.05286500127646-1.10825354962066]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	5E-10	9.301029995663981		1.0834533	[1.05604177574809-1.1115762691869]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	3q28	3	190807727	NR	CCT6P4 - GMNC	ENSG00000232610	ENSG00000205835		91328	45010	rs9870207-A	rs9870207	0	9870207	regulatory_region_variant	1	0.691354	3E-6	5.522878745280337		1.0994674	[1.05569458307584-1.14505523813592]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	1E-7	7.0		1.0802581	[1.04978354993499-1.11161732010102]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	2E-19	18.69897000433602		1.1611373	[1.12396655984348-1.19953742102822]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	2E-17	16.69897000433602		1.1311107	[1.09941695678777-1.16371793958399]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	2E-19	18.69897000433602		1.1357577	[1.10479964302488-1.16758323338693]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian clear cell cancer	1,366 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-A	rs7405776	0	7405776	intron_variant	0	0.58811	2E-7	6.698970004336019		1.25	[1.15-1.35]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian clear cell cancer	1,366 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-T	rs11651755	0	11651755	intron_variant	0	0.513535	7E-9	8.154901959985743		1.27	[1.16-1.37]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Endometrioid ovarian cancer	2,810 European ancestry cases, 40,941 European ancestry controls	NA	5q12.3	5	66825262	NR	MAST4			ENSG00000069020			rs555025179-GACAC	rs555025179	1	56076405	intron_variant	0	0.531475	5E-8	7.301029995663981		1.18	[1.11364451527015-1.25657782750532]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	2q14.1	2	113215368	NR	PAX8-AS1			ENSG00000189223			rs752590-G	rs752590	0	752590	intron_variant	0	0.210808	2E-12	11.698970004336019		1.2968692	[1.20743024891207-1.39293308913389]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	1E-14	14.0		1.2736082	[1.19835894617868-1.35358269315725]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	1E-13	13.0		1.2623247	[1.18761263149067-1.34173680787849]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	3q23	3	139130269	NR	MRPS22			ENSG00000175110			rs112071820-GCCAG	rs112071820	0	112071820	intron_variant	0	0.283067	2E-13	12.698970004336019		1.2854952	[1.20336051010928-1.37323590882365]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	9q31.1	9	102180944	NR	NA - RNU6-329P		ENSG00000238882			75660	rs320203-A	rs320203	0	320203	intergenic_variant	1	0.850197	2E-8	7.698970004336019		1.2856314	[1.17544642545976-1.4061450991104]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-T	rs11651755	0	11651755	intron_variant	0	0.513535	2E-6	5.698970004336019		1.1539987		Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	19q13.2	19	39242112	NR	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819	1441	rs688187-A	rs688187	0	688187	intergenic_variant	1	0.312892	1E-22	22.0		1.4258754	[1.32592116400102-1.5333648423891]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	1p34.3	1	37630749	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170	intron_variant	0	0.220826	2E-7	6.698970004336019		1.099984	[1.06129080940929-1.14008804057615]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	3E-14	13.522878745280337		1.1312215	[1.09591680302958-1.16766347713436]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	2E-14	13.698970004336019		1.1323612	[1.09696977445389-1.1688944318043]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	8E-8	7.096910013008056		1.0766991	[1.04796689850078-1.10621911687371]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	6p22.1	6	28512858	NR	GPX6			ENSG00000198704			rs6456822-T	rs6456822	0	6456822	intron_variant	0	0.690887	1E-6	6.0		1.0714362	[1.04202715140265-1.10167527662683]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	4E-10	9.397940008672037		1.1702297	[1.11383386875217-1.22948084125145]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	7E-26	25.154901959985743		1.232938	[1.18577432499114-1.28197774659809]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - NA	ENSG00000173068			45033		rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	5E-64	63.30102999566398		1.3368285	[1.29251250189538-1.38266389898672]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	2E-11	10.698970004336019		1.11572	[1.08085025008502-1.15171484355914]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911	intron_variant	0	0.309302	4E-11	10.397940008672037		1.0959264	[1.06647199521962-1.12619421828606]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	2E-10	9.698970004336019		1.09	[1.06-1.12]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.48646500000000004	8E-9	8.096910013008056		1.077992	[1.05087168925156-1.10581210313382]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29492	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	3E-46	45.52287874528034		1.5885553	[1.49139660538722-1.69204355063709]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	2E-12	11.698970004336019		1.1303236	[1.09267833241685-1.16926591871766]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	6E-10	9.221848749616356		1.1067635	[1.07188995128973-1.14277166876843]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	2E-9	8.698970004336019		1.1915798	[1.12527496598389-1.26179155485818]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	2E-24	23.69897000433602		1.2746594	[1.21607733088533-1.33606352682139]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - NA	ENSG00000173068			45033		rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	3E-43	42.52287874528034		1.3252935	[1.27262437839255-1.38014255146877]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	7E-11	10.154901959985743		1.1340009	[1.0921011879635-1.17750814490349]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911	intron_variant	0	0.309302	7E-9	8.154901959985743		1.0992962	[1.06472642475689-1.13498849236897]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	15q26.1	15	90963407	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282	2633	rs8037137-C	rs8037137	0	8037137	intergenic_variant	1	0.133618999999999	1E-7	7.0		1.1235955	[1.08-1.18]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	2E-10	9.698970004336019		1.1048253	[1.07145224223974-1.13923779281726]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	1E-8	8.0		1.0903314	[1.05822261240111-1.12341446823123]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	3E-12	11.522878745280337		1.1472089	[1.10406141518038-1.19204274035159]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	1E-14	14.0		1.13894	[1.10200256244972-1.17711551141243]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	4E-24	23.397940008672037		1.1823713	[1.14473972413471-1.22123996090847]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.898635	5E-9	8.301029995663981		1.1651025	[1.10668774857942-1.22660041924]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	4E-7	6.3979400086720375		1.0926361	[1.05582163841262-1.13073417257807]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	127805637	NR	PVT1			ENSG00000249859			rs9886651-G	rs9886651	0	9886651	intron_variant	0	0.461222	8E-6	5.096910013008056		1.0710524	[1.03930535696901-1.10376916464823]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	3E-7	6.522878745280337		1.0817573	[1.04973458497305-1.11475700006623]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	4q32.3	4	166265894	NR	NA - Y_RNA		ENSG00000264495			47041	rs13113999-T	rs13113999	0	13113999	intergenic_variant	1	0.515695999999999	5E-8	7.301029995663981		1.2250321	[1.13870977824743-1.31789814351814]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	4E-9	8.397940008672037		1.2546542	[1.16419555293272-1.35214154339342]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	6E-19	18.221848749616356		1.3829999	[1.28830538018993-1.48465482476452]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	2E-12	11.698970004336019		1.4812524	[1.32210226140915-1.65956066549562]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	10q24.33	10	103934543	NR	STN1 - SLK	ENSG00000107960	ENSG00000065613		16359	32597	rs7902587-T	rs7902587	0	7902587	intergenic_variant	1	0.0975691	9E-7	6.045757490560675		1.3209459	[1.18528926703463-1.47212825755187]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	5E-6	5.301029995663981		1.1726217	[1.09521694178849-1.25549703248424]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	8E-6	5.096910013008056		1.1832383	[1.09949355363646-1.27336159916358]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	18q11.2	18	23825589	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244	intron_variant	0	0.275360999999999	9E-6	5.045757490560675		1.1853783	[1.10016620517041-1.27719049018494]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	5E-8	7.301029995663981		1.1790794	[1.11145306187694-1.25082055006039]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	3E-6	5.522878745280337		1.1861752	[1.1045500086088-1.27383238173854]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	1p34.3	1	37630749	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170	intron_variant	0	0.220826	8E-8	7.096910013008056		1.1063784	[1.06640418255445-1.14785110269475]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	8E-13	12.096910013008056		1.1268522	[1.09069613461779-1.16420663147032]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	5E-13	12.301029995663981		1.1282876	[1.09203474654839-1.16574376009934]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29492	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	4E-49	48.39794000867204		1.630706	[1.52886835426178-1.73932685946596]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	5E-12	11.301029995663981		1.1310111	[1.09226786405932-1.17112854934655]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	2E-8	7.698970004336019		1.099452	[1.06380317084564-1.13629550714478]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	9E-10	9.045757490560675		1.2026194	[1.13408089642882-1.27530001906482]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	7E-22	21.154901959985743		1.2638669	[1.20425676967645-1.32642773080558]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - NA	ENSG00000173068			45033		rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	1E-47	47.0		1.358497	[1.30256836396842-1.41682722055063]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	9q31.1	9	104094512	NR	SMC2			ENSG00000136824			rs4742903-T	rs4742903	0	4742903	intron_variant	0	0.563	6E-6	5.221848749616356		1.0740868	[1.04130585570624-1.10789968145028]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	5E-12	11.301029995663981		1.146201	[1.10275565491329-1.19135797504449]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911	intron_variant	0	0.309302	2E-8	7.698970004336019		1.09834	[1.06283348839533-1.13503280772478]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	15q26.1	15	90963407	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282	2633	rs8037137-C	rs8037137	0	8037137	intergenic_variant	1	0.133618999999999	7E-8	7.154901959985743		1.1363636	[1.09-1.19]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	3E-9	8.522878745280337		1.1008928	[1.06665802122163-1.1362263861189]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	2E-8	7.698970004336019		1.0924964	[1.05939221330271-1.12663514204283]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	8E-14	13.096910013008056		1.1383171	[1.1003320875334-1.17761354130912]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	3E-26	25.522878745280337		1.1971419	[1.15799210345029-1.23761537074498]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	4E-7	6.3979400086720375		1.0954511	[1.05748739051043-1.1347778353567]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	8E-7	6.096910013008056		1.0811644	[1.04824881016487-1.11511353852335]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	3E-13	12.522878745280337		1.1585579	[1.11378456264581-1.20513099189349]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.898635	1E-8	8.0		1.1650093	[1.10493126343643-1.22835376686122]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous ovarian cancer	1,012 European ancestry cases, 40,941 European ancestry controls	NA	8q21.13	8	76408119	NR	LINC01111			ENSG00000254300			rs150293538-T	rs150293538	0	150293538	intron_variant	0	0.978	1E-6	6.0		3.0	[1.79409543681435-5.01001565578963]	Illumina [11595112] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	Xp22.11	X	23276803	Intergenic	PDCL2P1 - PTCHD1	ENSG00000228610	ENSG00000165186		78113	58046	rs972834-?	rs972834	0	972834	intron_variant	1	NR	7E-6	5.154901959985743		1.03	[1.02-1.05]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	18q22.1	18	65045831	Intergenic							rs192503876-?	rs192503876	0	192503876	intergenic_variant	1	NR	8E-6	5.096910013008056		3.31	[1.96-5.61]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	18q22.1	18	65221472	Intergenic							rs80314337-?	rs80314337	0	80314337	intergenic_variant	1	NR	5E-6	5.301029995663981		2.89	[1.83-4.56]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	18q23	18	75985500	Intergenic							rs11873753-?	rs11873753	0	11873753	intergenic_variant	1	NR	1E-6	6.0		1.85	[1.44-2.38]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	22q13.1	22	39337237	Intergenic	RPL3 - SYNGR1	ENSG00000100316	ENSG00000100321		16848	12688	rs137657-?	rs137657	0	137657	intergenic_variant	1	NR	8E-6	5.096910013008056		1.72	[1.35-2.17]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q12.2	16	54553941	LINC02183	LINC02183			ENSG00000283304			rs79219469-?	rs79219469	0	79219469	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[1.06-1.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	17q21.31	17	43048090	BRCA1	BRCA1			ENSG00000012048			rs567534295-?	rs567534295	0	567534295	intron_variant	0	NR	5E-8	7.301029995663981		1.19	[1.12-1.26]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	1p12	1	119307920	Intergenic	WARS2-AS1 - LINC01780	ENSG00000231365	ENSG00000232650		31947	19479	rs12031579-?	rs12031579	0	12031579	intron_variant	1	NR	2E-6	5.698970004336019		1.07	[1.04-1.10]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2q36.3	2	226482173	Intergenic							rs13402729-?	rs13402729	0	13402729	regulatory_region_variant	1	NR	3E-6	5.522878745280337		1.07	[1.04-1.09]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2q37.3	2	242012658	Intergenic	LINC01237, LINC01237			ENSG00000233806, ENSG00000280686			rs7563767-?	rs7563767	0	7563767	intron_variant	0	NR	2E-6	5.698970004336019		1.03	[1.02-1.05]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	4q32.3	4	164203350	Intergenic	MARCHF1			ENSG00000145416			rs7671115-?	rs7671115	0	7671115	intron_variant	0	NR	8E-6	5.096910013008056		1.0309278	[1.02-1.04]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	5p15.32	5	5174755	Intergenic	ADAMTS16			ENSG00000145536			rs1366161-?	rs1366161	0	1366161	intron_variant	0	NR	3E-6	5.522878745280337		1.0309278	[1.02-1.05]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	5q31.3	5	143894315	Intergenic	HMHB1 - NA	ENSG00000158497			73599		rs151055883-?	rs151055883	0	151055883	intergenic_variant	1	NR	2E-6	5.698970004336019		1.08	[1.05-1.12]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	6p21.1	6	44327218	Intergenic	AARS2 - SPATS1	ENSG00000124608	ENSG00000249481		13871	15432	rs77663385-?	rs77663385	0	77663385	intron_variant	1	NR	9E-6	5.045757490560675		1.14	[1.07-1.21]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	6q24.3	6	146677054	Intergenic	ADGB			ENSG00000118492			rs7740903-?	rs7740903	0	7740903	intron_variant	0	NR	5E-7	6.301029995663981		1.1	[1.06-1.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	7q21.13	7	89698682	Intergenic	NA - RNU6-274P		ENSG00000239075			55938	rs76926936-?	rs76926936	0	76926936	intergenic_variant	1	NR	9E-6	5.045757490560675		1.07	[1.04-1.11]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	9q22.33	9	98579569	Intergenic	GABBR2			ENSG00000136928			rs73494486-?	rs73494486	0	73494486	intron_variant	0	NR	7E-6	5.154901959985743		1.05	[1.03-1.07]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	10q11.22	10	48270719	Intergenic	FRMPD2			ENSG00000170324			rs77336990-?	rs77336990	0	77336990	intron_variant	0	NR	2E-6	5.698970004336019		1.12	[1.07-1.17]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	13q13.3	13	39329007	Intergenic	LHFPL6			ENSG00000183722			rs78375425-?	rs78375425	0	78375425	intron_variant	0	NR	3E-6	5.522878745280337		1.06	[1.03-1.09]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q12.2	16	54553941	Intergenic	LINC02183			ENSG00000283304			rs79219469-?	rs79219469	0	79219469	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[1.06-1.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q21	16	63960276	Intergenic							rs9989364-?	rs9989364	0	9989364	intergenic_variant	1	NR	9E-6	5.045757490560675		1.04	[1.02-1.06]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q22.1	16	68366522	Intergenic	SMPD3			ENSG00000103056			rs141803457-?	rs141803457	0	141803457	intron_variant	0	NR	3E-6	5.522878745280337		1.13	[1.07-1.19]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q22.1	16	68497433	Intergenic	RPL35AP33 - ZFP90	ENSG00000241334	ENSG00000184939		19863	32657	rs137866923-?	rs137866923	0	137866923	intergenic_variant	1	NR	8E-7	6.096910013008056		1.15	[1.09-1.22]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	17q22	17	57289728	Intergenic	MSI2			ENSG00000153944			rs139505845-?	rs139505845	0	139505845	intron_variant	0	NR	6E-6	5.221848749616356		1.17	[1.09-1.25]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	18q12.1	18	33625004	Intergenic	ASXL3			ENSG00000141431			rs138807553-?	rs138807553	0	138807553	intron_variant	0	NR	2E-6	5.698970004336019		1.15	[1.08-1.22]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	18q23	18	75988278	Intergenic							rs78286182-?	rs78286182	0	78286182	intergenic_variant	1	NR	1E-6	6.0		1.08	[1.05-1.11]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q12.2	16	54553941	LINC02183	LINC02183			ENSG00000283304			rs79219469-?	rs79219469	0	79219469	intron_variant	0	NR	3E-8	7.522878745280337		2.25	[1.12-1.26]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	17q21.31	17	43048090	BRCA1	BRCA1			ENSG00000012048			rs567534295-?	rs567534295	0	567534295	intron_variant	0	NR	3E-8	7.522878745280337		4.75	[2.73-8.24]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	1p21.2	1	101301117	Intergenic	PPIAP7 - LINC01307	ENSG00000173810	ENSG00000231671		29754	22220	rs143623984-?	rs143623984	0	143623984	regulatory_region_variant	1	NR	9E-6	5.045757490560675		3.25	[1.93-5.48]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	1p12	1	119307920	Intergenic	WARS2-AS1 - LINC01780	ENSG00000231365	ENSG00000232650		31947	19479	rs12031579-?	rs12031579	0	12031579	intron_variant	1	NR	1E-6	6.0		1.73	[1.39-2.16]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	1q24.3	1	172183062	Intergenic	DNM3			ENSG00000197959			rs484686-?	rs484686	0	484686	intron_variant	0	NR	8E-6	5.096910013008056		1.3	[1.16-1.46]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2q32.1	2	184453308	Intergenic	MIR548AE1 - NA	ENSG00000266808			74264		rs537364753-?	rs537364753	0	537364753	intergenic_variant	1	NR	6E-6	5.221848749616356		3.06	[1.89-4.96]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2q33.3	2	205631096	Intergenic	PARD3B - NRP2	ENSG00000116117	ENSG00000118257		10934	50894	rs75693602-?	rs75693602	0	75693602	intergenic_variant	1	NR	7E-6	5.154901959985743		1.89	[1.43-2.49]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2q36.3	2	226482173	Intergenic							rs13402729-?	rs13402729	0	13402729	regulatory_region_variant	1	NR	1E-6	6.0		1.74	[1.39-2.18]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2q37.3	2	242012658	Intergenic	LINC01237, LINC01237			ENSG00000233806, ENSG00000280686			rs7563767-?	rs7563767	0	7563767	intron_variant	0	NR	2E-6	5.698970004336019		1.34	[1.19-1.51]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	3p13	3	70110053	Intergenic	SAMMSON			ENSG00000240405			rs146572601-?	rs146572601	0	146572601	intron_variant	0	NR	5E-6	5.301029995663981		2.64	[1.74-4.02]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	3p13	3	70224942	Intergenic	SAMMSON, MDFIC2			ENSG00000240405, ENSG00000242120			rs191223340-?	rs191223340	0	191223340	intron_variant	0	NR	3E-6	5.522878745280337		2.74	[1.80-4.18]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	3q26.31	3	171410134	Intergenic	TNIK			ENSG00000154310			rs150007914-?	rs150007914	0	150007914	intron_variant	0	NR	7E-6	5.154901959985743		2.23	[1.57-3.16]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	4q32.3	4	164203350	Intergenic	MARCHF1			ENSG00000145416			rs7671115-?	rs7671115	0	7671115	intron_variant	0	NR	6E-6	5.221848749616356		1.2987013	[1.16-1.45]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	4q35.1	4	185621753	Intergenic	SORBS2			ENSG00000154556			rs57490377-?	rs57490377	0	57490377	intron_variant	0	NR	9E-6	5.045757490560675		2.3	[1.59-3.32]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	5p15.32	5	5174755	Intergenic	ADAMTS16			ENSG00000145536			rs1366161-?	rs1366161	0	1366161	intron_variant	0	NR	6E-6	5.221848749616356		1.2987013	[1.16-1.45]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	5q31.2	5	139690696	Intergenic	CXXC5 - RNU6-236P	ENSG00000171604	ENSG00000200756		6814	27289	rs148570926-?	rs148570926	0	148570926	intron_variant	1	NR	3E-6	5.522878745280337		2.9	[1.86-4.52]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	5q31.3	5	143894315	Intergenic	HMHB1 - NA	ENSG00000158497			73599		rs151055883-?	rs151055883	0	151055883	intergenic_variant	1	NR	6E-7	6.221848749616356		1.99	[1.52-2.60]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	6p21.1	6	44327218	Intergenic	AARS2 - SPATS1	ENSG00000124608	ENSG00000249481		13871	15432	rs77663385-?	rs77663385	0	77663385	intron_variant	1	NR	8E-6	5.096910013008056		3.17	[1.91-5.26]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	6q24.3	6	146677054	Intergenic	ADGB			ENSG00000118492			rs7740903-?	rs7740903	0	7740903	intron_variant	0	NR	4E-7	6.3979400086720375		2.19	[1.62-2.97]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	7q21.13	7	89698682	Intergenic	NA - RNU6-274P		ENSG00000239075			55938	rs76926936-?	rs76926936	0	76926936	intergenic_variant	1	NR	8E-6	5.096910013008056		1.84	[1.41-2.41]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	8q11.21	8	48645458	Intergenic	LINC02847 - EFCAB1	ENSG00000253702	ENSG00000034239		24440	65331	rs148037216-?	rs148037216	0	148037216	intron_variant	1	NR	2E-6	5.698970004336019		3.09	[1.95-4.91]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	9q33.3	9	126011262	Intergenic	PBX3 - NA	ENSG00000167081			43885		rs147476757-?	rs147476757	0	147476757	intergenic_variant	1	NR	8E-6	5.096910013008056		2.6	[1.71-3.96]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	10q11.22	10	48270719	Intergenic	FRMPD2			ENSG00000170324			rs77336990-?	rs77336990	0	77336990	intron_variant	0	NR	2E-6	5.698970004336019		2.77	[1.82-4.20]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	13q13.3	13	39329007	Intergenic	LHFPL6			ENSG00000183722			rs78375425-?	rs78375425	0	78375425	intron_variant	0	NR	3E-6	5.522878745280337		1.62	[1.33-1.99]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	13q14.3	13	52517465	Intergenic	LINC00345 - MRPS31P4	ENSG00000235660	ENSG00000250299		28249	82654	rs141118132-?	rs141118132	0	141118132	intron_variant	1	NR	8E-6	5.096910013008056		3.12	[1.89-5.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA				Intergenic							chr14:37233727-?	chr14:37233727	0			1	NR	9E-6	5.045757490560675		3.06	[1.87-5.02]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	14q23.3	14	64414689	Intergenic	MTHFD1			ENSG00000100714			rs201368489-?	rs201368489	0	201368489	intron_variant	0	NR	4E-6	5.3979400086720375		2.8	[1.81-4.34]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q22.1	16	68366522	Intergenic	SMPD3			ENSG00000103056			rs141803457-?	rs141803457	0	141803457	intron_variant	0	NR	1E-6	6.0		3.04	[1.94-4.77]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	16q22.1	16	68497433	Intergenic	RPL35AP33 - ZFP90	ENSG00000241334	ENSG00000184939		19863	32657	rs137866923-?	rs137866923	0	137866923	intergenic_variant	1	NR	3E-7	6.522878745280337		3.82	[2.29-6.36]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	17q11.2	17	27694464	Intergenic	CPDP1 - LGALS9DP	ENSG00000264240	ENSG00000266786		16377	51668	rs572011593-?	rs572011593	0	572011593	intergenic_variant	1	NR	4E-6	5.3979400086720375		2.89	[1.84-4.55]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	17q22	17	57289728	Intergenic	MSI2			ENSG00000153944			rs139505845-?	rs139505845	0	139505845	intron_variant	0	NR	1E-6	6.0		4.52	[2.47-8.30]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	17q24.3	17	69216249	Intergenic	ABCA10			ENSG00000154263			rs146540010-?	rs146540010	0	146540010	missense_variant	0	NR	9E-6	5.045757490560675		2.84	[1.79-4.50]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	18q12.1	18	33625004	Intergenic	ASXL3			ENSG00000141431			rs138807553-?	rs138807553	0	138807553	intron_variant	0	NR	2E-6	5.698970004336019		3.57	[2.12-6.01]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Gynecologic disease (multivariate analysis)	up to 7,975 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	2p16.3	2	51836223	LOC730100	CRYGGP - CCDC12P1	ENSG00000223710	ENSG00000226366		60821	90659	rs937380553-?	rs937380553	0	937380553	intron_variant	1	NR	4E-11	10.397940008672037	(endometriosis, ovarian cancer, uterine endometriosisometrial cancer)			Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Gynecologic disease (multivariate analysis)	up to 7,975 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA				BRCA1							chr17:41200107-?	17:41200107	0			1	NR	1E-8	8.0	(ovarian cancer)			Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Gynecologic disease (multivariate analysis)	up to 7,975 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	9q22.33	9	98579569	GABBR2	GABBR2			ENSG00000136928			rs73494486-?	rs73494486	0	73494486	intron_variant	0	NR	5E-8	7.301029995663981	(uterine fibroid, ovarian cancer)			Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Gynecologic disease (multivariate analysis)	up to 7,975 Japanese ancestry cases, 39,556 Japanese ancestry controls	NA	21q22.2	21	39047396	LOC107985484	LINC01700 - RPL23AP12	ENSG00000232837	ENSG00000228861		69622	80172	rs147427629-?	rs147427629	0	147427629	intron_variant	1	NR	4E-8	7.3979400086720375	(ovarian cancer, uterine endometriosisometrial cancer)			Illumina [7645193] (imputed)	N
2020-10-15	32289280	Zhang Y	2020-04-11	Am J Obstet Gynecol	www.ncbi.nlm.nih.gov/pubmed/32289280	A genome-wide association study of polycystic ovary syndrome identified from electronic health records.	Polycystic ovary syndrome	1,735 European ancestry cases, 1,007 European, African American and unknown ancestry cases, 27,812 European ancestry controls, 23,626 European, African American and unknown ancestry controls	253 European ancestry cases, 2,161 European ancestry controls				NR							chr1:120172286-T	chr1:120172286	0			1	0.0106	6E-7	6.221848749616356		0.9817	[0.6-1.37] unit increase	NR [at least 5648769] (imputed)	N
2020-10-15	32289280	Zhang Y	2020-04-11	Am J Obstet Gynecol	www.ncbi.nlm.nih.gov/pubmed/32289280	A genome-wide association study of polycystic ovary syndrome identified from electronic health records.	Polycystic ovary syndrome	1,735 European ancestry cases, 1,007 European, African American and unknown ancestry cases, 27,812 European ancestry controls, 23,626 European, African American and unknown ancestry controls	253 European ancestry cases, 2,161 European ancestry controls				NR							chr10:96167706-A	chr10:96167706	0			1	0.0068	1E-6	6.0		1.0969	[0.65-1.54] unit increase	NR [at least 5648769] (imputed)	N
2020-10-15	32289280	Zhang Y	2020-04-11	Am J Obstet Gynecol	www.ncbi.nlm.nih.gov/pubmed/32289280	A genome-wide association study of polycystic ovary syndrome identified from electronic health records.	Polycystic ovary syndrome	1,735 European ancestry cases, 1,007 European, African American and unknown ancestry cases, 27,812 European ancestry controls, 23,626 European, African American and unknown ancestry controls	253 European ancestry cases, 2,161 European ancestry controls	6q25.3	6	159477229	SOD2	LINC02529 - NA	ENSG00000234777			76082		rs17186366-C	rs17186366	0	17186366	intron_variant	1	0.084	3E-8	7.522878745280337		1.37	[1.23-1.54]	NR [at least 5648769] (imputed)	N
2020-10-15	32289280	Zhang Y	2020-04-11	Am J Obstet Gynecol	www.ncbi.nlm.nih.gov/pubmed/32289280	A genome-wide association study of polycystic ovary syndrome identified from electronic health records.	Polycystic ovary syndrome	1,735 European ancestry cases, 1,007 European, African American and unknown ancestry cases, 27,812 European ancestry controls, 23,626 European, African American and unknown ancestry controls	253 European ancestry cases, 2,161 European ancestry controls	2q34	2	211427047	ERBB4	ERBB4			ENSG00000178568			rs113168128-A	rs113168128	0	113168128	intron_variant	0	0.021	5E-8	7.301029995663981		1.72	[1.42-2.10]	NR [at least 5648769] (imputed)	N
2020-10-15	32289280	Zhang Y	2020-04-11	Am J Obstet Gynecol	www.ncbi.nlm.nih.gov/pubmed/32289280	A genome-wide association study of polycystic ovary syndrome identified from electronic health records.	Polycystic ovary syndrome	1,735 European ancestry cases, 1,007 European, African American and unknown ancestry cases, 27,812 European ancestry controls, 23,626 European, African American and unknown ancestry controls	253 European ancestry cases, 2,161 European ancestry controls	3q25.1	3	149602086	WWTR1	WWTR1			ENSG00000018408			rs144248326-C	rs144248326	0	144248326	intron_variant	0	0.0103	8E-7	6.096910013008056		2.13	[1.56-2.86]	NR [at least 5648769] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (reproductive subtype)	123 European ancestry cases, 2,964 European ancestry controls	84 European ancestry cases, 1,134 European ancestry controls	1p36.21	1	14404304	KAZN, PRDM2	KAZN-AS1, KAZN			ENSG00000234593, ENSG00000189337			rs78025940-A	rs78025940	0	78025940	intron_variant	0	0.02	2E-10	9.698970004336019		4.75	[2.82-7.98]	Illumina [NR] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (reproductive subtype)	123 European ancestry cases, 2,964 European ancestry controls	84 European ancestry cases, 1,134 European ancestry controls	2q37.3	2	236518238	IQCA1	IQCA1 - ACKR3	ENSG00000132321	ENSG00000144476		10703	49549	rs76182733-G	rs76182733	0	76182733	regulatory_region_variant	1	0.01	3E-9	8.522878745280337		5.68	3.00-10.78	Illumina [NR] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (reproductive subtype)	123 European ancestry cases, 2,964 European ancestry controls	84 European ancestry cases, 1,134 European ancestry controls	4q22.3	4	95183520	BMPR1B, UNC5C	UNC5C			ENSG00000182168			rs17023134-G	rs17023134	0	17023134	intron_variant	0	0.05	1E-8	8.0		3.02	2.06-4.42	Illumina [NR] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (reproductive subtype)	123 European ancestry cases, 2,964 European ancestry controls	84 European ancestry cases, 1,134 European ancestry controls	5p14.1	5	24728347	CDH10	CDH10 - BTG4P1	ENSG00000040731	ENSG00000248156		83369	58495	rs7735176-A	rs7735176	0	7735176	intergenic_variant	1	0.01	1E-8	8.0		5.09	2.62-9.86	Illumina [NR] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (reproductive subtype)	123 European ancestry cases, 2,964 European ancestry controls	84 European ancestry cases, 1,134 European ancestry controls	11p14.1	11	30204981	FSHB	ARL14EP-DT			ENSG00000254532			rs11031006-?	rs11031006	0	11031006	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [NR] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (metabolic subtype)	201 European ancestry cases, 2,964 European ancestry controls	128 European ancestry cases, 1,134 European ancestry controls	2q24.3	2	163325912	KCNH7, FIGN	RNU6-627P - NA	ENSG00000200902			36816		rs55762028-C	rs55762028	0	55762028	intergenic_variant	1	0.01	1E-8	8.0		1.86	0.92-3.75	Illumina [NR] (imputed)	N
2020-09-16	32574161	Dapas M	2020-06-23	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/32574161	Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.	Polycystic ovary syndrome (indeterminate subtype)	231 European ancestry cases, 2,964 European ancestry controls	126 European ancestry cases, 1,134 European ancestry controls	11p14.1	11	30230805	FSHB	ARL14EP-DT			ENSG00000254532			rs10835638-T	rs10835638	0	10835638	intron_variant	0	0.16	5E-12	11.301029995663981		1.81	1.44-2.27	Illumina [NR] (imputed)	N
2020-04-23	31001917	Grant DJ	2019-04-18	Cancer Med	www.ncbi.nlm.nih.gov/pubmed/31001917	Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.	Epithelial ovarian cancer	755 African American cases, 1,235 African American controls	NA	4q13.3	4	69591303	UGT2A1/2	UGT2A1, UGT2A2			ENSG00000173610, ENSG00000271271			rs10017134-C	rs10017134	0	10017134	intron_variant	0	0.73	1E-6	6.0		1.4	[1.2-1.7]	Illumina [471780]	N
2020-07-21	32185793	Yan J	2020-03-17	Clin Genet	www.ncbi.nlm.nih.gov/pubmed/32185793	A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels.	Follicle stimulating hormone levels in polycystic ovary syndrome	1,882 Han Chinese ancestry individuals	NA	2p16.3	2	48967370	NR	FSHR			ENSG00000170820			rs2300441-A	rs2300441	0	2300441	intron_variant	0	0.3578	7E-14	13.154901959985743		0.4335	NR unit decrease	Affymetrix [3101376] (imputed)	N
2020-07-21	32185793	Yan J	2020-03-17	Clin Genet	www.ncbi.nlm.nih.gov/pubmed/32185793	A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels.	Follicle stimulating hormone levels in polycystic ovary syndrome	1,882 Han Chinese ancestry individuals	NA	2p16.3	2	49135229	NR	FSHR			ENSG00000170820			rs140123771-AT	rs140123771	0	140123771	intron_variant	0	0.2041	5E-6	5.301029995663981		0.3058	NR unit decrease	Affymetrix [3101376] (imputed)	N
2020-07-21	32185793	Yan J	2020-03-17	Clin Genet	www.ncbi.nlm.nih.gov/pubmed/32185793	A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels.	Follicle stimulating hormone levels in polycystic ovary syndrome	1,882 Han Chinese ancestry individuals	NA	14q21.2	14	46123550	NR	LINC00871			ENSG00000258700			rs7151257-A	rs7151257	0	7151257	intron_variant	0	0.3538	8E-6	5.096910013008056		0.2607	NR unit decrease	Affymetrix [3101376] (imputed)	N
2020-07-21	32185793	Yan J	2020-03-17	Clin Genet	www.ncbi.nlm.nih.gov/pubmed/32185793	A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels.	Follicle stimulating hormone levels in polycystic ovary syndrome	1,882 Han Chinese ancestry individuals	NA	15q14	15	39027810	NR	LINC02694			ENSG00000175779			rs11070169-T	rs11070169	0	11070169	intron_variant	0	0.33	9E-6	5.045757490560675		0.2557	NR unit increase	Affymetrix [3101376] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	9q21.32	9	81548365		GLIS3 - TLE1	ENSG00000107249	ENSG00000196781		77199973	35318	rs72745575-?	rs72745575	0	72745575	intergenic_variant	1	NR	2E-6	5.698970004336019	(lmp)	2.07		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	Xp22.11	X	23151499		FAM3C2P - PDCL2P1	ENSG00000174028	ENSG00000228610		74732	46840	rs73468194-?	rs73468194	0	73468194	intron_variant	1	NR	8E-6	5.096910013008056	(mucinous_all)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	10q23.1	10	80653667		LINC02655			ENSG00000231082			rs74477043-?	rs74477043	0	74477043	non_coding_transcript_exon_variant	0	NR	7E-6	5.154901959985743	(overall)	1.51		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p14.3	7	34585100		NPSR1-AS1			ENSG00000197085			rs7455465-?	rs7455465	0	7455465	intron_variant	0	NR	8E-6	5.096910013008056	(lmp)	3.32		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2q14.1	2	113530775		PGM5P4-AS1			ENSG00000231943			rs74828133-?	rs74828133	1	3877418	intron_variant	0	NR	6E-6	5.221848749616356	(endometrioid)	1.53		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2q37.3	2	238022053		UBE2F, UBE2F-SCLY			ENSG00000184182, ENSG00000258984			rs74917072-?	rs74917072	0	74917072	intron_variant	0	NR	5E-7	6.301029995663981	(overall)	1.25		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2p24.2	2	18193172		KCNS3			ENSG00000170745			rs75157307-?	rs75157307	0	75157307	intron_variant	0	NR	3E-6	5.522878745280337	(serous_hg)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2p22.1	2	38517625		LINC02613 - HNRNPLL	ENSG00000231367	ENSG00000143889		1691	44344	rs7559097-?	rs7559097	0	7559097	intergenic_variant	1	NR	6E-6	5.221848749616356	(mucinous_all)	1.61		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3q26.32	3	176972255		NA - MTND5P15		ENSG00000231888			38464	rs7644028-?	rs7644028	0	7644028	intergenic_variant	1	NR	3E-6	5.522878745280337	(clearcell)	1.57		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	10q11.21	10	41850928								rs76731728-?	rs76731728	0	76731728	regulatory_region_variant	1	NR	4E-6	5.3979400086720375	(endometrioid)	1.95		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3q13.31	3	116459821		LSAMP			ENSG00000185565			rs77122835-?	rs77122835	0	77122835	intron_variant	0	NR	9E-6	5.045757490560675	(overall)	1.29		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	13q34	13	113481059		DCUN1D2			ENSG00000150401			rs78649302-?	rs78649302	0	78649302	intron_variant	0	NR	3E-6	5.522878745280337	(lmp)	1.86		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	1p31.3	1	63315469		LINC00466			ENSG00000224209			rs78720768-?	rs78720768	0	78720768	intron_variant	0	NR	4E-6	5.3979400086720375	(lmp)	2.2		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	13q12.3	13	29266071		MTUS2			ENSG00000132938			rs78950910-?	rs78950910	0	78950910	intron_variant	0	NR	9E-6	5.045757490560675	(lmp)	4.82		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q31.2	5	138171416		BRD8			ENSG00000112983			rs79812184-?	rs79812184	1	34106093	intron_variant	0	NR	7E-6	5.154901959985743	(overall)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	9q22.2	9	89469330		SEMA4D			ENSG00000187764			rs79925169-?	rs79925169	0	79925169	intron_variant	0	NR	5E-6	5.301029995663981	(overall)	1.23		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	8p22	8	13963095								rs80119973-?	rs80119973	0	80119973	intergenic_variant	1	NR	2E-6	5.698970004336019	(endometrioid)	3.03		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	16q22.3	16	73418955		ZFHX3, LINC01568			ENSG00000140836, ENSG00000258779			rs8060270-?	rs8060270	0	8060270	intron_variant	0	NR	3E-6	5.522878745280337	(mucinous_all)	1.67		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	17p13.2	17	5064847		SLC52A1 - ZFP3-DT	ENSG00000132517	ENSG00000262693		12838	10831	rs8069681-?	rs8069681	0	8069681	intergenic_variant	1	NR	1E-6	6.0	(lmp)	1.7		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	21q22.11	21	31347809		TIAM1			ENSG00000156299			rs845930-?	rs845930	0	845930	non_coding_transcript_exon_variant	0	NR	8E-6	5.096910013008056	(overall)	1.18		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	10q26.13	10	122120548		TACC2			ENSG00000138162			rs870274-?	rs870274	0	870274	intron_variant	0	NR	7E-6	5.154901959985743	(ser_lg_lmp)	1.7		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	13q14.2	13	48747718		CYSLTR2 - PSME2P2	ENSG00000152207	ENSG00000225131		36492	23410	rs9316411-?	rs9316411	0	9316411	intergenic_variant	1	NR	2E-6	5.698970004336019	(overall)	1.37		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6q11.1	6	60484461								rs9382808-?	rs9382808	0	9382808	intron_variant	1	NR	2E-6	5.698970004336019	(clearcell)	1.82		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	1p36.33	1	1175206		TTLL10, TTLL10-AS1			ENSG00000162571, ENSG00000205231			rs9442387-?	rs9442387	0	9442387	non_coding_transcript_exon_variant	0	NR	8E-6	5.096910013008056	(ser_lg_lmp)	2.78		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p14.1	7	42053156		GLI3			ENSG00000106571			rs9791676-?	rs9791676	0	9791676	intron_variant	0	NR	8E-6	5.096910013008056	(clearcell)	1.96		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	Xp22.33	X	3776745		RPS27AP20 - NA	ENSG00000182888			59145		rs113446565-?	rs113446565	0	113446565	intergenic_variant	1	NR	4E-6	5.3979400086720375	(endometrioid)	1.43		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7q11.22	7	71128079		NA - GALNT17		ENSG00000185274			4065	rs113494645-?	rs113494645	1	59083618	intergenic_variant	1	NR	9E-6	5.045757490560675	(mucinous_all)	1.79		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4q34.3	4	176652990		NA - VEGFC		ENSG00000150630			30548	rs113732232-?	rs113732232	0	113732232	intergenic_variant	1	NR	7E-6	5.154901959985743	(serous_hg)	1.63		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	17p13.2	17	4274200		UBE2G1			ENSG00000132388			rs11426758-?	rs11426758	0	11426758	intron_variant	0	NR	7E-6	5.154901959985743	(mucinous_all)	1.56		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	8p12	8	31005773		PURG			ENSG00000172733			rs11451120-?	rs11451120	0	11451120	intron_variant	0	NR	8E-6	5.096910013008056	(overall)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	13q32.1	13	96391464		HS6ST3			ENSG00000185352			rs1164587-?	rs1164587	0	1164587	intron_variant	0	NR	3E-6	5.522878745280337	(mucinous_all)	1.53		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	18q21.1	18	49657424		SMUG1P1 - NA	ENSG00000267444			6264		rs11659469-?	rs11659469	0	11659469	intergenic_variant	1	NR	5E-6	5.301029995663981	(mucinous_all)	1.5		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2q23.3	2	150393944		LINC01818 - RND3	ENSG00000230645	ENSG00000115963		37484	74251	rs11684751-?	rs11684751	0	11684751	intergenic_variant	1	NR	4E-6	5.3979400086720375	(ser_lg_lmp)	1.74		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4q35.1	4	185843593		SORBS2			ENSG00000154556			rs11724690-?	rs11724690	0	11724690	intron_variant	0	NR	2E-6	5.698970004336019	(clearcell)	2.9		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p15.2	7	27853217		JAZF1			ENSG00000153814			rs11973028-?	rs11973028	0	11973028	intron_variant	0	NR	1E-6	6.0	(mucinous_all)	1.51		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7q33	7	133141119		RNU6-92P - ST13P7	ENSG00000272393	ENSG00000237821		58187	28297	rs11980115-?	rs11980115	0	11980115	intergenic_variant	1	NR	2E-6	5.698970004336019	(ser_lg_lmp)	4.45		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	8q24.21	8	127619425		NA - CASC11		ENSG00000249375			66918	rs12546957-?	rs12546957	0	12546957	intron_variant	1	NR	3E-6	5.522878745280337	(serous_hg)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	1q41	1	221657667		NA - DUSP10		ENSG00000143507			43757	rs12568748-?	rs12568748	0	12568748	intergenic_variant	1	NR	9E-6	5.045757490560675	(mucinous_all)	1.9		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	17q22	17	57668632		MSI2			ENSG00000153944			rs12603880-?	rs12603880	0	12603880	intron_variant	0	NR	7E-6	5.154901959985743	(clearcell)	1.59		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2p25.1	2	7182908		RN7SKP112 - NA	ENSG00000223145			41364		rs12623068-?	rs12623068	0	12623068	intergenic_variant	1	NR	4E-6	5.3979400086720375	(overall)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2p21	2	44110941		NA - RNU6-566P		ENSG00000252599			43848	rs13420007-?	rs13420007	0	13420007	intergenic_variant	1	NR	6E-6	5.221848749616356	(endometrioid)	1.56		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	22q13.31	22	46131359		MIRLET7BHG - PPARA	ENSG00000197182	ENSG00000186951		17431	19162	rs135573-?	rs135573	0	135573	TF_binding_site_variant	1	NR	3E-6	5.522878745280337	(mucinous_all)	2.45		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	13q31.3	13	90884180		NA - LINC00410		ENSG00000231674			6774	rs140884924-?	rs140884924	1	55678794	intergenic_variant	1	NR	8E-6	5.096910013008056	(lmp)	1.76		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	20p12.1	20	12691366								rs1413017-?	rs1413017	0	1413017	intergenic_variant	1	NR	4E-6	5.3979400086720375	(ser_lg_lmp)	1.75		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7q36.3	7	157716799		PTPRN2, PTPRN2			ENSG00000282185, ENSG00000155093			rs142825068-?	rs142825068	1	112728111	intron_variant	0	NR	8E-6	5.096910013008056	(overall)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	17q11.2	17	28302026		KRT18P55			ENSG00000265480			rs144055451-?	rs144055451	0	144055451	intron_variant	0	NR	2E-6	5.698970004336019	(serous_hg)	1.91		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	Xp11.3	X	43022624		SMIM15P1 - NA	ENSG00000270280			22228		rs144199732-?	rs144199732	0	144199732	intergenic_variant	1	NR	7E-7	6.154901959985743	(lmp)	2.86		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	10p15.3	10	1186289		ADARB2, LINC00200			ENSG00000185736, ENSG00000229205			rs145022376-?	rs145022376	0	145022376	intron_variant	0	NR	1E-6	6.0	(clearcell)	4.1		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6p22.3	6	17689625		NUP153			ENSG00000124789			rs146343288-?	rs146343288	0	146343288	intron_variant	0	NR	3E-6	5.522878745280337	(serous_hg)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3q13.2	3	112609782		CCDC80			ENSG00000091986			rs146917711-?	rs146917711	0	146917711	intron_variant	0	NR	4E-6	5.3979400086720375	(mucinous_all)	2.33		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	10p12.1	10	28484549		LINC02652			ENSG00000237128			rs1934363-C	rs1934363	0	1934363	intron_variant	0	0.94	3E-10	9.522878745280337	(CCOC)	11.0	[5.3-24]	Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6p25.2	6	3580855								rs7748275-A	rs7748275	0	7748275	intergenic_variant	1	0.16	9E-9	8.045757490560675	(serous)	1.4	[1.2-1.5]	Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6p25.2	6	3580855								rs7748275-A	rs7748275	0	7748275	intergenic_variant	1	0.16	4E-8	7.3979400086720375	(HGSOC)	1.4	[1.2-1.5]	Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr1:22569919-?	chr1:22569919	0			1	NR	3E-6	5.522878745280337	(lmp)	3.83		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr12:121386263-?	chr12:121386263	0			1	NR	2E-7	6.698970004336019	(lmp)	2.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr12:128445504-?	chr12:128445504	0			1	NR	3E-7	6.522878745280337	(serous_hg)	1.49		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr12:45837095-?	chr12:45837095	0			1	NR	2E-6	5.698970004336019	(serous_hg)	1.4		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr12:98579587-?	chr12:98579587	0			1	NR	9E-6	5.045757490560675	(ser_lg_lmp)	6.95		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr13:45661665-?	chr13:45661665	0			1	NR	9E-6	5.045757490560675	(endometrioid)	1.54		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr14:106452461-?	chr14:106452461	0			1	NR	2E-6	5.698970004336019	(lmp)	4.73		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr16:76182702-?	chr16:76182702	0			1	NR	1E-6	6.0	(mucinous_all)	1.84		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr2:29228648-?	chr2:29228648	0			1	NR	8E-6	5.096910013008056	(clearcell)	6.32		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr1:150718602-?	chr1:150718602	0			1	NR	7E-7	6.154901959985743	(ser_lg_lmp)	2.43		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr12:118425547-?	chr12:118425547	0			1	NR	6E-6	5.221848749616356	(ser_lg_lmp)	2.1		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chr6:168526822-?	chr6:168526822	0			1	NR	7E-6	5.154901959985743	(clearcell)	1.55		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											chrX:107586364-?	chrX:107586364	0			1	NR	3E-6	5.522878745280337	(overall)	1.29		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											kgp7416783-?	kgp7416783	0			1	NR	9E-6	5.045757490560675	(clearcell)	1.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											kgp7556451-?	kgp7556451	0			1	NR	9E-8	7.045757490560675	(serous_hg)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4q31.3	4	153242242		TRIM2			ENSG00000109654			rs10009522-?	rs10009522	0	10009522	intron_variant	0	NR	9E-6	5.045757490560675	(overall)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p21.3	7	11524758		THSD7A			ENSG00000005108			rs10260419-?	rs10260419	0	10260419	intron_variant	0	NR	1E-7	7.0	(overall)	1.33		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	15q12	15	27084081		GABRG3, GABRG3-AS1			ENSG00000182256, ENSG00000228740			rs10400919-?	rs10400919	0	10400919	intron_variant	0	NR	6E-6	5.221848749616356	(clearcell)	1.55		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	1p36.12	1	21141378		EIF4G3			ENSG00000075151			rs10627733-?	rs10627733	0	10627733	intron_variant	0	NR	2E-6	5.698970004336019	(endometrioid)	1.89		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	21q21.1	21	21308069		NCAM2			ENSG00000154654			rs111478044-?	rs111478044	0	111478044	intron_variant	0	NR	9E-7	6.045757490560675	(ser_lg_lmp)	2.0		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	16q23.2	16	79856062		LINC01228 - NA	ENSG00000261082			28912		rs11150225-?	rs11150225	0	11150225	intergenic_variant	1	NR	7E-6	5.154901959985743	(overall)	1.21		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q21.1	5	102301954		SLCO4C1 - RN7SKP68	ENSG00000173930	ENSG00000222987		5670	550	rs111970895-?	rs111970895	0	111970895	intergenic_variant	1	NR	3E-7	6.522878745280337	(clearcell)	2.34		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q32	5	148321490		SPINK9			ENSG00000204909			rs376296328-?	rs376296328	1	200597924	intron_variant	0	NR	8E-6	5.096910013008056	(serous_hg)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	18q21.33	18	63664376		SERPINB11			ENSG00000206072			rs3867263-?	rs3867263	0	3867263	intron_variant	0	NR	4E-6	5.3979400086720375	(serous_hg)	1.25		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3p14.2	3	61992237		PTPRG			ENSG00000144724			rs40409-?	rs40409	0	40409	intron_variant	0	NR	2E-6	5.698970004336019	(clearcell)	1.57		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4q32.3	4	167363437		NA - RN7SL776P		ENSG00000240772			37058	rs4362851-?	rs4362851	0	4362851	intergenic_variant	1	NR	2E-6	5.698970004336019	(ser_lg_lmp)	1.81		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6q26	6	163301732		PACRG			ENSG00000112530			rs4709698-?	rs4709698	0	4709698	intron_variant	0	NR	3E-6	5.522878745280337	(serous_hg)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	10q25.2	10	111552672		RPS6P15 - NA	ENSG00000230809			53731		rs4918665-?	rs4918665	0	4918665	intergenic_variant	1	NR	7E-6	5.154901959985743	(serous)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	11q23.1	11	111430057		POU2AF1			ENSG00000110777			rs4936453-?	rs4936453	0	4936453	intron_variant	0	NR	8E-6	5.096910013008056	(clearcell)	1.54		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p12.1	7	51423896		CICP17 - NA	ENSG00000227233			39236		rs56236040-?	rs56236040	0	56236040	intergenic_variant	1	NR	4E-6	5.3979400086720375	(ser_lg_lmp)	6.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6q25.1	6	151590844		CCDC170			ENSG00000120262			rs57960590-?	rs57960590	0	57960590	intron_variant	0	NR	4E-6	5.3979400086720375	(serous)	1.61		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q14.3	5	90981864		ADGRV1			ENSG00000164199			rs58142303-?	rs58142303	0	58142303	intron_variant	0	NR	7E-6	5.154901959985743	(serous)	1.63		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	Xq25	X	128926215		RPL32P35 - NA	ENSG00000223995			87381		rs5932545-?	rs5932545	0	5932545	intron_variant	1	NR	3E-6	5.522878745280337	(endometrioid)	1.45		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	16q12.1	16	49765545		ZNF423			ENSG00000102935			rs59923016-?	rs59923016	0	59923016	intron_variant	0	NR	1E-6	6.0	(overall)	1.21		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	22q11.21	22	19681497		NA - SEPTIN5		ENSG00000184702			33006	rs5993791-?	rs5993791	0	5993791	TF_binding_site_variant	1	NR	8E-6	5.096910013008056	(clearcell)	3.94		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											rs60930737-?	rs60930737	0	60930737		1	NR	2E-6	5.698970004336019	(ser_lg_lmp)	2.09		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	20p12.2	20	11586401		NA - PGAM3P		ENSG00000237256			34650	rs6134303-?	rs6134303	0	6134303	intergenic_variant	1	NR	8E-7	6.096910013008056	(mucinous_all)	1.59		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	9q21.13	9	74295222								rs61658193-?	rs61658193	0	61658193	intergenic_variant	1	NR	9E-6	5.045757490560675	(serous)	1.3		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	14q12	14	26740487		LINC02588						rs61974021-?	rs61974021	0	61974021	intron_variant	0	NR	4E-6	5.3979400086720375	(ser_lg_lmp)	4.17		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q35.3	5	177806110		FAM153A - OR1X5P	ENSG00000170074	ENSG00000214351		22712	30324	rs62397673-?	rs62397673	0	62397673	regulatory_region_variant	1	NR	3E-6	5.522878745280337	(endometrioid)	1.97		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p22.2	7	2916633		CARD11			ENSG00000198286			rs6461701-?	rs6461701	0	6461701	intron_variant	0	NR	5E-6	5.301029995663981	(clearcell)	1.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	8q11.21	8	50701586		SNTG1			ENSG00000147481			rs67729017-?	rs67729017	0	67729017	intron_variant	0	NR	8E-6	5.096910013008056	(mucinous_all)	2.53		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2p16.1	2	60572849		BCL11A - RN7SL361P	ENSG00000119866	ENSG00000242158		18382	67856	rs70959845-?	rs70959845	0	70959845	intergenic_variant	1	NR	4E-6	5.3979400086720375	(overall)	1.22		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	15q22.2	15	59949310		NA - NMNAT1P5		ENSG00000259573			15632	rs7172033-?	rs7172033	0	7172033	intergenic_variant	1	NR	7E-6	5.154901959985743	(lmp)	1.97		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											rs71877790-?	rs71877790	0	71877790		1	NR	5E-6	5.301029995663981	(endometrioid)	1.56		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	16q23.3	16	81619883		CMIP			ENSG00000153815			rs7206411-?	rs7206411	0	7206411	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019	(clearcell)	1.65		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6p21.32	6	32541977		HLA-DRB5 - RNU1-61P	ENSG00000198502	ENSG00000251916		11690	7963	rs72492309-?	rs72492309	0	72492309	intergenic_variant	1	NR	2E-6	5.698970004336019	(serous)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	7p11.2	7	57784687								rs151224156-?	rs151224156	0	151224156	intergenic_variant	1	NR	3E-6	5.522878745280337	(overall)	1.43		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	20p11.21	20	22393040								rs169225-?	rs169225	0	169225	intron_variant	1	NR	7E-7	6.154901959985743	(serous_hg)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6q16.1	6	97730186								rs17057973-?	rs17057973	0	17057973	intron_variant	1	NR	8E-6	5.096910013008056	(ser_lg_lmp)	2.77		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3p25.3	3	11007643		SLC6A1-AS1, SLC6A1			ENSG00000232287, ENSG00000157103			rs1728807-?	rs1728807	0	1728807	intron_variant	0	NR	9E-6	5.045757490560675	(serous)	1.23		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q35.2	5	175210799		NA - ARL2BPP6		ENSG00000248355			79932	rs17808848-?	rs17808848	0	17808848	intergenic_variant	1	NR	3E-6	5.522878745280337	(ser_lg_lmp)	2.11		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	11q23.3	11	116120763								rs1791890-?	rs1791890	0	1791890	intergenic_variant	1	NR	3E-7	6.522878745280337	(mucinous_all)	1.61		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA											rs1800351-?	rs1800351	0	1800351	synonymous_variant	1	NR	7E-6	5.154901959985743	(lmp)	1.62		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3p24.1	3	26787883		LRRC3B - NA	ENSG00000179796			70346		rs185335029-?	rs185335029	0	185335029	intergenic_variant	1	NR	8E-6	5.096910013008056	(overall)	1.18		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q32	5	147579243		JAKMIP2-AS1			ENSG00000280780			rs185652178-?	rs185652178	0	185652178	intron_variant	0	NR	8E-7	6.096910013008056	(serous_hg)	1.55		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	6q24.2	6	143007986		LINC01277			ENSG00000229017			rs199256-?	rs199256	0	199256	intron_variant	0	NR	8E-6	5.096910013008056	(mucinous_all)	1.52		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4p15.33	4	14172253		LINC01085 - NA	ENSG00000248698			32201		rs200114742-?	rs200114742	0	200114742	intron_variant	1	NR	8E-6	5.096910013008056	(serous_hg)	1.25		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q14.3	5	87170215		MIR4280HG - LINC01949	ENSG00000233828	ENSG00000288569		31818	35193	rs200529678-?	rs200529678	0	200529678	intergenic_variant	1	NR	5E-6	5.301029995663981	(lmp)	2.59		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4q13.1	4	64932417		LINC02232			ENSG00000250125			rs2119438-?	rs2119438	0	2119438	intron_variant	0	NR	6E-6	5.221848749616356	(ser_lg_lmp)	1.77		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	2q34	2	211451963		ERBB4			ENSG00000178568			rs2371271-?	rs2371271	0	2371271	intron_variant	0	NR	6E-6	5.221848749616356	(endometrioid)	1.46		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	14q32.11	14	89546219		FOXN3			ENSG00000053254			rs243172-?	rs243172	0	243172	intron_variant	0	NR	4E-6	5.3979400086720375	(serous)	1.22		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	21q21.2	21	24659554								rs2829235-?	rs2829235	0	2829235	intergenic_variant	1	NR	7E-6	5.154901959985743	(overall)	1.18		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3p23	3	31878815		OSBPL10			ENSG00000144645			rs28568660-?	rs28568660	1	10546963	intron_variant	0	NR	2E-6	5.698970004336019	(serous_hg)	1.28		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	4p16.3	4	3824215		ADRA2C - OR7E163P	ENSG00000184160	ENSG00000251166		55689	65141	rs28734075-?	rs28734075	0	28734075	intergenic_variant	1	NR	7E-6	5.154901959985743	(clearcell)	3.22		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	Xp21.1	X	33452415								rs34097398-?	rs34097398	0	34097398	intergenic_variant	1	NR	4E-7	6.3979400086720375	(ser_lg_lmp)	2.1		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	16q23.1	16	77008512								rs34344307-?	rs34344307	0	34344307	intergenic_variant	1	NR	1E-6	6.0	(endometrioid)	1.51		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	Xq24	X	119837616		UPF3B			ENSG00000125351			rs34350340-?	rs34350340	0	34350340	intron_variant	0	NR	4E-6	5.3979400086720375	(clearcell)	1.87		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	19p13.3	19	3197622		NCLN			ENSG00000125912			rs34357515-?	rs34357515	0	34357515	intron_variant	0	NR	1E-6	6.0	(clearcell)	1.69		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	5q34	5	165518039		NA - RN7SKP60		ENSG00000252794			91402	rs34470775-?	rs34470775	0	34470775	intron_variant	1	NR	8E-6	5.096910013008056	(clearcell)	2.19		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	22q12.1	22	28343530		TTC28			ENSG00000100154			rs35941888-?	rs35941888	0	35941888	intron_variant	0	NR	5E-6	5.301029995663981	(lmp)	1.66		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	1q23.1	1	159009146		IFI16			ENSG00000163565			rs3754464-?	rs3754464	0	3754464	5_prime_UTR_variant	0	NR	2E-6	5.698970004336019	(serous)	1.29		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls	NA	3q26.2	3	169266197		MECOM			ENSG00000085276			rs987254-?	rs987254	0	987254	intron_variant	0	NR	8E-6	5.096910013008056	(lmp)	1.83		Illumina [11595112] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	3q25.1	3	151163121	NR	MED12L			ENSG00000144893			rs3116549-?	rs3116549	0	3116549	intron_variant	0	0.2294	3E-7	6.522878745280337		0.045792	[0.028-0.063] unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	12q22	12	94823160	NR	NA - KRT19P2		ENSG00000216306			10987	rs12580507-?	rs12580507	0	12580507	regulatory_region_variant	1	0.2266	4E-7	6.3979400086720375		0.045234	[0.028-0.063] unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	8q24.23	8	137457107	NR	ZYXP1 - NA	ENSG00000274572			32086		rs34346284-?	rs34346284	0	34346284	intergenic_variant	1	0.1045	1E-6	6.0		0.057875	[0.034-0.081] unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	3p25.1	3	14636792	NR	RHBDF1P1 - CCDC174	ENSG00000234123	ENSG00000154781		62000	14954	rs3846121-?	rs3846121	0	3846121	intron_variant	1	0.2152	2E-6	5.698970004336019		0.042923	[0.025-0.061] unit increase	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	5q34	5	161280574	NR	NA - GABRB2		ENSG00000145864			7855	rs602310-?	rs602310	0	602310	intergenic_variant	1	0.1574	2E-6	5.698970004336019		0.048079	[0.028-0.068] unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	18q21.31	18	57806419	NR	ATP8B1 - RSL24D1P11	ENSG00000081923	ENSG00000231544		3104	32057	rs2571244-?	rs2571244	0	2571244	upstream_gene_variant	1	0.08083	3E-6	5.522878745280337		0.062398	[0.036-0.088] unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	5,108 European ancestry individuals (unimpaired cognition, mild cognitive impairment or Alzheimers disease)	NA	22q12.3	22	33761539	NR	LARGE1			ENSG00000133424			rs16992986-?	rs16992986	0	16992986	5_prime_UTR_variant	0	0.1159	3E-6	5.522878745280337		0.054526	[0.032-0.077] unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	1q43	1	243451403	NR	SDCCAG8, SDCCAG8			ENSG00000054282, ENSG00000276111			rs12127073-?	rs12127073	0	12127073	intron_variant	0	0.1055	1E-6	6.0		0.084412	NR unit increase	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	2q12.1	2	102563483	NR	SLC9A4 - SLC9A2	ENSG00000180251	ENSG00000115616		29511	56070	rs12623748-?	rs12623748	0	12623748	intergenic_variant	1	0.03799	3E-6	5.522878745280337		0.129165	NR unit increase	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	3p25.1	3	14636792	NR	RHBDF1P1 - CCDC174	ENSG00000234123	ENSG00000154781		62000	14954	rs3846121-?	rs3846121	0	3846121	intron_variant	1	0.2152	8E-6	5.096910013008056		0.059753	NR unit increase	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	3q23	3	140277803	NR	CLSTN2			ENSG00000158258			rs7635923-?	rs7635923	0	7635923	intron_variant	0	0.4525	6E-6	5.221848749616356		0.048935	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	3q26.1	3	161263760	NR	NMD3 - EEF1GP4	ENSG00000169251	ENSG00000240138		10228	61153	rs7615592-?	rs7615592	0	7615592	regulatory_region_variant	1	0.4809	2E-6	5.698970004336019		0.052155	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	3q26.1	3	161380764	NR	SPTSSB - LINC02067	ENSG00000196542	ENSG00000240567		7884	45663	rs465985-?	rs465985	0	465985	intergenic_variant	1	0.4817	5E-6	5.301029995663981		0.050528	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	4q35.1	4	185508820	NR	PDLIM3			ENSG00000154553			rs1840-?	rs1840	0	1840	intron_variant	0	0.142	2E-6	5.698970004336019		0.075377	NR unit increase	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	6p12.3	6	51093682	NR	FTH1P5 - PKHD1	ENSG00000230204	ENSG00000170927		180426	521617	rs283562-?	rs283562	0	283562	intergenic_variant	1	0.436	7E-6	5.154901959985743		0.049429	NR unit increase	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	11q21	11	93548963	NR	SMCO4 - RN7SL223P	ENSG00000166002	ENSG00000240202		5572	7950	rs11605469-?	rs11605469	0	11605469	regulatory_region_variant	1	0.0585	9E-6	5.045757490560675		0.100251	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	11q23.2	11	112783274	NR							rs1447462-?	rs1447462	0	1447462	intergenic_variant	1	0.07184	8E-6	5.096910013008056		0.09553	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	12q22	12	94823160	NR	NA - KRT19P2		ENSG00000216306			10987	rs12580507-?	rs12580507	0	12580507	regulatory_region_variant	1	0.2266	6E-7	6.221848749616356		0.064962	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	15q26.2	15	94039878	NR	LINC01579, LINC01581			ENSG00000258754, ENSG00000259724			rs11074247-?	rs11074247	0	11074247	intron_variant	0	0.3323	8E-6	5.096910013008056		0.051774	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	18q21.31	18	57806419	NR	ATP8B1 - RSL24D1P11	ENSG00000081923	ENSG00000231544		3104	32057	rs2571244-?	rs2571244	0	2571244	upstream_gene_variant	1	0.08083	2E-8	7.698970004336019		0.108502	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2021-03-24	32844198	Dumitrescu L	2020-08-01	Brain	www.ncbi.nlm.nih.gov/pubmed/32844198	Genetic variants and functional pathways associated with resilience to Alzheimer's disease.	Combined resilience (covariance of educational attainment with residual cognitive resilience)	3,820 European ancestry cognitively unimpaired individuals	NA	20q11.21	20	33269600	NR	BPIFA1 - RPL12P3	ENSG00000198183	ENSG00000233106		26289	2662	rs982563-?	rs982563	0	982563	regulatory_region_variant	1	0.2337	7E-6	5.154901959985743		0.059082	NR unit decrease	Affymetrix, Illumina [4840740] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	19q13.43	19	58202868	ZNF274	ZNF274			ENSG00000171606			rs12151036-G	rs12151036	0	12151036	intron_variant	0	0.0119	5E-6	5.301029995663981		2.2075055	[1.57-3.11]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	20q13.31	20	56648010	TFAP2C	TFAP2C - RNU6-1146P	ENSG00000087510	ENSG00000252091		8727	19420	rs1884920-A	rs1884920	0	1884920	intergenic_variant	1	0.5027	8E-6	5.096910013008056		1.4064697	[1.21-1.64]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	22q13.1	22	39341089	SYNGR1	RPL3 - SYNGR1	ENSG00000100316	ENSG00000100321		20700	8836	rs137672-C	rs137672	0	137672	intergenic_variant	1	0.0601	1E-7	7.0		1.7452006	[1.42-2.15]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1p22.1	1	93933038	GCLM	MTCO1P21 - ABCA4	ENSG00000226960	ENSG00000198691		4736	59796	rs185345278-A	rs185345278	0	185345278	intergenic_variant	1	0.0216	5E-6	5.301029995663981		2.8735633	[1.83-4.52]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1p12	1	119307920	HAO2	WARS2-AS1 - LINC01780	ENSG00000231365	ENSG00000232650		31947	19479	rs12031579-G	rs12031579	0	12031579	intron_variant	1	0.0547	8E-7	6.096910013008056		1.8248177	[1.44-2.31]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1q22	1	156114696	LMNA	LMNA			ENSG00000160789			rs188625872-C	rs188625872	0	188625872	5_prime_UTR_variant	0	0.0034	2E-6	5.698970004336019		3.7593985	[2.17-6.49]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1q24.3	1	172072640	DNM3	DNM3			ENSG00000197959			rs12117623-C	rs12117623	0	12117623	intron_variant	0	0.5306	1E-6	6.0		1.312336	[1.18-1.46]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	2p11.2	2	86459965	KDM3A	KDM3A			ENSG00000115548			rs17027263-C	rs17027263	0	17027263	intron_variant	0	0.1172	2E-6	5.698970004336019		1.4430014	[1.24-1.68]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	3q27.3	3	186920430	RPL29P9	RPS20P14 - ST6GAL1	ENSG00000223803	ENSG00000073849		19873	9895	rs6801612-A	rs6801612	0	6801612	regulatory_region_variant	1	0.683	8E-6	5.096910013008056		1.328	[1.174-1.503]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	5p15.32	5	5169477	ADAMTS16	ADAMTS16			ENSG00000145536			rs12658731-G	rs12658731	0	12658731	intron_variant	0	0.6438	9E-7	6.045757490560675		1.405	[1.227-1.608]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	5q31.2	5	139712729	CXXC5	CXXC5 - RNU6-236P	ENSG00000171604	ENSG00000200756		28847	5256	rs147867139-A	rs147867139	0	147867139	intron_variant	1	0.0175	8E-6	5.096910013008056		2.197802	[1.56-3.11]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	5q35.3	5	180485036	CNOT6	RNU6-525P - CNOT6	ENSG00000200555	ENSG00000113300		40424	9343	rs60982503-G	rs60982503	0	60982503	intergenic_variant	1	0.7345	5E-6	5.301029995663981		1.384	[1.204-1.591]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6p24.3	6	10403963	TFAP2A	TFAP2A			ENSG00000137203			rs303051-A	rs303051	0	303051	intron_variant	0	0.3947	6E-6	5.221848749616356		1.2886598	[1.15-1.44]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6p21.31	6	35464877	FANCE	FANCE			ENSG00000112039			rs56855829-C	rs56855829	0	56855829	intron_variant	0	0.0036	2E-6	5.698970004336019		3.8022811	[2.18-6.62]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6q16.1	6	96284381	FUT9	UFL1-AS1			ENSG00000233797			rs4599655-A	rs4599655	0	4599655	intron_variant	0	0.1365	8E-6	5.096910013008056		1.3927578	[1.21-1.61]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6q24.3	6	146688554	C6orf103	ADGB			ENSG00000118492			rs73589840-C	rs73589840	0	73589840	intron_variant	0	0.0329	7E-6	5.154901959985743		1.7452006	[1.37-2.22]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	7p12.3	7	47770503	MGC16075	PKD1L1			ENSG00000158683			rs181474944-C	rs181474944	0	181474944	intron_variant	0	0.0150	6E-6	5.221848749616356		2.4570024	[1.67-3.62]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	7q21.13	7	89698682	ZNF804B	NA - RNU6-274P		ENSG00000239075			55938	rs76926936-T	rs76926936	0	76926936	intergenic_variant	1	0.0517	9E-6	5.045757490560675		1.923077	[1.44-2.56]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	9q21.33	9	87680655	DAPK1	DAPK1			ENSG00000196730			rs10117922-A	rs10117922	0	10117922	intron_variant	0	0.325	7E-6	5.154901959985743		1.3351135	[1.18-1.51]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	9q34.3	9	135247660	C9orf62	C9orf62						rs10858374-T	rs10858374	0	10858374	intron_variant	0	0.1106	1E-6	6.0		1.4684289	[1.26-1.72]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	10q25.3	10	115937294	ATRNL1	ATRNL1			ENSG00000107518			rs2615880-A	rs2615880	0	2615880	intron_variant	0	0.1234	8E-6	5.096910013008056		1.4025246	[1.21-1.63]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70028700	C12orf28	PRANCR			ENSG00000257815			rs789336-C	rs789336	0	789336	intron_variant	0	0.6082	1E-7	7.0		1.369	[1.217-1.540]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70148026	LOC100125409	PRANCR			ENSG00000257815			rs7969255-T	rs7969255	0	7969255	intron_variant	0	0.5313	8E-7	6.096910013008056		1.325	[1.184-1.481]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70257391	CNOT2	CNOT2			ENSG00000111596			rs58355101-T	rs58355101	0	58355101	intron_variant	0	0.5658	9E-7	6.045757490560675		1.35	[1.198-1.521]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70359064	CNOT2	CNOT2 - KCNMB4	ENSG00000111596	ENSG00000135643		4071	7226	rs1495352-A	rs1495352	0	1495352	intergenic_variant	1	0.5489	3E-6	5.522878745280337		1.31	[1.169-1.468]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	16q12.2	16	54596587	IRX3	LINC02183 - NA	ENSG00000283304			37487		rs75921351-C	rs75921351	0	75921351	intergenic_variant	1	0.0304	8E-7	6.096910013008056		2.1691973	[1.59-2.95]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	16q12.2	16	55347327	RPL31P56	IRX6 - RPL31P56	ENSG00000159387	ENSG00000240760		16571	5394	rs145065165-G	rs145065165	0	145065165	intergenic_variant	1	0.0223	2E-7	6.698970004336019		2.8735633	[1.93-4.29]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	17p13.2	17	5857509	LOC339166							rs11870446-C	rs11870446	0	11870446	intron_variant	1	0.1238	3E-6	5.522878745280337		1.4836795	[1.26-1.75]	Illumina [7521072] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	2p21	2	43334641	THADA	THADA			ENSG00000115970			rs7563201-A	rs7563201	0	7563201	intron_variant	0	0.45	4E-10	9.397940008672037		0.1081	[0.074-0.142] unit decrease	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	2q34	2	212527042	ERRB4	ERBB4			ENSG00000178568			rs2178575-A	rs2178575	0	2178575	intron_variant	0	0.15	3E-14	13.522878745280337		0.1663	[0.12-0.21] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	5q31.1	5	132477512	IRF1, RAD50	IRF1, IRF1-AS1			ENSG00000125347, ENSG00000197536			rs13164856-T	rs13164856	0	13164856	intron_variant	0	0.73	1E-10	10.0		0.1235	[0.086-0.161] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	8p23.1	8	11766380	C8orf49	GATA4 - NEIL2	ENSG00000285109	ENSG00000154328		6378	3259	rs804279-A	rs804279	0	804279	regulatory_region_variant	1	0.26	4E-12	11.397940008672037		0.1276	[0.092-0.164] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	9p24.1	9	5440589	PLGRKT	PLGRKT - CD274	ENSG00000107020	ENSG00000120217		2664	9914	rs10739076-A	rs10739076	0	10739076	intergenic_variant	1	0.31	3E-8	7.522878745280337		0.1097	[0.071-0.148] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	9q22.32	9	94960984	C9orf3	AOPEP			ENSG00000148120			rs7864171-A	rs7864171	0	7864171	intron_variant	0	0.43	3E-8	7.522878745280337		0.0933	[0.06-0.126] unit decrease	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	9q33.3	9	123856954	DENND1A	DENND1A			ENSG00000119522			rs9696009-A	rs9696009	0	9696009	intron_variant	0	0.07	8E-11	10.096910013008056		0.202	[0.14-0.26] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	11p14.1	11	30204809	ARL14EP, FSHB	ARL14EP-DT			ENSG00000254532			rs11031005-T	rs11031005	0	11031005	intron_variant	0	0.85	9E-13	12.045757490560675		0.1593	[0.12-0.2] unit decrease	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	11q22.1	11	102172509	YAP1	YAP1			ENSG00000137693			rs11225154-A	rs11225154	0	11225154	intron_variant	0	0.09	5E-11	10.301029995663981		0.1787	[0.13-0.23] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	11q23.2	11	114078510	ZBTB16	ZBTB16			ENSG00000109906			rs1784692-T	rs1784692	0	1784692	intron_variant	0	0.82	2E-10	9.698970004336019		0.1438	[0.1-0.188] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	12q13.2	12	56083910	ERRB3, RAB5B	ERBB3			ENSG00000065361			rs2271194-A	rs2271194	0	2271194	splice_region_variant	0	0.42	5E-9	8.301029995663981		0.0971	[0.065-0.13] unit increase	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	12q21.2	12	75547262	KRR1	KRR1 - NA	ENSG00000111615			35626		rs1795379-T	rs1795379	0	1795379	intergenic_variant	1	0.24	2E-9	8.698970004336019		0.1174	[0.079-0.156] unit decrease	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	16q12.1	16	52341865	TOX3	CASC22 - TOX3	ENSG00000260887	ENSG00000103460		61227	94552	rs8043701-A	rs8043701	0	8043701	intergenic_variant	1	0.82	1E-9	9.0		0.1273	[0.087-0.168] unit decrease	Illumina [> 10000000] (imputed)	N
2019-02-08	30566500	Day F	2018-12-19	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/30566500	Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.	Polycystic ovary syndrome	10,074 European ancestry cases, 103,164 European ancestry controls	NA	20q11.21	20	32832951	MAPRE1	MAPRE1			ENSG00000101367			rs853854-T	rs853854	0	853854	intron_variant	0	0.5	2E-9	8.698970004336019		0.0975	[0.066-0.129] unit decrease	Illumina [> 10000000] (imputed)	N
2020-11-13	32887889	Rashkin SR	2020-09-04	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Ovarian cancer	1,259 European ancestry cases, 410,350 European ancestry controls	NA	1p36.32	1	3779792		LRRC47			ENSG00000130764			rs12061931-T	rs12061931	0	12061931	3_prime_UTR_variant	0	NR	6E-8	7.221848749616356		5.79	NR	Affymetrix [7846216] (imputed)	N
2018-12-03	30343302	Kim SH	2018-10-19	Gynecol Obstet Invest	www.ncbi.nlm.nih.gov/pubmed/30343302	High Genetic Risk Scores of ASIC2, MACROD2, CHRM3, and C2orf83 Genetic Variants Associated with Polycystic Ovary Syndrome Impair Insulin Sensitivity and Interact with Energy Intake in Korean Women.	Polycystic ovary syndrome	182 Korean ancestry cases, 240 Korean ancestry controls	NA	4p12	4	47001059	GABRA4	GABRB1			ENSG00000163288			rs1159315-G	rs1159315	0	1159315	intron_variant	0	0.3655	2E-7	6.698970004336019		1.117	NR unit increase	Affymetrix [NR]	N
2018-12-03	30343302	Kim SH	2018-10-19	Gynecol Obstet Invest	www.ncbi.nlm.nih.gov/pubmed/30343302	High Genetic Risk Scores of ASIC2, MACROD2, CHRM3, and C2orf83 Genetic Variants Associated with Polycystic Ovary Syndrome Impair Insulin Sensitivity and Interact with Energy Intake in Korean Women.	Polycystic ovary syndrome	182 Korean ancestry cases, 240 Korean ancestry controls	NA	17q11.2	17	33053293	ASIC2	ASIC2			ENSG00000108684			rs12450465-G	rs12450465	0	12450465	intron_variant	0	0.3312	8E-6	5.096910013008056		0.8755	NR unit decrease	Affymetrix [NR]	N
2018-12-03	30343302	Kim SH	2018-10-19	Gynecol Obstet Invest	www.ncbi.nlm.nih.gov/pubmed/30343302	High Genetic Risk Scores of ASIC2, MACROD2, CHRM3, and C2orf83 Genetic Variants Associated with Polycystic Ovary Syndrome Impair Insulin Sensitivity and Interact with Energy Intake in Korean Women.	Polycystic ovary syndrome	182 Korean ancestry cases, 240 Korean ancestry controls	NA	17q21.1	17	39826630	IKZF3	IKZF3			ENSG00000161405			rs2060941-A	rs2060941	0	2060941	intron_variant	0	0.02708	5E-8	7.301029995663981		2.139	NR unit decrease	Affymetrix [NR]	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist-hip ratio	4,658 Korean ancestry females	5,295 Korean ancestry females	3p25.2	3	12269007	NR	GSTM5P1 - PPARG	ENSG00000236062	ENSG00000132170		10547	18361	rs139702234-A	rs139702234	0	139702234	regulatory_region_variant	1	0.02	5E-7	6.301029995663981		0.023	[0.013-0.033] unit increase	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist-hip ratio	4,658 Korean ancestry females	5,295 Korean ancestry females	6p21.32	6	32482357	NR	HLA-DRB9 - HLA-DRB5	ENSG00000226035	ENSG00000198502		8857	34996	rs5020945-C	rs5020945	0	5020945	intergenic_variant	1	0.49	3E-7	6.522878745280337		0.005	[0.003-0.007] unit increase	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist-hip ratio	4,658 Korean ancestry females	5,295 Korean ancestry females	3p25.1	3	14425755	NR	SLC6A6			ENSG00000131389			rs2341967-A	rs2341967	0	2341967	intron_variant	0	0.27	5E-7	6.301029995663981		0.006	[0.004-0.008] unit decrease	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist-hip ratio	4,658 Korean ancestry females	5,295 Korean ancestry females	3q27.3	3	187382298	NR	RTP4 - LINC02041	ENSG00000136514	ENSG00000228952		10222	66547	rs73059848-T	rs73059848	0	73059848	intergenic_variant	1	0.02	2E-7	6.698970004336019		0.024	[0.014-0.034] unit decrease	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist-hip ratio	4,658 Korean ancestry females	5,295 Korean ancestry females	13q22.2	13	74913034	NR	RIOK3P1 - NA	ENSG00000225944			82954		rs550532151-C	rs550532151	0	550532151	intergenic_variant	1	0.01	3E-7	6.522878745280337		0.037	[0.023-0.051] unit increase	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist-hip ratio	4,658 Korean ancestry females	5,295 Korean ancestry females	14q22.1	14	52009821	NR	NID2, RTRAF			ENSG00000087303, ENSG00000087302			rs61971548-T	rs61971548	0	61971548	3_prime_UTR_variant	0	0.2	1E-7	7.0		0.006	[0.004-0.008] unit decrease	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist circumference	4,658 Korean ancestry females	5,295 Korean ancestry females	5p15.33	5	3141301	NR	NA - LINC01377		ENSG00000249808			36534	rs7722169-T	rs7722169	0	7722169	intergenic_variant	1	0.09	2E-7	6.698970004336019		1.233	[0.76-1.7] unit decrease	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Waist circumference	4,658 Korean ancestry females	5,295 Korean ancestry females	16q12.2	16	53763996		FTO			ENSG00000140718			rs7206790-G	rs7206790	0	7206790	intron_variant	0	0.15	4E-7	6.3979400086720375		0.887	[0.54-1.23] unit increase	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Body mass index	4,658 Korean ancestry females	5,295 Korean ancestry females	1p31.1	1	78979021	NR	ADGRL4			ENSG00000162618			rs11162584-A	rs11162584	0	11162584	intron_variant	0	0.19	2E-7	6.698970004336019		0.325	[0.2-0.45] unit increase	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Body mass index	4,658 Korean ancestry females	5,295 Korean ancestry females	2p25.3	2	622388	NR	LINC01875 - TMEM18	ENSG00000225942	ENSG00000151353		75721	41489	rs6760543-G	rs6760543	0	6760543	intergenic_variant	1	0.09	5E-7	6.301029995663981		0.432	[0.26-0.6] unit decrease	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Body mass index	4,658 Korean ancestry females	5,295 Korean ancestry females	9q33.3	9	125252356	NR	HSPA5 - GAPVD1	ENSG00000044574	ENSG00000165219		10974	9438	rs828104-G	rs828104	0	828104	intron_variant	1	0.41	6E-7	6.221848749616356		0.225	[0.14-0.31] unit increase	Affymetrix [NR] (imputed)	N
2021-06-01	33209044	Ahn Y	2020-11-12	Diabetes Metab Syndr Obes	www.ncbi.nlm.nih.gov/pubmed/33209044	Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome.	Body mass index	4,658 Korean ancestry females	5,295 Korean ancestry females	16q12.2	16	53791993	NR	FTO			ENSG00000140718			rs56137030-A	rs56137030	0	56137030	intron_variant	0	0.13	3E-8	7.522878745280337		0.382	[0.25-0.52] unit increase	Affymetrix [NR] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023	NR	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-?	rs3814113	0	3814113	upstream_gene_variant	1	0.68	4E-29	28.397940008672037	(All invasive)	1.21	[1.17-1.25]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023	NR	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-?	rs3814113	0	3814113	upstream_gene_variant	1	0.68	4E-32	31.397940008672037	(Serious invasive)	1.28	[1.23-1.33]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703	MYC	LINC00824			ENSG00000254275			rs10088218-?	rs10088218	0	10088218	intron_variant	0	0.87	3E-12	11.522878745280337	(All invasive)	1.18	[1.13-1.24]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703	NR	LINC00824			ENSG00000254275			rs10088218-?	rs10088218	0	10088218	intron_variant	0	0.87	1E-17	17.0	(Serious invasive)	1.29	[1.21-1.36]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-?	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.32	5E-11	10.301029995663981	(All invasive)	1.11	[1.08-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-?	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.32	3E-10	9.522878745280337	(Serious invasive)	1.13	[1.09-1.18]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208	NR	TIPARP			ENSG00000163659			rs7651446-?	rs7651446	0	7651446	intron_variant	0	0.05	2E-29	28.69897000433602	(All invasive)	1.44	[1.35-1.54]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208	NR	TIPARP			ENSG00000163659			rs7651446-?	rs7651446	0	7651446	intron_variant	0	0.05	2E-34	33.69897000433602	(Serious invasive)	1.59	[1.48-1.71]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	2E-7	6.698970004336019	(All invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	3E-14	13.522878745280337	(Serious invasive)	1.19	[1.14-1.25]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138	NR	SKAP1			ENSG00000141293			rs9303542-?	rs9303542	0	9303542	intron_variant	0	0.27	6E-9	8.221848749616356	(All invasive)	1.12	[1.08-1.16]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138	NR	SKAP1			ENSG00000141293			rs9303542-?	rs9303542	0	9303542	intron_variant	0	0.27	3E-10	9.522878745280337	(Serious invasive)	1.14	[1.09-1.18]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			ENSG00000164695			rs11782652-A	rs11782652	0	11782652	intron_variant	0	0.07	6E-9	8.221848749616356	(All invasive)	1.19	[1.12-1.26]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			ENSG00000078403			rs1243180-T	rs1243180	0	1243180	intron_variant	0	0.31	2E-8	7.698970004336019	(All invasive)	1.1	[1.06-1.13]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			ENSG00000078403			rs1243180-T	rs1243180	0	1243180	intron_variant	0	0.31	1E-7	7.0	(Serious invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q12	17	37736525	HNF1B, ACACA, C17orf78, TADA2A, DUSP14, SYNRG, DDX52, TBC1D3F, TBC1D3, MRPL45, GPR179, SOCS7, ARHGAP23	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs757210-G	rs757210	0	757210	intron_variant	0	0.37	8E-10	9.096910013008056	(Serious invasive)	1.12	[1.08-1.17]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			ENSG00000164695			rs11782652-A	rs11782652	0	11782652	intron_variant	0	0.07	7E-10	9.154901959985743	(Serious invasive)	1.24	[1.16-1.33]	Illumina [2508744] (imputed)	N
2015-10-26	25574032	Lee H	2015-01-08	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/25574032	Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome.	Polycystic ovary syndrome	976 Korean ancestry cases, 946 Korean ancestry controls	249 Korean ancestry cases, 778 Korean ancestry controls	4q35.2	4	188576910	TRIML1, TRIML2	LINC01060, LINC01060			ENSG00000281580, ENSG00000249378			rs7666129-A	rs7666129	0	7666129	intron_variant	0	0.75	6E-6	5.221848749616356		1.59	[NR]	Illumina [636870]	N
2015-10-26	25574032	Lee H	2015-01-08	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/25574032	Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome.	Polycystic ovary syndrome	976 Korean ancestry cases, 946 Korean ancestry controls	249 Korean ancestry cases, 778 Korean ancestry controls	8q24.23	8	136144207	KHDRBS3	LINC02055			ENSG00000254101			rs10505648-A	rs10505648	0	10505648	intron_variant	0	0.906	5E-8	7.301029995663981		1.92	[NR]	Illumina [636870]	N
2015-10-26	25574032	Lee H	2015-01-08	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/25574032	Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome.	Polycystic ovary syndrome	976 Korean ancestry cases, 946 Korean ancestry controls	249 Korean ancestry cases, 778 Korean ancestry controls	16p13.3	16	1000877	SOX8, LMF1, SSTR5	SOX8 - SSTR5-AS1	ENSG00000005513	ENSG00000261713		13898	63216	rs500492-A	rs500492	0	500492	non_coding_transcript_exon_variant	1	0.65	6E-6	5.221848749616356		1.32	[NR]	Illumina [636870]	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	9p22.2	9	16915023	BNC2	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-G	rs3814113	0	3814113	upstream_gene_variant	1	0.32	6E-50	49.221848749616356		1.2658228	[1.22-1.32]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	8q24.21	8	128531703	CMYC	LINC00824			ENSG00000254275			rs10088218-A	rs10088218	0	10088218	intron_variant	0	0.13	1E-20	20.0		1.2987013	[1.22-1.37]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	2q31.1	2	176177905	HOXD1	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-A	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.68	9E-14	13.045757490560675		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	3q25.31	3	156689208	TIPARP	TIPARP			ENSG00000163659			rs7651446-A	rs7651446	0	7651446	intron_variant	0	0.05	6E-51	50.221848749616356		1.59	[1.48-1.70]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	19p13.11	19	17278895	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.19	5E-14	13.301029995663981		1.18	[1.13-1.23]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q21.32	17	48334138	SKAP1	SKAP1			ENSG00000141293			rs9303542-G	rs9303542	0	9303542	intron_variant	0	0.27	5E-15	14.301029995663981		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	8q21.13	8	81741409	CHMP4C	CHMP4C			ENSG00000164695			rs11782652-G	rs11782652	0	11782652	intron_variant	0	0.07	3E-10	9.522878745280337			[1.16-1.32]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	10p12.31	10	21626690	MLLT10	MLLT10			ENSG00000078403			rs1243180-A	rs1243180	0	1243180	intron_variant	0	0.31	1E-9	9.0		1.1	[1.06-1.14]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q12	17	37736525	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs757210-A	rs757210	0	757210	intron_variant	0	0.63	2E-8	7.698970004336019		1.11	[1.07-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-A	rs10069690	0	10069690	intron_variant	0	0.26	9E-9	8.045757490560675		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q21.31	17	46710944	PLEKHM1	NSF, NSF			ENSG00000276262, ENSG00000073969			rs183211-A	rs183211	0	183211	intron_variant	0	0.24	2E-13	12.698970004336019		1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p36.12	1	22141722	WNT4	WNT4			ENSG00000162552			rs3820282-?	rs3820282	0	3820282	intron_variant	0	NR	2E-8	7.698970004336019		1.11	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p34.3	1	37616450	RSPO1	RSPO1			ENSG00000169218			rs12039431-?	rs12039431	0	12039431	intron_variant	0	NR	1E-8	8.0		1.07	[1.03-1.11]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	4q26	4	119028805	SYNPO2	SYNPO2			ENSG00000172403			rs17329882-?	rs17329882	0	17329882	intron_variant	0	NR	2E-8	7.698970004336019		1.09	[1.06-1.13]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	6p22.1	6	28518321	GPX6	GPX6			ENSG00000198704			rs115344852-?	rs115344852	1	6456823	intron_variant	0	NR	6E-6	5.221848749616356		1.0638298	[1.03-1.1]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	16q21	16	58942687	intergenic	NA - Metazoa_SRP		ENSG00000276525			61526	rs8044477-?	rs8044477	0	8044477	intron_variant	1	NR	1E-8	8.0		1.1		Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p36.12	1	22141722	WNT4	WNT4			ENSG00000162552			rs3820282-?	rs3820282	0	3820282	intron_variant	0	NR	8E-8	7.096910013008056	(Serous)	1.12	[1.07-1.17]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p34.3	1	37616450	RSPO1	RSPO1			ENSG00000169218			rs12039431-?	rs12039431	0	12039431	intron_variant	0	NR	1E-11	11.0	(Serous)	1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	4q26	4	119028805	SYNPO2	SYNPO2			ENSG00000172403			rs17329882-?	rs17329882	0	17329882	intron_variant	0	NR	2E-8	7.698970004336019	(Serous)	1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	6p22.1	6	28518321	GPX6	GPX6			ENSG00000198704			rs115344852-?	rs115344852	1	6456823	intron_variant	0	NR	3E-8	7.522878745280337	(Serous)	1.098901	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	16q21	16	58942687	intergenic	NA - Metazoa_SRP		ENSG00000276525			61526	rs8044477-?	rs8044477	0	8044477	intron_variant	1	NR	2E-7	6.698970004336019	(Serous)	1.1	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17278895	C19orf62, MERIT40	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-T	rs8170	0	8170	synonymous_variant	0	NR	4E-6	5.3979400086720375	(Susceptibility)	1.12	[1.07-1.17]	Illumina [540573]	N
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17283315	ANKLE1	ANKLE1			ENSG00000160117			rs2363956-T	rs2363956	0	2363956	missense_variant	0	NR	1E-7	7.0	(Susceptibility)	1.1	[1.06-1.15]	Illumina [540573]	N
2011-01-16	21151128	Chen ZJ	2010-12-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21151128	Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.	Polycystic ovary syndrome	744 Han Chinese ancestry cases, 895 Han Chinese ancestry controls	3,338 Han Chinese ancestry cases, 5,792 Han Chinese ancestry controls	2p21	2	43411699	ZFP36L2, LOC100129726, THADA	THADA			ENSG00000115970			rs13429458-A	rs13429458	0	13429458	intron_variant	0	0.91	2E-23	22.69897000433602		1.49	[1.39-1.61]	Affymetrix [611633]	N
2011-01-16	21151128	Chen ZJ	2010-12-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21151128	Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.	Polycystic ovary syndrome	744 Han Chinese ancestry cases, 895 Han Chinese ancestry controls	3,338 Han Chinese ancestry cases, 5,792 Han Chinese ancestry controls	9q33.3	9	123684499	DENND1A	DENND1A			ENSG00000119522			rs10818854-A	rs10818854	0	10818854	intron_variant	0	0.09	9E-18	17.045757490560675		1.51	[1.37-1.65]	Affymetrix [611633]	N
2011-01-16	21151128	Chen ZJ	2010-12-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21151128	Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.	Polycystic ovary syndrome	744 Han Chinese ancestry cases, 895 Han Chinese ancestry controls	3,338 Han Chinese ancestry cases, 5,792 Han Chinese ancestry controls	9q33.3	9	123762933	DENND1A	DENND1A			ENSG00000119522			rs2479106-G	rs2479106	0	2479106	intron_variant	0	0.22	8E-19	18.096910013008056		1.34	[1.26-1.43]	Affymetrix [611633]	N
2011-01-16	21151128	Chen ZJ	2010-12-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21151128	Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.	Polycystic ovary syndrome	744 Han Chinese ancestry cases, 895 Han Chinese ancestry controls	3,338 Han Chinese ancestry cases, 5,792 Han Chinese ancestry controls	2p16.3	2	48751020	FSHR, GTF2A1L, LHCGR	LHCGR, STON1-GTF2A1L			ENSG00000138039, ENSG00000068781			rs13405728-A	rs13405728	0	13405728	intron_variant	0	0.76	8E-21	20.096910013008056		1.41	[1.30-1.49]	Affymetrix [611633]	N
2011-01-16	21151128	Chen ZJ	2010-12-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21151128	Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.	Polycystic ovary syndrome	744 Han Chinese ancestry cases, 895 Han Chinese ancestry controls	3,338 Han Chinese ancestry cases, 5,792 Han Chinese ancestry controls	2p21	2	43494369	ZFP36L2, LOC100129726, THADA	THADA			ENSG00000115970			rs12478601-C	rs12478601	0	12478601	intron_variant	0	0.71	3E-23	22.522878745280337		1.39	[1.30-1.49]	Affymetrix [611633]	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs17631303-?	rs17631303	0	17631303	intron_variant	0	NR	1E-8	8.0				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944	NR	NSF, NSF			ENSG00000276262, ENSG00000073969			rs183211-?	rs183211	0	183211	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	9p22.2	9	16915023	intergenic	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-A	rs3814113	0	3814113	upstream_gene_variant	1	0.66	6E-11	10.221848749616356		1.3	[1.2-1.41]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	3q25.31	3	156679960	intergenic	TIPARP			ENSG00000163659			rs2665390-C	rs2665390	0	2665390	intron_variant	0	0.043	7E-6	5.154901959985743		1.46	[1.25-1.71]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036	intergenic	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs17631303-G	rs17631303	0	17631303	intron_variant	0	0.19	1E-8	8.0		1.27	[1.17-1.38]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944	intergenic	NSF, NSF			ENSG00000276262, ENSG00000073969			rs183211-A	rs183211	0	183211	intron_variant	0	0.23	3E-8	7.522878745280337		1.25	[1.16-1.35]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	4q32.3	4	164987569	intergenic	TRIM61 - TRIM60	ENSG00000183439	ENSG00000176979		9901	28889	rs4691139-G	rs4691139	0	4691139	non_coding_transcript_exon_variant	1	0.48	3E-8	7.522878745280337		1.2	[1.17-1.38]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	6q25.1	6	151627231	intergenic	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-C	rs2046210	0	2046210	regulatory_region_variant	1	0.08	5E-9	8.301029995663981		1.28	[1.18-1.39]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	12p11.22	12	28002147	intergenic	PTHLH - NA	ENSG00000087494			29414		rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.86	8E-6	5.096910013008056		1.18	[1.1-1.27]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	1q32.1	1	204546897	MDM4	MDM4			ENSG00000198625			rs2290854-A	rs2290854	0	2290854	intron_variant	0	0.31	1E-7	7.0		1.13	[1.08-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	10q25.2	10	112974337	TCF7L2	TCF7L2			ENSG00000148737			rs11196174-G	rs11196174	0	11196174	intron_variant	0	0.28	8E-7	6.096910013008056		1.13	[1.07-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	7p21.3	7	8512984	NR	NXPH1			ENSG00000122584			rs765855-?	rs765855	0	765855	intron_variant	0	NR	4E-6	5.3979400086720375				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	19p13.11	19	17278895	intergenic	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-G	rs8170	0	8170	synonymous_variant	0	0.48	4E-13	12.397940008672037		1.19	[1.14-1.25]	Illumina [2568349] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	3q25.31	3	156679960	TIPARP	TIPARP			ENSG00000163659			rs2665390-C	rs2665390	0	2665390	intron_variant	0	NR	3E-7	6.522878745280337		1.19	[1.11-1.27]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	1p36.12	1	22164231	NR	WNT4 - MIR4418	ENSG00000162552	ENSG00000266564		20262	102008	rs7521902-?	rs7521902	0	7521902	regulatory_region_variant	1	NR	5E-6	5.301029995663981		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	11p14.3	11	25186158	NR							rs12794435-?	rs12794435	0	12794435	intergenic_variant	1	NR	5E-6	5.301029995663981		1.16	[1.09-1.23]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	2q31.1	2	176177905	HOXD1, HOXD3	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-T	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	NR	5E-14	13.301029995663981		1.16	[1.12-1.21]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	8q24.21	8	128531703	MYC, THEM75	LINC00824			ENSG00000254275			rs10088218-G	rs10088218	0	10088218	intron_variant	0	NR	3E-9	8.522878745280337		1.19	[1.12-1.25]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48334138	SKAP1	SKAP1			ENSG00000141293			rs9303542-G	rs9303542	0	9303542	intron_variant	0	NR	1E-6	6.0		1.11	[1.06-1.16]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48279758	NR	SKAP1			ENSG00000141293			rs2084881-?	rs2084881	0	2084881	intron_variant	0	NR	2E-6	5.698970004336019		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N
2009-09-04	19648919	Song H	2009-08-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19648919	A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.	Ovarian cancer	1,817 European ancestry cases, 2,353 European ancestry controls	6,944 European ancestry cases, 9,477 European ancestry controls	9p22.2	9	16915023	BNC2, LOC648570, CNTLN	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-T	rs3814113	0	3814113	upstream_gene_variant	1	0.68	5E-19	18.30102999566398		1.22	[1.16-1.27]	Illumina [up to 2000000] (imputed)	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	12p13.1	12	13774962	GRIN2B	GRIN2B			ENSG00000273079			rs6488619-?	rs6488619	0	6488619	intron_variant	0	NR	9E-7	6.045757490560675	(FSH levels - EA)			Affymetrix [677261]	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	5p13.3	5	32748531	NPR3	NPR3			ENSG00000113389			rs10061804-?	rs10061804	0	10061804	intron_variant	0	NR	1E-6	6.0	(FSH levels - EA)			Affymetrix [677261]	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	3p25.1	3	13919660	TPRXL	WNT7A - VN1R20P	ENSG00000154764	ENSG00000233121		39589	7153	rs9875589-?	rs9875589	0	9875589	intergenic_variant	1	NR	4E-6	5.3979400086720375	(AMH levels - AA)			Affymetrix [677261]	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	11p15.1	11	18668106	TMEM86A	SRSF3P1 - TMEM86A	ENSG00000257043	ENSG00000151117		2558	25016	rs12295403-?	rs12295403	0	12295403	regulatory_region_variant	1	NR	5E-6	5.301029995663981	(AMH levels- AA)			Affymetrix [677261]	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	6p23	6	14586772	JARID2	NA - RNU6-793P		ENSG00000206960			59763	rs12213875-?	rs12213875	0	12213875	intergenic_variant	1	NR	3E-7	6.522878745280337	(AMH - EA)			Affymetrix [677261]	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	2p22.3	2	34405965	MYADML	LINC01320			ENSG00000228262			rs6543833-?	rs6543833	0	6543833	intron_variant	0	NR	8E-8	7.096910013008056	(FSH levels - AA)			Affymetrix [677261]	N
2012-01-11	22116950	Schuh-Huerta SM	2011-11-24	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/22116950	Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women.	Ovarian reserve	232 European ancestry female individuals, 200 African American female individuals	NA	10p14	10	7694941	ITIH2	ITIH5 - ITIH2	ENSG00000123243	ENSG00000151655		27943	8375	rs11255291-?	rs11255291	0	11255291	intergenic_variant	1	NR	2E-6	5.698970004336019	(FSH levels - AA)			Affymetrix [677261]	N
2011-11-08	21989058	Qin Y	2011-10-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21989058	Association of 8q22.3 locus in Chinese Han with idiopathic premature ovarian failure (POF).	Premature ovarian failure	391 Han Chinese ancestry cases, 895 Han Chinese ancestry controls	400 Han Chinese ancestry cases, 800 Han Chinese ancestry controls	8q22.3	8	100800928	intergenic	RPS20P23 - RNU4-83P	ENSG00000242399	ENSG00000222795		24063	30800	rs3847153-?	rs3847153	0	3847153	intergenic_variant	1	0.38	9E-8	7.045757490560675		1.42	[NR]	Affymetrix [642069]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr1:2428447-?	chr1:2428447	0			1	NR	2E-6	5.698970004336019		63.6913	[61.98-65.4]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	1p33	1	48298840		SPATA6			ENSG00000132122			rs146976708-?	rs146976708	0	146976708	missense_variant	0	NR	4E-7	6.3979400086720375		28.2301	[26.94-29.52]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											rs144914170-?	rs144914170	0	144914170		1	NR	2E-6	5.698970004336019		138.28	[136.25-140.31]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	1p13.2	1	114673738		AMPD1			ENSG00000116748			rs115092288-?	rs115092288	0	115092288	missense_variant	0	NR	1E-7	7.0		8.08829	[7.31-8.86]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	1q31.2	1	192554787		RGS21 - RGS1	ENSG00000253148	ENSG00000090104		187502	20976	rs17676711-?	rs17676711	0	17676711	intron_variant	1	NR	2E-7	6.698970004336019		2.14014	[1.85-2.43]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr2:112917417-?	chr2:112917417	0			1	NR	7E-6	5.154901959985743		42.8899	[41.25-44.53]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr2:220497736-?	chr2:220497736	0			1	NR	2E-8	7.698970004336019		40.6028	[39.32-41.89]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	3p21.31	3	45158636		CDCP1 - RPS24P8	ENSG00000163814	ENSG00000224094		12214	1138	rs80104686-?	rs80104686	0	80104686	intergenic_variant	1	NR	2E-6	5.698970004336019		2.50127	[2.12-2.88]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr3:136019929-?	chr3:136019929	0			1	NR	1E-6	6.0		75.6952	[73.95-77.44]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	4p14	4	40121779		N4BP2			ENSG00000078177			rs80192073-?	rs80192073	0	80192073	missense_variant	0	NR	1E-6	6.0		72.5348	[70.79-74.28]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	6p21.33	6	31129248		PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs74375290-?	rs74375290	0	74375290	intron_variant	0	NR	6E-6	5.221848749616356		2.32386	[1.96-2.69]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	6q24.3	6	145686276		EPM2A			ENSG00000112425			rs137852915-?	rs137852915	0	137852915	missense_variant	0	NR	4E-6	5.3979400086720375		41.4303	[39.85-43.01]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	7p11.2	7	57372353		RNU7-157P - MIR3147	ENSG00000238431	ENSG00000266168		145287	32672	rs115128033-?	rs115128033	0	115128033	intergenic_variant	1	NR	9E-6	5.045757490560675		16.1143	[14.89-17.34]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	7q31.32	7	122011697		PTPRZ1			ENSG00000106278			rs150698072-?	rs150698072	0	150698072	missense_variant	0	NR	4E-8	7.3979400086720375		8.76932	[7.99-9.55]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	7q36.1	7	151775905		PRKAG2			ENSG00000106617			rs4726091-?	rs4726091	0	4726091	intron_variant	0	NR	3E-6	5.522878745280337		1.34051	[1.22-1.46]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	8q24.3	8	144437000		TONSL			ENSG00000160949			rs182634476-?	rs182634476	0	182634476	intron_variant	0	NR	8E-6	5.096910013008056		10.5913	[9.56-11.63]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	9p13.3	9	34972355		PHF24			ENSG00000122733			rs181962423-?	rs181962423	0	181962423	missense_variant	0	NR	8E-6	5.096910013008056		2.69781	[2.26-3.13]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	11p15.4	11	10778732		CTR9			ENSG00000198730			rs141131642-?	rs141131642	0	141131642	missense_variant	0	NR	5E-6	5.301029995663981		4.80411	[4.13-5.48]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	11q12.1	11	57776189		CTNND1			ENSG00000198561			rs67812265-?	rs67812265	0	67812265	intron_variant	0	NR	6E-6	5.221848749616356		1.43119	[1.28-1.59]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	11q24.2	11	126209490		RPUSD4			ENSG00000165526			rs75453040-?	rs75453040	0	75453040	splice_donor_variant	0	NR	8E-7	6.096910013008056		26.7083	[25.4-28.01]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	12q24.32	12	127203336		LINC02405 - LINC02376	ENSG00000249345	ENSG00000256292		142771	70929	rs75214037-?	rs75214037	0	75214037	intron_variant	1	NR	8E-6	5.096910013008056		1.55338	[1.36-1.75]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr14:23894993-?	chr14:23894993	0			1	NR	4E-7	6.3979400086720375		25.3555	[24.1-26.61]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr16:67324783-?	chr16:67324783	0			1	NR	2E-6	5.698970004336019		79.7287	[77.91-81.54]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA	17q21.2	17	41734613		HAP1			ENSG00000173805			rs201166499-?	rs201166499	0	201166499	missense_variant	0	NR	8E-6	5.096910013008056		15.9551	[14.74-17.17]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls	NA											chr20:43739036-?	chr20:43739036	0			1	NR	6E-6	5.221848749616356		38.6328	[37.05-40.22]	NR [666300]	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241788683		GAL3ST2			ENSG00000154252			rs62193063-T	rs62193063	0	62193063	intron_variant	0	0.17	1E-184	184.0		0.5343	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	16p13.3	16	778080		MSLNL			ENSG00000162006			rs114590746-T	rs114590746	0	114590746	intron_variant	0	0.012	5E-48	47.30102999566398		1.0386	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241762574		D2HGDH			ENSG00000180902			rs7569717-T	rs7569717	0	7569717	intron_variant	0	0.27	1E-41	41.0		0.2178	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241808893		GAL3ST2 - NEU4	ENSG00000154252	ENSG00000204099		4606	172	rs62193087-A	rs62193087	0	62193087	5_prime_UTR_variant	1	0.76	4E-34	33.39794000867204		0.1842	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241784018		GAL3ST2			ENSG00000154252			rs73011950-A	rs73011950	0	73011950	intron_variant	0	0.94	1E-26	26.0		0.3606	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	16p13.3	16	770888		MSLNL			ENSG00000162006			rs12599339-T	rs12599339	0	12599339	missense_variant	0	0.75	7E-25	24.154901959985743		0.1681	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	19p13.2	19	9025630		BOLA3P2 - OR1M4P	ENSG00000267332	ENSG00000267154		5646	57482	rs11672713-C	rs11672713	0	11672713	intergenic_variant	1	0.72	2E-24	23.69897000433602		0.163	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	19p13.2	19	8898485		MUC16			ENSG00000181143			rs12976386-A	rs12976386	0	12976386	intron_variant	0	0.45	1E-16	16.0		0.1298	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	20q13.2	20	55968150		LINC01440 - CBLN4	ENSG00000235166	ENSG00000054803		283235	29207	rs4811647-T	rs4811647	0	4811647	intergenic_variant	1	0.05	1E-6	6.0		1.05	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females, 4,182 Korean ancestry males	NA	1p36.32	1	2588863		PRXL2B, PRXL2B			ENSG00000157870, ENSG00000275125			rs6667564-C	rs6667564	0	6667564	non_coding_transcript_exon_variant	0	0.45	5E-6	5.301029995663981		0.34	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females, 4,182 Korean ancestry males	NA	3p24.1	3	29804902		RBMS3			ENSG00000144642			rs41402044-A	rs41402044	0	41402044	intron_variant	0	0.04	5E-7	6.301029995663981		0.94	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females, 4,182 Korean ancestry males	NA	6q27	6	166055427		LINC00602 - GAPDHP72	ENSG00000281832	ENSG00000216624		65812	3078	rs300614-C	rs300614	0	300614	intergenic_variant	1	0.04	8E-7	6.096910013008056		0.95	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females, 4,182 Korean ancestry males	NA	13q13.3	13	37386881		RPS12P24 - LINC01048	ENSG00000230283	ENSG00000230390		165635	94586	rs17833980-A	rs17833980	0	17833980	regulatory_region_variant	1	0.02	3E-6	5.522878745280337		1.25	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females, 4,182 Korean ancestry males	NA	14q23.3	14	64956078		RAB15, CHURC1-FNTB			ENSG00000139998, ENSG00000125954			rs4902352-G	rs4902352	0	4902352	intron_variant	0	0.19	3E-7	6.522878745280337		0.48	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females, 4,182 Korean ancestry males	NA	18q23	18	75712821		LINC01898			ENSG00000261194			rs7240284-T	rs7240284	0	7240284	non_coding_transcript_exon_variant	0	0.01	7E-6	5.154901959985743		1.5	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	1p36.32	1	2588863		PRXL2B, PRXL2B			ENSG00000157870, ENSG00000275125			rs6667564-C	rs6667564	0	6667564	non_coding_transcript_exon_variant	0	0.45	5E-6	5.301029995663981		0.5	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	2p14	2	64218429		LINC00309 - MIR4433B	ENSG00000230923	ENSG00000264297		12944	122318	rs1898445-C	rs1898445	0	1898445	intron_variant	1	0.03	8E-6	5.096910013008056		1.32	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	3p24.3	3	18103572		TBC1D5			ENSG00000131374			rs7624278-G	rs7624278	0	7624278	intron_variant	0	0.01	2E-7	6.698970004336019		2.5	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	3p24.1	3	29804902		RBMS3			ENSG00000144642			rs41402044-A	rs41402044	0	41402044	intron_variant	0	0.04	4E-7	6.3979400086720375		1.38	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	3q21.3	3	127762475		MGLL			ENSG00000074416			rs664954-T	rs664954	0	664954	intron_variant	0	0.04	1E-5	5.0		1.25	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	6q27	6	166055427		LINC00602 - GAPDHP72	ENSG00000281832	ENSG00000216624		65812	3078	rs300614-C	rs300614	0	300614	intergenic_variant	1	0.04	9E-7	6.045757490560675		1.37	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	7q11.22	7	71169469		GALNT17			ENSG00000185274			rs17142629-T	rs17142629	0	17142629	intron_variant	0	0.01	2E-6	5.698970004336019		2.73	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	10q21.3	10	64620360		DBF4P1 - RPL17P35	ENSG00000235489	ENSG00000233900		449510	14	rs748701-C	rs748701	0	748701	intron_variant	1	0.21	5E-6	5.301029995663981		0.63	unit decrease	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	10q23.1	10	80671657		LINC02655 - RPS7P9	ENSG00000231082	ENSG00000233353		17925	44826	rs12255425-A	rs12255425	0	12255425	intergenic_variant	1	0.48	7E-6	5.154901959985743		0.47	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	13q13.3	13	37386881		RPS12P24 - LINC01048	ENSG00000230283	ENSG00000230390		165635	94586	rs17833980-A	rs17833980	0	17833980	regulatory_region_variant	1	0.02	3E-6	5.522878745280337		1.82	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	14q23.3	14	64956078		RAB15, CHURC1-FNTB			ENSG00000139998, ENSG00000125954			rs4902352-G	rs4902352	0	4902352	intron_variant	0	0.19	4E-6	5.3979400086720375		0.62	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	18p11.21	18	15069727		LINC01443 - BNIP3P3	ENSG00000266554	ENSG00000265631		95512	177702	rs12605904-T	rs12605904	0	12605904	intergenic_variant	1	0.15	4E-6	5.3979400086720375		0.67	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,658 Korean ancestry females	NA	20q12	20	41680591		CHD6 - RNU6-1018P	ENSG00000124177	ENSG00000252386		62207	4395	rs17210039-G	rs17210039	0	17210039	intergenic_variant	1	0.19	2E-6	5.698970004336019		0.62	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	1q25.3	1	181593133		CACNA1E			ENSG00000198216			rs16857762-T	rs16857762	0	16857762	intron_variant	0	0.02	1E-6	6.0		1.89	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	2q22.3	2	145395839		RPL6P5 - METAP2P1	ENSG00000214064	ENSG00000234119		57782	430446	rs16824898-A	rs16824898	0	16824898	intergenic_variant	1	0.13	2E-6	5.698970004336019		0.69	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	3p26.3	3	2514110		CNTN4			ENSG00000144619			rs9864558-T	rs9864558	0	9864558	intron_variant	0	0.05	2E-6	5.698970004336019		1.05	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	3p22.1	3	40086933		EIF1B-AS1, MYRIP			ENSG00000280739, ENSG00000170011			rs17075541-T	rs17075541	0	17075541	intron_variant	0	0.2	6E-6	5.221848749616356		0.59	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	3q26.1	3	166247742		MCUR1P2 - LINC01326	ENSG00000242326	ENSG00000244321		65922	321951	rs9831653-A	rs9831653	0	9831653	intergenic_variant	1	0.01	3E-6	5.522878745280337		1.94	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	4q13.1	4	63389761		LARP1BP1 - TECRL	ENSG00000231442	ENSG00000205678		38289	885496	rs10434233-G	rs10434233	0	10434233	intergenic_variant	1	0.02	7E-6	5.154901959985743		1.63	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	8q21.3	8	87535552		CNBD1			ENSG00000176571			rs10504835-G	rs10504835	0	10504835	intron_variant	0	0.15	8E-7	6.096910013008056		0.68	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	11p12	11	39031277		LINC01493 - RNU6-99P	ENSG00000254562	ENSG00000201591		344954	229830	rs2861585-T	rs2861585	0	2861585	intron_variant	1	0.01	2E-6	5.698970004336019		1.97	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	16q23.3	16	82855330		CDH13			ENSG00000140945			rs286679-G	rs286679	0	286679	intron_variant	0	0.04	2E-6	5.698970004336019		1.18	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	17p13.1	17	8354295		ODF4 - KRBA2	ENSG00000184650	ENSG00000184619		8247	2607	rs4792346-C	rs4792346	0	4792346	regulatory_region_variant	1	0.27	3E-6	5.522878745280337		0.51	unit decrease	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	18q23	18	75712821		LINC01898			ENSG00000261194			rs7240284-T	rs7240284	0	7240284	non_coding_transcript_exon_variant	0	0.01	4E-6	5.3979400086720375		2.04	unit increase	Affymetrix [NR] (imputed)	N
2021-10-20	34304350	Lim WY	2021-07-25	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/34304350	Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.	Insulin levels	4,182 Korean ancestry male	NA	19q13.43	19	56739530		ZIM2-AS1			ENSG00000269793			rs9967637-G	rs9967637	0	9967637	intron_variant	0	0.01	3E-6	5.522878745280337		2.03	unit increase	Affymetrix [NR] (imputed)	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	16q12.2	16	53782363		FTO			ENSG00000140718			rs8050136-A	rs8050136	0	8050136	intron_variant	0	0.41	2E-85	84.69897000433602				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	18q21.32	18	60302011		RNU4-17P - MC4R	ENSG00000202468	ENSG00000166603		138304	69051	rs9675376-A	rs9675376	0	9675376	downstream_gene_variant	1	0.3	4E-10	9.397940008672037				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	1q32.3	1	214007176		PROX1			ENSG00000117707			rs72753599-T	rs72753599	0	72753599	intron_variant	0	0.2	4E-13	12.397940008672037				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	4p12	4	45184122		PRDX4P1 - THAP12P9	ENSG00000248987	ENSG00000248320		239161	139131	rs10938398-A	rs10938398	0	10938398	intergenic_variant	1	0.42	1E-12	12.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	16q12.2	16	53796540		FTO			ENSG00000140718			rs9930501-A	rs9930501	0	9930501	intron_variant	0	0.55	6E-15	14.221848749616356				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	2q24.3	2	164881421		RNA5SP110 - SLC38A11	ENSG00000199508	ENSG00000169507		22875	12933	rs1509097-T	rs1509097	0	1509097	intron_variant	1	0.5	3E-8	7.522878745280337				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	19q13.32	19	45675403		GIPR			ENSG00000010310			rs2238689-T	rs2238689	0	2238689	non_coding_transcript_exon_variant	0	0.57	1E-23	23.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	1q32.3	1	214007176		PROX1			ENSG00000117707			rs72753599-T	rs72753599	0	72753599	intron_variant	0	0.2	6E-14	13.221848749616356				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 74,124 type 2 diabetes European ancestry cases, upto 824,006 European ancestry controls without type 2 diabetes, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	3q21.1	3	123300916		ADCY5			ENSG00000173175			rs3934729-T	rs3934729	0	3934729	intron_variant	0	0.61	1E-8	8.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting glucose, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	1q32.3	1	214007176		PROX1			ENSG00000117707			rs72753599-T	rs72753599	0	72753599	intron_variant	0	0.2	2E-12	11.698970004336019				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting glucose, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	3q21.1	3	123303023		ADCY5			ENSG00000173175			rs9844212-C	rs9844212	0	9844212	intron_variant	0	0.59	4E-13	12.397940008672037				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting glucose, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	11p11.2	11	46777081		CKAP5			ENSG00000175216			rs6485690-A	rs6485690	0	6485690	intron_variant	0	0.34	1E-10	10.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting insulin, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	8p23.1	8	11758186		GATA4			ENSG00000285109			rs745379-A	rs745379	0	745379	intron_variant	0	0.48	1E-9	9.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting insulin, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	16q23.2	16	79721183		MAFTRR, LINC01229			ENSG00000261390, ENSG00000260876			rs3813583-A	rs3813583	0	3813583	intron_variant	0	0.62	3E-8	7.522878745280337				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting insulin, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	3p25.2	3	12355089		PPARG			ENSG00000132170			rs4135247-A	rs4135247	0	4135247	intron_variant	0	0.56	6E-9	8.221848749616356				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	16q12.2	16	53764710		FTO			ENSG00000140718			rs8047587-T	rs8047587	0	8047587	intron_variant	0	0.45	3E-10	9.522878745280337				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	12q24.11	12	111270654		CUX2			ENSG00000111249			rs1265564-A	rs1265564	0	1265564	non_coding_transcript_exon_variant	0	0.58	3E-13	12.522878745280337				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	19q13.32	19	45675403		GIPR			ENSG00000010310			rs2238689-T	rs2238689	0	2238689	non_coding_transcript_exon_variant	0	0.57	1E-8	8.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome	NA	7q31.32	7	123643895		ASB15 - LMOD2	ENSG00000146809	ENSG00000170807		4414	11971	rs4731113-T	rs4731113	0	4731113	downstream_gene_variant	1	0.97	3E-9	8.522878745280337				NR [NR]	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	2q34	2	212523176	ERB4	ERBB4			ENSG00000178568			rs7564590-T	rs7564590	0	7564590	intron_variant	0	0.3556	5E-11	10.301029995663981		1.19	[1.131.25]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	5p15.1	5	16835896	MYO10	MYO10			ENSG00000145555			rs9312937-C	rs9312937	0	9312937	intron_variant	0	0.4458	2E-8	7.698970004336019		1.16	[1.101.22]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	9q33.3	9	123773274	DENND1A	DENND1A			ENSG00000119522			rs3945628-C	rs3945628	0	3945628	intron_variant	0	0.0699	3E-12	11.522878745280337		1.4	[1.271.55]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	11p14.1	11	30193714	FSHB	NA - ARL14EP-DT		ENSG00000254532			129274	rs11031002-A	rs11031002	0	11031002	intron_variant	1	0.12210000000000001	9E-9	8.045757490560675		1.24	[1.151.34]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	11q23.2	11	114081775	ZBTB16	ZBTB16			ENSG00000109906			rs1672716-G	rs1672716	0	1672716	intron_variant	0	0.1451	1E-8	8.0		0.81	[0.760.87]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	22q12.1	22	29020414	ZNFR3	ZNRF3			ENSG00000183579			rs145598156-T	rs145598156	0	145598156	intron_variant	0	0.0052	4E-8	7.3979400086720375		3.01	[2.024.50]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age)	797 European ancestry cases, 140,558 European ancestry controls	2,812 European ancestry cases, 229,788 European ancestry controls	22q12.1	22	28702388	TTC28	CHEK2			ENSG00000183765			rs182075939-G	rs182075939	0	182075939	intron_variant	0	0.0441	2E-16	15.698970004336019		1.69	[1.491.91]	NR [24154061] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age and BMI)	482 European ancestry cases, 91,631 European ancestry controls	2,137 European ancestry cases, 68,690 European ancestry controls	2q34	2	212523176	ERBB4	ERBB4			ENSG00000178568			rs7564590-T	rs7564590	0	7564590	intron_variant	0	0.3556	5E-9	8.301029995663981		1.19	[1.131.25]	NR [24481103] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age and BMI)	482 European ancestry cases, 91,631 European ancestry controls	2,137 European ancestry cases, 68,690 European ancestry controls	5p15.1	5	16835896	MYO10	MYO10			ENSG00000145555			rs9312937-C	rs9312937	0	9312937	intron_variant	0	0.4458	3E-6	5.522878745280337		1.15	[1.081.22]	NR [24481103] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age and BMI)	482 European ancestry cases, 91,631 European ancestry controls	2,137 European ancestry cases, 68,690 European ancestry controls	9q33.3	9	123773274	DENND1A	DENND1A			ENSG00000119522			rs3945628-C	rs3945628	0	3945628	intron_variant	0	0.0699	1E-8	8.0		1.38	[1.231.54]	NR [24481103] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age and BMI)	482 European ancestry cases, 91,631 European ancestry controls	2,137 European ancestry cases, 68,690 European ancestry controls	11q23.2	11	114081775	ZBTB16	ZBTB16			ENSG00000109906			rs1672716-G	rs1672716	0	1672716	intron_variant	0	0.1451	5E-7	6.301029995663981		0.8	[0.740.87]	NR [24481103] (imputed)	N
2021-12-15	34791234	Tyrmi JS	2021-11-13	Hum Reprod	www.ncbi.nlm.nih.gov/pubmed/34791234	Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.	Polycystic ovary syndrome (adjusted for age and BMI)	482 European ancestry cases, 91,631 European ancestry controls	2,137 European ancestry cases, 68,690 European ancestry controls	22q12.1	22	28702388	TTC28	CHEK2			ENSG00000183765			rs182075939-A	rs182075939	0	182075939	intron_variant	0	0.0441	5E-14	13.301029995663981		1.74	[1.52.01]	NR [24481103] (imputed)	N
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ovarian cyst	10,847 European ancestry cases, 207,622 European ancestry controls, 2,896 East Asian ancestry cases, 79,865 East Asian ancestry controls	NA	2p25.1	2	11581956		GREB1			ENSG00000196208			rs10200851-T	rs10200851	0	10200851	intron_variant	0	NR	6E-10	9.221848749616356		0.0795	[0.054-0.105] unit decrease	Affymetrix, Illumina [25752875] (imputed)	N
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ovarian cyst	10,847 European ancestry cases, 207,622 European ancestry controls, 2,896 East Asian ancestry cases, 79,865 East Asian ancestry controls	NA	5p15.33	5	1280823		TERT			ENSG00000164362			rs6897196-G	rs6897196	0	6897196	intron_variant	0	NR	6E-9	8.221848749616356		0.0778	[0.052-0.104] unit increase	Affymetrix, Illumina [25752875] (imputed)	N
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ovarian cyst	10,847 European ancestry cases, 207,622 European ancestry controls, 2,896 East Asian ancestry cases, 79,865 East Asian ancestry controls	NA	11p14.1	11	30204809		ARL14EP-DT			ENSG00000254532			rs11031005-C	rs11031005	0	11031005	intron_variant	0	NR	2E-8	7.698970004336019		0.1103	[0.072-0.149] unit decrease	Affymetrix, Illumina [25752875] (imputed)	N
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ovarian cyst	10,847 European ancestry cases, 207,622 European ancestry controls, 2,896 East Asian ancestry cases, 79,865 East Asian ancestry controls	NA	19q13.2	19	39248147		IFNL4			ENSG00000272395			rs12979860-T	rs12979860	0	12979860	intron_variant	0	NR	2E-8	7.698970004336019		0.085	[0.055-0.115] unit decrease	Affymetrix, Illumina [25752875] (imputed)	N
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ovarian cyst	10,847 European ancestry cases, 207,622 European ancestry controls, 2,896 East Asian ancestry cases, 79,865 East Asian ancestry controls	NA	22q12.1	22	28365160		TTC28			ENSG00000100154			rs62237617-T	rs62237617	0	62237617	intron_variant	0	NR	2E-8	7.698970004336019		0.5578	[0.36-0.75] unit increase	Affymetrix, Illumina [25752875] (imputed)	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	9q34.2	9	133279294		ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3270	58434	rs495828-G	rs495828	0	495828	upstream_gene_variant	1	NR	7E-11	10.154901959985743				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	9p22.2	9	16915023		BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-T	rs3814113	0	3814113	upstream_gene_variant	1	NR	2E-43	42.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	10q26.13	10	121586676		FGFR2			ENSG00000066468			rs1219648-A	rs1219648	0	1219648	intron_variant	0	NR	4E-254	253.39794000867204				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	10p12.31	10	21545607		MLLT10			ENSG00000078403			rs7098100-G	rs7098100	0	7098100	intron_variant	0	NR	4E-27	26.397940008672037				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	14q32.11	14	91283251		CCDC88C			ENSG00000015133			rs2277509-C	rs2277509	0	2277509	intron_variant	0	NR	2E-11	10.698970004336019				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	14q32.12	14	92636964		RIN3			ENSG00000100599			rs10498635-C	rs10498635	0	10498635	intron_variant	0	NR	9E-13	12.045757490560675				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	15q26.1	15	90969037		PRC1-AS1, PRC1			ENSG00000258725, ENSG00000198901			rs2290202-G	rs2290202	0	2290202	3_prime_UTR_variant	0	NR	4E-20	19.397940008672037				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	17q11.2	17	30909727		ADAP2			ENSG00000184060			rs35958868-G	rs35958868	0	35958868	intron_variant	0	NR	5E-13	12.301029995663981				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	17q21.31	17	45818287		CRHR1, CRHR1, CRHR1, MAPT-AS1, MAPT-AS1, MAPT-AS1, LINC02210-CRHR1, LINC02210-CRHR1			ENSG00000276191, ENSG00000278232, ENSG00000120088, ENSG00000264589, ENSG00000281578, ENSG00000282067, ENSG00000263715, ENSG00000282456			rs4277389-A	rs4277389	0	4277389	intron_variant	0	NR	1E-23	23.0				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	17q22	17	55117408		STXBP4			ENSG00000166263			rs244353-G	rs244353	0	244353	intron_variant	0	NR	1E-31	31.0				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	19p13.11	19	17292224		ABHD8			ENSG00000127220			rs4808616-C	rs4808616	0	4808616	3_prime_UTR_variant	0	NR	2E-23	22.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	19p13.11	19	19419461		GATAD2A			ENSG00000167491			rs2916074-G	rs2916074	0	2916074	intron_variant	0	NR	2E-11	10.698970004336019				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	2q31.1	2	173348166		RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-G	rs1550623	0	1550623	intron_variant	1	NR	3E-9	8.522878745280337				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	2q33.1	2	201258272		CASP8			ENSG00000064012			rs3769823-A	rs3769823	0	3769823	missense_variant	0	NR	1E-16	16.0				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	21q11.2	21	14981210		NRIP1			ENSG00000180530			rs2822991-T	rs2822991	0	2822991	intron_variant	0	NR	6E-10	9.221848749616356				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	22q12.1	22	28643439		TTC28			ENSG00000100154			rs1474961-C	rs1474961	0	1474961	intron_variant	0	NR	2E-15	14.698970004336019				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	3p13	3	71486187		FOXP1			ENSG00000114861			rs9878602-T	rs9878602	0	9878602	intron_variant	0	NR	4E-8	7.3979400086720375				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	4q34.1	4	174924959		ADAM29			ENSG00000168594			rs6826366-G	rs6826366	0	6826366	intron_variant	0	NR	3E-28	27.522878745280337				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	4p14	4	38785595		TLR10 - TLR1	ENSG00000174123	ENSG00000174125		2605	5082	rs12233670-C	rs12233670	0	12233670	upstream_gene_variant	1	NR	8E-12	11.096910013008056				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	5p15.33	5	1279675		TERT			ENSG00000164362			rs10069690-C	rs10069690	0	10069690	intron_variant	0	NR	5E-23	22.30102999566398				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	6p23	6	13716491		RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		4656	70066	rs381551-G	rs381551	0	381551	upstream_gene_variant	1	NR	2E-12	11.698970004336019				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	6q25.1	6	151706820		ESR1			ENSG00000091831			rs851980-T	rs851980	0	851980	intron_variant	0	NR	9E-20	19.045757490560675				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	7q35	7	144377836		ARHGEF5, ARHGEF5			ENSG00000050327, ENSG00000284933			rs720475-G	rs720475	0	720475	intron_variant	0	NR	9E-11	10.045757490560675				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	8q24.21	8	128192016		PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		4915	28488	rs7017073-T	rs7017073	0	7017073	downstream_gene_variant	1	NR	4E-14	13.397940008672037				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	8q21.13	8	75564502		HNF4G			ENSG00000164749			rs2941478-A	rs2941478	0	2941478	3_prime_UTR_variant	0	NR	5E-8	7.301029995663981				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	9q31.1	9	104094629		SMC2			ENSG00000136824			rs4743687-C	rs4743687	0	4743687	5_prime_UTR_variant	0	NR	5E-9	8.301029995663981				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls	NA	9q31.2	9	108123199		CHCHD4P2 - RPL36AP35	ENSG00000237360	ENSG00000231810		25348	698498	rs630965-C	rs630965	0	630965	intergenic_variant	1	NR	1E-63	63.0				NR [NR]	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	10q23.2	10	86171880	NR	GRID1			ENSG00000182771			rs12243396-T	rs12243396	0	12243396	intron_variant	0	NR	5E-6	5.301029995663981		0.7423	[0.42-1.06] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	1p31.3	1	65863804	NR	PDE4B			ENSG00000184588			rs147138325-T	rs147138325	0	147138325	intron_variant	0	NR	4E-6	5.3979400086720375		0.5471	[0.32-0.78] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA				NR							chr12:55356258-T	chr12:55356258	0			1	NR	6E-6	5.221848749616356		0.4133	[0.23-0.59] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	1q32.1	1	203527110	NR	OPTC - ATP2B4	ENSG00000188770	ENSG00000058668		18161	99677	rs138544011-CA	rs138544011	0	138544011	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.3342	[0.19-0.47] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA				NR							chr12:115323654-A	chr12:115323654	0			1	NR	7E-7	6.154901959985743		0.3793	[0.23-0.53] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	2p12	2	79121070	NR	REG1A			ENSG00000115386			rs2070707-T	rs2070707	0	2070707	intron_variant	0	NR	2E-6	5.698970004336019		0.2518	[0.15-0.36] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	22q12.1	22	27807762	NR	MN1 - PITPNB	ENSG00000169184	ENSG00000180957		6006	43907	rs5752640-A	rs5752640	0	5752640	intergenic_variant	1	NR	2E-6	5.698970004336019		0.1813	[0.11-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	2q14.3	2	124177399	NR	CNTNAP5			ENSG00000155052			rs115676291-A	rs115676291	0	115676291	intron_variant	0	NR	7E-6	5.154901959985743		0.4154	[0.23-0.6] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	2q14.3	2	124314988	NR	CNTNAP5			ENSG00000155052			rs66530326-CT	rs66530326	0	66530326	intron_variant	0	NR	7E-6	5.154901959985743		0.1934	[0.11-0.28] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	3p12.3	3	76808163	NR	ROBO2			ENSG00000185008			rs1082422-A	rs1082422	0	1082422	intron_variant	0	NR	2E-6	5.698970004336019		0.6159	[0.36-0.87] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	3q11.2	3	97419624	NR	EPHA6			ENSG00000080224			rs113526453-T	rs113526453	0	113526453	intron_variant	0	NR	5E-6	5.301029995663981		1.1278	[0.65-1.61] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	3q26.32	3	177846247	NR	LINC02015			ENSG00000231574			rs1369564-T	rs1369564	0	1369564	intron_variant	0	NR	3E-6	5.522878745280337		0.2272	[0.13-0.32] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	4q26	4	113992589	NR	ARSJ - NA	ENSG00000180801			12862		rs142157655-CA	rs142157655	0	142157655	intergenic_variant	1	NR	9E-6	5.045757490560675		1.5034	[0.84-2.17] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	5q13.1	5	67424966	NR							rs146507619-A	rs146507619	0	146507619	intron_variant	1	NR	8E-6	5.096910013008056		0.2101	[0.12-0.3] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	5q13.3	5	76450735	NR	IQGAP2			ENSG00000145703			rs35893266-T	rs35893266	0	35893266	intron_variant	0	NR	2E-6	5.698970004336019		0.2425	[0.14-0.34] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	6p24.2	6	10841524	NR	TMEM14B			ENSG00000137210			rs74760478-A	rs74760478	0	74760478	intron_variant	0	NR	5E-6	5.301029995663981		0.2165	[0.12-0.31] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	7p14.1	7	37228787	NR	ELMO1			ENSG00000155849			rs139827288-T	rs139827288	0	139827288	intron_variant	0	NR	9E-6	5.045757490560675		0.3111	[0.17-0.45] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	9q21.33	9	84923681	NR	NTRK2			ENSG00000148053			rs2017441-A	rs2017441	0	2017441	intron_variant	0	NR	8E-6	5.096910013008056		0.1133	[0.064-0.163] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA				NR							chr10:21621903-CA	chr10:21621903	0			1	NR	1E-6	6.0		0.4261	[0.25-0.6] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA				NR							chr12:9449247-T	chr12:9449247	0			1	NR	8E-6	5.096910013008056		0.1374	[0.077-0.198] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA				NR							chr12:68091702-T	chr12:68091702	0			1	NR	9E-7	6.045757490560675		0.222	[0.13-0.31] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	8q24.13	8	121577705	NR	NA - HAS2		ENSG00000170961			34411	rs72718849-A	rs72718849	0	72718849	intergenic_variant	1	NR	6E-6	5.221848749616356		0.4402	[0.25-0.63] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	14q23.1	14	58210731	NR	ARMH4, ACTR10			ENSG00000139971, ENSG00000131966			rs58244431-A	rs58244431	0	58244431	intron_variant	0	NR	3E-6	5.522878745280337		0.2576	[0.15-0.37] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	9q21.33	9	87620879	NR	DAPK1			ENSG00000196730			rs11141915-A	rs11141915	0	11141915	intron_variant	0	NR	7E-6	5.154901959985743		0.2	[0.11-0.29] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	10p15.1	10	6072330	NR	RPL32P23 - RBM17	ENSG00000214015	ENSG00000134453		412	16704	rs10752194-A	rs10752194	0	10752194	intergenic_variant	1	NR	2E-6	5.698970004336019		0.184	[0.11-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	10p15.1	10	6239119	NR	PFKFB3			ENSG00000170525			rs11257492-A	rs11257492	0	11257492	intron_variant	0	NR	6E-6	5.221848749616356		0.683	[0.39-0.98] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	1p35.3	1	29843122	NR							rs55950243-G	rs55950243	0	55950243	intergenic_variant	1	NR	2E-6	5.698970004336019		0.2197	[0.13-0.31] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	10q26.3	10	133024074	NR	LINC01168 - ADGRA1-AS1	ENSG00000240707	ENSG00000256925		47720	58999	rs35709804-A	rs35709804	0	35709804	intergenic_variant	1	NR	2E-6	5.698970004336019		0.1894	[0.11-0.27] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	1p31.1	1	81655410	NR	ADGRL2			ENSG00000117114			rs58116956-A	rs58116956	0	58116956	intron_variant	0	NR	2E-6	5.698970004336019		0.4545	[0.27-0.64] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA				NR							chr12:101373070-A	chr12:101373070	0			1	NR	2E-6	5.698970004336019		0.1823	[0.11-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	1q32.1	1	204379514	NR	PLEKHA6 - PPP1R15B	ENSG00000143850	ENSG00000158615		1849	23867	rs35568631-A	rs35568631	1	5780234	intron_variant	1	NR	6E-6	5.221848749616356		0.2069	[0.12-0.3] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA				NR							chr12:132041198-T	chr12:132041198	0			1	NR	1E-8	8.0		0.2148	[0.14-0.29] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	2p12	2	80340409	NR	CTNNA2			ENSG00000066032			rs17018999-C	rs17018999	0	17018999	intron_variant	0	NR	3E-7	6.522878745280337		0.6282	[0.39-0.87] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	22q13.31	22	47124913	NR	TBC1D22A			ENSG00000054611			rs735252-T	rs735252	0	735252	intron_variant	0	NR	5E-6	5.301029995663981		0.1816	[0.1-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	Xp21.2	X	31133020	NR	DMD			ENSG00000198947			rs17338346-T	rs17338346	0	17338346	non_coding_transcript_exon_variant	0	NR	1E-5	5.0		1.8884	[1.05-2.72] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	2p24.3	2	15170390	NR	NBAS			ENSG00000151779			rs67654717-T	rs67654717	0	67654717	intron_variant	0	NR	9E-6	5.045757490560675		0.1649	[0.092-0.238] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA				NR							chr3:8504273-T	chr3:8504273	0			1	NR	4E-6	5.3979400086720375		0.163	[0.094-0.232] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	4p14	4	36092509	NR	ARAP2			ENSG00000047365			rs11096798-T	rs11096798	0	11096798	intron_variant	0	NR	9E-6	5.045757490560675		0.5053	[0.28-0.73] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	4p15.31	4	18116414	NR	LCORL - NA	ENSG00000178177			94538		rs2125653-A	rs2125653	0	2125653	intergenic_variant	1	NR	8E-7	6.096910013008056		0.1445	[0.087-0.202] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	5q11.2	5	59531580	NR	PDE4D			ENSG00000113448			rs59152766-T	rs59152766	0	59152766	intron_variant	0	NR	6E-6	5.221848749616356		2.4042	[1.36-3.44] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	5q15	5	97715297	NR	LINC01340 - NA	ENSG00000250331			25117		rs1816300-A	rs1816300	0	1816300	intergenic_variant	1	NR	2E-6	5.698970004336019		0.5632	[0.33-0.8] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	6p22.3	6	21962773	NR	CASC15			ENSG00000272168			rs115721567-T	rs115721567	0	115721567	intron_variant	0	NR	9E-6	5.045757490560675		0.4018	[0.22-0.58] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	7q31.1	7	114572597	NR	FOXP2			ENSG00000128573			rs144087161-T	rs144087161	0	144087161	intron_variant	0	NR	1E-6	6.0		0.6189	[0.37-0.87] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	7q36.3	7	155319558	NR	INSIG1 - BLACE	ENSG00000186480	ENSG00000204960		9323	37427	rs139156430-C	rs139156430	0	139156430	intergenic_variant	1	NR	8E-6	5.096910013008056		0.402	[0.23-0.58] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	8p21.3	8	19794927	NR	CSGALNACT1 - INTS10	ENSG00000147408	ENSG00000104613		36898	22464	rs6985728-A	rs6985728	0	6985728	intergenic_variant	1	NR	1E-6	6.0		0.2111	[0.13-0.3] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	8q22.3	8	101283767	NR	LINC02844 - RNU7-67P	ENSG00000253679	ENSG00000239115		20864	23600	rs681304-A	rs681304	0	681304	intergenic_variant	1	NR	2E-6	5.698970004336019		0.1763	[0.1-0.25] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	14q13.3	14	36881274	NR	SLC25A21			ENSG00000183032			rs78007224-T	rs78007224	0	78007224	intron_variant	0	NR	2E-6	5.698970004336019		0.3126	[0.18-0.44] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals	NA	8q24.3	8	140548315	NR	AGO2			ENSG00000123908			rs35318074-T	rs35318074	1	34521232	intron_variant	0	NR	7E-6	5.154901959985743		0.1871	[0.11-0.27] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA				NR							chr14:102823719-A	chr14:102823719	0			1	NR	5E-6	5.301029995663981		0.2847	[0.16-0.41] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	18q12.2	18	36339642	NR	FHOD3			ENSG00000134775			rs2847516-T	rs2847516	0	2847516	intron_variant	0	NR	7E-6	5.154901959985743		0.1265	[0.071-0.182] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	20q13.13	20	47960104	NR	RNU7-92P - LINC01522	ENSG00000238785	ENSG00000237423		55681	16635	rs6066569-T	rs6066569	0	6066569	regulatory_region_variant	1	NR	9E-6	5.045757490560675		0.1173	[0.066-0.169] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA				NR							chr20:56016512-T	chr20:56016512	0			1	NR	6E-6	5.221848749616356		0.197	[0.11-0.28] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals	NA	22q12.1	22	29117568	NR	KREMEN1			ENSG00000183762			rs35241450-CA	rs35241450	0	35241450	intron_variant	0	NR	8E-6	5.096910013008056		0.123	[0.069-0.177] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	1p36.32	1	3092123	NR	PRDM16			ENSG00000142611			rs2376820-C	rs2376820	0	2376820	intron_variant	0	NR	2E-6	5.698970004336019		0.2344	[0.14-0.33] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	1p31.3	1	65863804	NR	PDE4B			ENSG00000184588			rs147138325-T	rs147138325	0	147138325	intron_variant	0	NR	1E-5	5.0		0.596	[0.33-0.86] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA				NR							chr1:217590388-A	chr1:217590388	0			1	NR	1E-5	5.0		0.5809	[0.32-0.84] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	2p21	2	44805022	NR	CAMKMT - NA	ENSG00000143919			32430		rs138082585-CG	rs138082585	1	112420119	regulatory_region_variant	1	NR	4E-6	5.3979400086720375		0.3585	[0.21-0.51] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	2p21	2	47011089	NR	TTC7A			ENSG00000068724			rs77652838-T	rs77652838	0	77652838	intron_variant	0	NR	4E-6	5.3979400086720375		0.6578	[0.38-0.94] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	2p12	2	80340409	NR	CTNNA2			ENSG00000066032			rs17018999-C	rs17018999	0	17018999	intron_variant	0	NR	6E-6	5.221848749616356		0.6136	[0.35-0.88] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	2q22.1	2	136288123	NR	HNRNPKP2 - UBBP1	ENSG00000227347	ENSG00000230037		87620	41318	rs117774911-A	rs117774911	0	117774911	intergenic_variant	1	NR	2E-6	5.698970004336019		5.193	[3.06-7.33] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	3p12.3	3	76485727	NR	ROBO2			ENSG00000185008			rs74801337-A	rs74801337	0	74801337	intron_variant	0	NR	2E-6	5.698970004336019		0.4268	[0.25-0.6] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	3p11.1	3	89297772	NR	EPHA3			ENSG00000044524			rs143886976-T	rs143886976	0	143886976	intron_variant	0	NR	4E-6	5.3979400086720375		0.8991	[0.52-1.28] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	4q34.1	4	173772135	NR	LINC02269			ENSG00000250708			rs62337885-A	rs62337885	0	62337885	intron_variant	0	NR	7E-6	5.154901959985743		0.2342	[0.13-0.34] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	5q11.2	5	59531580	NR	PDE4D			ENSG00000113448			rs59152766-T	rs59152766	0	59152766	intron_variant	0	NR	9E-6	5.045757490560675		2.4084	[1.35-3.47] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	5q13.3	5	76450735	NR	IQGAP2			ENSG00000145703			rs35893266-T	rs35893266	0	35893266	intron_variant	0	NR	6E-7	6.221848749616356		0.284	[0.17-0.4] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	6q12	6	64953580	NR	EYS			ENSG00000188107			rs7738568-T	rs7738568	0	7738568	intron_variant	0	NR	2E-6	5.698970004336019		0.4707	[0.28-0.66] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	7p15.3	7	23357410	NR	IGF2BP3			ENSG00000136231			rs78503057-A	rs78503057	0	78503057	intron_variant	0	NR	1E-6	6.0		0.6555	[0.39-0.92] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	7q21.3	7	95515509	NR	ASB4			ENSG00000005981			rs111401235-A	rs111401235	0	111401235	intron_variant	0	NR	8E-6	5.096910013008056		0.4668	[0.26-0.67] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	8p21.3	8	19785969	NR	CSGALNACT1 - INTS10	ENSG00000147408	ENSG00000104613		27940	31422	rs7821642-A	rs7821642	0	7821642	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.2311	[0.13-0.33] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	9p23	9	12865681	NR	LURAP1L - Y_RNA	ENSG00000153714	ENSG00000264495		42621	19640	rs142620543-A	rs142620543	0	142620543	intergenic_variant	1	NR	8E-6	5.096910013008056		0.7137	[0.4-1.03] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	9q21.33	9	87620879	NR	DAPK1			ENSG00000196730			rs11141915-A	rs11141915	0	11141915	intron_variant	0	NR	1E-6	6.0		0.239	[0.14-0.34] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	11p13	11	35219865	NR	CD44			ENSG00000026508			rs11323103-A	rs11323103	0	11323103	intron_variant	0	NR	9E-6	5.045757490560675		0.2418	[0.13-0.35] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	9q33.3	9	126858271	NR	ZBTB43 - ZBTB34	ENSG00000169155	ENSG00000177125		20061	2394	rs74865532-C	rs74865532	0	74865532	intergenic_variant	1	NR	3E-6	5.522878745280337		2.0551	[1.2-2.91] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	10p15.1	10	6030464	NR	IL2RA			ENSG00000134460			rs1323657-A	rs1323657	0	1323657	intron_variant	0	NR	2E-6	5.698970004336019		0.2081	[0.12-0.29] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA				NR							chr10:90789461-T	chr10:90789461	0			1	NR	6E-6	5.221848749616356		0.267	[0.15-0.38] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	11p14.3	11	25650836	NR	RPL36AP40 - LINC02699	ENSG00000240298	ENSG00000254456		62041	83921	rs151311539-A	rs151311539	0	151311539	intergenic_variant	1	NR	8E-6	5.096910013008056		0.2171	[0.12-0.31] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	9q22.31	9	92905580	NR	SNX18P2 - ALOX15P2	ENSG00000232843	ENSG00000188101		11075	7576	rs6479436-A	rs6479436	0	6479436	intergenic_variant	1	NR	7E-7	6.154901959985743		0.2135	[0.13-0.3] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA				NR							chr12:115323654-A	chr12:115323654	0			1	NR	3E-6	5.522878745280337		0.4053	[0.24-0.57] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA				NR							chr12:117638331-A	chr12:117638331	0			1	NR	5E-6	5.301029995663981		2.3175	[1.32-3.32] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA				NR							chr12:132058489-T	chr12:132058489	0			1	NR	4E-6	5.3979400086720375		0.1932	[0.11-0.28] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	13q12.12	13	24364286	NR	LINC00566 - CYCSP33	ENSG00000261498	ENSG00000233545		27165	36417	rs376435808-A	rs376435808	0	376435808	regulatory_region_variant	1	NR	1E-6	6.0		0.6085	[0.36-0.86] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	13q13.3	13	35896592	NR	DCLK1			ENSG00000133083			rs11450161-G	rs11450161	0	11450161	intron_variant	0	NR	6E-6	5.221848749616356		0.4323	[0.25-0.62] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	14q22.3	14	57015823	NR	OTX2-AS1			ENSG00000248550			rs4898923-C	rs4898923	0	4898923	intron_variant	0	NR	3E-6	5.522878745280337		0.2575	[0.15-0.37] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	15q26.3	15	100153308	NR	ADAMTS17			ENSG00000140470			rs28538685-T	rs28538685	0	28538685	intron_variant	0	NR	7E-6	5.154901959985743		3.5474	[2-5.09] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	16p13.2	16	9015221	NR	USP7 - C16orf72	ENSG00000187555	ENSG00000182831		39893	76423	rs35925564-A	rs35925564	0	35925564	intergenic_variant	1	NR	7E-6	5.154901959985743		0.3693	[0.21-0.53] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	18q22.1	18	65675931	NR	NA - CDH7		ENSG00000081138			74321	rs148873983-A	rs148873983	0	148873983	intergenic_variant	1	NR	2E-6	5.698970004336019		0.5391	[0.32-0.76] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	21q22.2	21	38573750	NR	ERG			ENSG00000157554			rs140397425-A	rs140397425	0	140397425	intron_variant	0	NR	5E-6	5.301029995663981		1.1596	[0.66-1.66] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	22q12.1	22	25815823	NR	MYO18B			ENSG00000133454			rs116481116-T	rs116481116	0	116481116	intron_variant	0	NR	3E-6	5.522878745280337		1.2571	[0.73-1.78] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals	NA	22q12.1	22	27807762	NR	MN1 - PITPNB	ENSG00000169184	ENSG00000180957		6006	43907	rs5752640-A	rs5752640	0	5752640	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.2011	[0.12-0.29] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	1q22	1	156545504	NR	IQGAP3			ENSG00000183856			rs111440978-CTT	rs111440978	1	34641885	intron_variant	0	NR	8E-6	5.096910013008056		0.1311	[0.074-0.189] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	2p22.2	2	36756075	NR	VIT			ENSG00000205221			rs183171911-A	rs183171911	0	183171911	intron_variant	0	NR	8E-6	5.096910013008056		0.8475	[0.47-1.22] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	2p12	2	80339512	NR	CTNNA2			ENSG00000066032			rs56928399-A	rs56928399	0	56928399	intron_variant	0	NR	2E-6	5.698970004336019		0.4797	[0.28-0.68] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	3p14.3	3	55592887	NR	ERC2			ENSG00000187672			rs1875108-T	rs1875108	0	1875108	intron_variant	0	NR	5E-6	5.301029995663981		0.1342	[0.076-0.192] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	3q26.32	3	177846247	NR	LINC02015			ENSG00000231574			rs1369564-T	rs1369564	0	1369564	intron_variant	0	NR	8E-6	5.096910013008056		0.2428	[0.14-0.35] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	3q29	3	197379538	NR	DLG1-AS1 - NA	ENSG00000227375			75783		rs9841147-A	rs9841147	0	9841147	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.1559	[0.09-0.222] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	4p16.2	4	4870660	NR	MSX1 - LDHAP1	ENSG00000163132	ENSG00000251587		6724	23522	rs116521001-A	rs116521001	0	116521001	regulatory_region_variant	1	NR	2E-6	5.698970004336019		0.366	[0.22-0.52] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	5q15	5	97715297	NR	LINC01340 - NA	ENSG00000250331			25117		rs1816300-A	rs1816300	0	1816300	intergenic_variant	1	NR	1E-6	6.0		0.6306	[0.38-0.89] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	6p12.3	6	48070152	NR	PTCHD4			ENSG00000244694			rs10595258-G	rs10595258	0	10595258	intron_variant	0	NR	2E-6	5.698970004336019		0.1817	[0.11-0.26] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	7p12.3	7	48200991	NR	ABCA13			ENSG00000179869			rs35878068-G	rs35878068	0	35878068	intron_variant	0	NR	9E-6	5.045757490560675		0.134	[0.075-0.193] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	7q31.1	7	108471296	NR	PNPLA8			ENSG00000135241			rs13238345-T	rs13238345	0	13238345	3_prime_UTR_variant	0	NR	6E-6	5.221848749616356		0.3228	[0.18-0.46] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	8q11.23	8	53908184	NR	RGS20			ENSG00000147509			rs111774916-C	rs111774916	0	111774916	intron_variant	0	NR	6E-6	5.221848749616356		0.4504	[0.26-0.65] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	9p24.2	9	4460023	NR	RNU6-694P - SLC1A1	ENSG00000200941	ENSG00000106688		73467	30445	rs74855156-T	rs74855156	0	74855156	intergenic_variant	1	NR	9E-6	5.045757490560675		0.1932	[0.11-0.28] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr10:21536523-A	chr10:21536523	0			1	NR	7E-6	5.154901959985743		0.403	[0.23-0.58] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr10:77083827-T	chr10:77083827	0			1	NR	6E-6	5.221848749616356		0.3469	[0.2-0.5] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr12:106057893-T	chr12:106057893	0			1	NR	6E-6	5.221848749616356		0.3981	[0.23-0.57] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr14:96677435-T	chr14:96677435	0			1	NR	6E-6	5.221848749616356		0.132	[0.075-0.189] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	15q15.1	15	41722121	NR	MGA			ENSG00000174197			rs202172222-CA	rs202172222	0	202172222	intron_variant	0	NR	3E-6	5.522878745280337		0.2031	[0.12-0.29] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr16:10600523-CT	chr16:10600523	0			1	NR	2E-6	5.698970004336019		0.1958	[0.11-0.28] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr16:15927591-A	chr16:15927591	0			1	NR	3E-6	5.522878745280337		0.136	[0.079-0.193] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA				NR							chr17:52101271-A	chr17:52101271	0			1	NR	8E-6	5.096910013008056		0.322	[0.18-0.46] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	20p11.21	20	24332133	NR	RNU1-23P - NA	ENSG00000200231			94735		rs80077319-A	rs80077319	0	80077319	intergenic_variant	1	NR	4E-7	6.3979400086720375		0.3647	[0.22-0.51] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals	NA	22q12.1	22	29117568	NR	KREMEN1			ENSG00000183762			rs35241450-CA	rs35241450	0	35241450	intron_variant	0	NR	7E-6	5.154901959985743		0.1377	[0.078-0.198] unit decrease	Illumina [12770451] (imputed)	N
2022-11-04	34930913	Dai H	2021-12-21	Cell Discov	www.ncbi.nlm.nih.gov/pubmed/34930913	Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women.	Overall survival in ovarian cancer	1,346 Chinese ancestry individuals	784 Chinese ancestry individuals	3p26.1	3	4709568		ITPR1			ENSG00000150995			rs7631664-G	rs7631664	0	7631664	intron_variant	0	0.1521	9E-10	9.045757490560675		1.58	[1.37-1.83]	Illumina [6577217] (imputed)	N
2022-11-04	34930913	Dai H	2021-12-21	Cell Discov	www.ncbi.nlm.nih.gov/pubmed/34930913	Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women.	Overall survival in ovarian cancer	1,346 Chinese ancestry individuals	784 Chinese ancestry individuals	8p23.1	8	8164189		ENPP7P1			ENSG00000249188			rs142897723-GA	rs142897723	1	57874171	intron_variant	0	0.5964	4E-6	5.3979400086720375		0.66	[0.55-0.78]	Illumina [6577217] (imputed)	N
2023-04-03	34648354	Pietzner M	2021-11-12	Science	www.ncbi.nlm.nih.gov/pubmed/34648354	Mapping the proteo-genomic convergence of human diseases.	Ovarian cancer G-protein coupled receptor 1 levels	10,708 European ancestry individuals	NA	1q24.2	1	169537838		F5			ENSG00000198734			rs10800453-A	rs10800453	0	10800453	intron_variant	0	0.27	2E-13	12.698970004336019		0.109	[0.08-0.138] unit decrease	Affymetrix, Illumina [10200000] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	2p25.3	2	630070		LINC01875 - TMEM18	ENSG00000225942	ENSG00000151353		83403	33807	rs66906321-T	rs66906321	0	66906321	intergenic_variant	1	NR	1E-8	8.0	(random effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	2q24.2	2	160772472		RBMS1 - RN7SL423P	ENSG00000153250	ENSG00000244372		278665	105075	rs146071273-A	rs146071273	0	146071273	intergenic_variant	1	NR	8E-9	8.096910013008056	(fixed effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	2q32.1	2	187377642		CALCRL			ENSG00000064989			rs62172372-A	rs62172372	0	62172372	intron_variant	0	NR	1E-8	8.0	(fixed effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	2q37.1	2	232651825		EFHD1			ENSG00000115468			rs34755199-A	rs34755199	0	34755199	intron_variant	0	NR	9E-9	8.045757490560675	(2-sided ASSET)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	6p24.3	6	7231610		RREB1			ENSG00000124782			rs9379084-A	rs9379084	0	9379084	missense_variant	0	NR	9E-9	8.045757490560675	(random effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	15q15.3	15	43896656		FRMD5			ENSG00000171877			rs533143-T	rs533143	0	533143	intron_variant	0	NR	4E-10	9.397940008672037				NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls	NA	18q21.31	18	57650664		ATP8B1			ENSG00000081923			rs8097764-A	rs8097764	0	8097764	intron_variant	0	NR	1E-8	8.0	(random effect)			NR [NR] (imputed)	N
2023-06-23	35870639	Surapaneni A	2022-07-21	Kidney Int	www.ncbi.nlm.nih.gov/pubmed/35870639	Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension.	Ovarian cancer G-protein coupled receptor 1 level in Chronic kidney disease with hypertension and no diabetes (12503_5)	466 African American individuals	NA	17q11.2	17	28367840		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-A	rs704	0	704	missense_variant	0	0.56	1E-12	12.0		0.43	[0.31-0.55] unit increase	Illumina [14870897] (imputed)	N
